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This dissertation describes a series of studies addressing the prevalence, correlates
and longitudinal changes in soft neurological signs (SNS) in schizophrenia. SNS are
found to be increased in schizophrenia. The increase appeared to have both a genetic
and a non-genetic component. It has been proposed that SNS could be considered as
one of the biological markers expressing a mediating risk for schizophrenia. In order
to clarify the role of SNS in this perspective it is important to understand factors that
affect the expression of SNS in a given population. Previous studies have identified
possible relationships between SNS on one hand, and age, ethnicity, intelligence as
well as education levels on the other. Associations with clinical features as well as
cognitive function impairment have also been suggested. Antipsychotic medication
side-effects appear not to be directly related to SNS, nevertheless their impacts
cannot be entirely ruled out. Inconsistencies have also emerged as a result of
sampling and methodological variations. The potential change of SNS with time in
different phases of the disorder is another important issue that has not been
adequately addressed with longitudinal studies. This dissertation describes works that
addressed some of these issues in different samples using the same assessment
methodology. A relatively extensive cross-sectional study addresses the relationship
of SNS with demographic, educational, clinical and cognitive factors. The level of
SNS in a Chinese sample is also compared with that obtained in a Caucasian sample
to investigate effects of ethnicity. Data from the cross-sectional study also allow a
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limited analysis addressing the contributions of age and illness duration across a
wider time range. Two longitudinal studies then focus on specific phases of the
disorder. The first study investigates changes in SNS amongst chronic patients
approaching old age (the fifth decade). The second study addresses changes in SNS
following first episode psychosis.
In the first chapter a broad introduction to methodological issues is presented.
Chapter 2 continues with a more detailed review of the existing data about SNS in
schizophrenia. Chapter 3 presents the core methodology and assessment instruments
used in the studies. In Chapter 4 the recruitment procedures and the characteristics of
the samples are described. Data analysis and results are presented in Chapters 5 to 8.
In Chapter 5 important correlates of SNS are explored using data from a larger cross-
sectional sample of Chinese patients and controls. These include age, gender,
education level, intelligence, as well as symptom correlates of SNS. The potential
effects of ethnicity were further explored by comparison between Chinese and
Caucasian control samples. Additional analyses were carried out to attempt to
address the relative importance of age and illness duration for SNS in patients.
Chapter 6 describes in more detail the relationship between SNS and cognitive
functions in this cross-sectional sample. Chapters 7 and 8 describe two longitudinal
studies. Chapter 7 deals with a 3-year follow-up study for stable chronic patients.
Chapter 8 addresses a 2-year follow-up study of SNS in first episode patients. In
Chapter 9 the dissertation ends with a general discussion of the current findings and
suggestions for key areas for future research.
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This chapter provides a general background to the studies described in the
dissertation. Some wider methodological issues concerning the study of soft
neurological signs in schizophrenia research are discussed. A detailed review of the
existing literature will be presented in Chapter 2.
General background
Schizophrenia is an important psychiatric disorder characterized by disturbance in
perception, thought, language, motivation, and emotional processes. Earlier accounts
were followed by the seminal work ofKraepelin (Kraepelin, 1913, cited in (1))
where "dementia praecox" was described and distinguished from affective disorders
based on clinical characteristics and longitudinal course. This definition of
schizophrenia as a syndrome was in anticipation of the eventual identification of an
underlying neuropathological lesion. This objective still remains elusive today. In the
meantime there has been various attempts to refine the definition and categorization
of the disorder. Bleuler (2) in proposing the description of "the Group of
Schizophrenias" have emphasized that while there may well be heterogeneity in the
disorder, there exist certain "fundamental symptoms" beyond the florid psychotic
symptoms. These core features are believed to be relatively specific and
longitudinally stable in comparison to the psychotic symptoms. Bleuler(2) has
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located the core features at a psychopathological and cognitive level (autism,
ambivalence, association, affective disturbance). Although the definition and
identification of the "core features" in schizophrenia has been difficult, these
attempts have attracted extensive considerations from investigators exploring
aetiological factors in schizophrenia. These efforts reflect the expectation that
features could be identified that may act as mediators between distal etiological
factors and the ultimate expression of the diagnosable clinical disorder. Subsequently
various emphases have been put on features such as cognitive dysfunction, thought
and language deviations, schizotypal features, etc.
Although the detailed mechanisms underlying "core features" are currently unknown,
there is considerable evidence that both genetic and non-genetic factors are
significantly involved. Kraepelin himself speculated that progressive and destructive
processes maybe present(l). Against this background, current researches have placed
much emphasis on the role of neurodevelopmental processes (3). Till now relatively
few environmental causes are known, viral infection during fetal development (4-8),
and peri-natal delivery complications (9), are amongst the few identified factors but
their contributions are modest. The natures of genetic factors involved are also
unknown, though there is some optimism that more understanding will emerge
alongside technical advances in genetics research. The mode of inheritance probably
involves a large number of genes each of a small effect (10; 11). One implication of
this mode of inheritance is that below the threshold for clinical manifestation,
detectable features may be expressed (for instance, as personality traits, social
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dysfunction, or neurocognitive underperformance).
The concept of such "target features" has been reviewed, amongst others, by Tsuang
(12). "Target features" encompasses the idea that genetic and non-genetic processes
lead to maldevelopment in neurocognitive systems. These abnormalities then interact
with brain maturational processes and environmental factors in determining the onset
of psychosis. It is also acknowledged that neurodegenerative processes may also be
involved after the onset of illness. In recognition of the possible aetiological
heterogeneity of schizophrenia, it is expected that target features are multiple and
heterogeneous. According to this account target features should be present in at-risk
individuals from childhood; it may be modified during development and particularly
at the time around illness onset. Putative subsequent degenerative processes might
also modify these particular target features. Target features should be increased in
relatives of patients but perhaps not to a similar extent. In addition, the manifestation
ofmultiple genes of small effect would lead to an expectation that target features
should be present (but not to the same extent) in the general population.
Many candidate target features have been suggested for schizophrenia. Apart from
soft neurological signs, other features include measures of attention (13),




In the past decades, soft neurological signs (SNS) have been described and studied in
schizophrenia and a number of other psychiatric disorders. This dissertation
describes a series ofwork targeting the characterization of SNS in schizophrenia. In
particular, the focus will be on the study of change in SNS over time, as well as
various correlates of SNS in clinical, demographic and neuropsychological domains.
Historical notes
Some of the earlier applications of soft neurological signs were associated with the
observation that a number of signs appeared to be present early in the course of
normal childhood development, before they disappear by adulthood (18), some of
these signs re-emerge later under pathological conditions. They have often been
considered under the concept of a "release phenomena". In explaining these release
phenomena it has been postulated that brain functions are organized in a hierarchical
system, in which ontologically earlier functions are more at the "core" and less
susceptible to disintegration caused by later illness. During the course of
development, these earlier manifestations are subsequently inhibited by the
emergence of later functions. In pathological situations the later functions are more
vulnerable to disintegration. When they are disabled by illness, their "inhibiting"
effects on the earlier functions are nullified, leading to the re-emergence of an earlier
function. Explanations such as these have often been employed to account for the
appearance of primitive reflexes in patients with frontal lobe lesions. In considering
-21 -
soft neurological signs it is necessary to supplement this view with a developmental
perspective that some of the earlier signs remain expressed because the later
functions fail to develop fully due to a developmental anomaly. In this context, early
investigators of childhood development have been interested in the expression of
SNS in various childhood clinical conditions.
Since SNS expression involves mutual modulation of normal functions, variation in
individual expression is expected. In general the difference in SNS between a healthy
population and a clinical population lies more in quantity than in quality. This is in
notable contrast to some other categories of neurological signs (e.g. dyskinesia,
which are primarily present only in pathological conditions). As such it is important
to note that SNS are very much quantitative variables to be measured, rather than
merely observed to be present. The fact that SNS are present in the normal
population discourages expectations that SNS could be highly specific in relation to
clinical diagnosis.
Nature and boundaries ofsoft neurological signs
Signs in clinical medicine
Conventionally, "signs" and "symptoms" constitute the basic clinical manifestations
of a disorder. Whereas symptoms are reported by patients, signs refer to observations
that could be evaluated "objectively" by the clinician. In clinical medicine, "signs"
ranges from simple passive measurement (such as a skin mass) to observations of
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responses that are made using a standard testing procedure (such as blood pressure,
or tendon reflex). In contrast to symptoms it is assumed that expressions of signs are
usually not under voluntary control of either the subject or the observer.
Unique features of central nervous system (CNS) signs
Disorders of the central nervous system produce signs of a more complex nature. In
CNS disorders elicitation of signs often requires the subject to carry out behavioural
responses. While some CNS signs, particularly those of the primary motor and
sensory systems are less open to voluntary control; many other signs of higher CNS
function involves cognitive processes that are more difficult to shield from
motivational or voluntary factors.
In addition, the nature of higher CNS signs is likely to be more "integrative" (i.e.
involving coordination of a number of lower level units each of which is functionally
independent). An example (non-soft sign) is "apraxia", the sign is only considered
valid when the basic motor system is intact and yet the subject failed to carry out
more complex motor sequences. It is expected that such higher level signs are more
affected by various cognitive and motivational processes and merge with more
systematic neuropsychological test paradigms. It is important to note that as the
assessment of SNS are more open to cognitive and motivational factors, it raised the
possibility that illness processes may indirectly affect the assessment of soft
neurological signs through these variables. Despite this concern, it is noteworthy that
reliable assessment of SNS has been achieved with patients with psychotic disorders
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(see below).
Soft neurological signs and extrapyramidal signs
Among CNS signs, a further group merits particular consideration in relation to their
significance in psychotic disorders. This group of signs is also present in conditions
affecting the basal ganglia system (e.g. Parkinson's disease, Huntingdon's chorea,
Wilson's disease). They are commonly considered under extrapyramidal signs
(rigidity, tremor, bradykinesia, dyskinesia, dystonia and akasthisia) (19). It is
recognized that they are often accompanied by cognitive and subjective symptoms
(20). Previously it was assumed that they were largely consequences of antipsychotic
medication. Recent studies in medication-naive patients have however shown that
extrapyramidal signs were present in patients never treated with medication, and that
the extent of their presence may be similar to patients treated with medication (21-
26). These studies suggested that spontaneous extrapyramidal signs might be an
expression of the core illness process. In this context, imaging studies have also
suggested that patients with extrapyramidal signs might have increased ventricular
sizes (25;27). As extrapyramidal signs are conventionally conceptualized as being
distinct from SNS and are usually studied separately from SNS they will not be the
focus of the current dissertation.
Soft neurological signs and neuropsychological paradigms
The boundary between neuropsychological tests and soft neurological signs also
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requires consideration. Traditionally these are two independent approaches
originating from different disciplines and theoretical positions. Soft neurological
signs evolved within the medical tradition of identifying "signs" accompanying
disorders, and as such, carry with them a "bedside" characteristic (that the tests are
relatively simple, portable, brief, and can be carried out with minimal additional
tools). These characteristics have influenced the development of SNS.
In contrast the neuropsychological approach aims at designing sensitive and specific
test paradigms to capture brain system dysfunction in an objective manner (28). The
ultimate aim is to relate test performance to macroscopic brain structure abnormality.
Neuropsychological assessments involve more use of instrumentation (whether
digital or not), and make more extensive use of specially designed stimulus sets.
These two approaches run in parallel in many study of psychiatric disorders. With the
development of standardized assessment procedures, soft signs assessments have
evolved to be more akin to neuropsychological testing. While there have been a few
comparison studies, relationship between SNS and neuropsychology has not been
extensively addressed. Past studies have at times incorporated items of
neuropsychological nature into SNS batteries. At other times, neuropsychological
performance was compared with SNS to identify correlation patterns. In either case,
it is important that studies address the degree of overlap and non-overlap between
these two domains. Areas ofnon-overlap may indicate involvement of different
neural systems. Knowledge of areas of overlap is also practically useful as signs are
-25 -
far more economically assessed than neuropsychological tests. Thus if a sign and a
neuropsychological test carry comparable information value, it is probably more
cost-effective to measure the former rather than the latter.
Measurement issues
Standardization ofmeasurement
Soft neurological signs are numerous; many of the signs were originally described in
less accessible sources (Appendix 4). As they do not constitute part of an obligatory
clinical examination (because the significance of their presence is less distinct), they
do not have the advantage of propagation through standard textbooks on clinical
examination. Furthermore the inclusion of items within soft signs scales originated
from different research efforts with considerable dispersion in time and space.
Intense deliberations over their theoretical constructs and empirical findings have
been relatively limited. Finally it is important to recognize that compared to
conventional neurological signs, SNS are more open to a variety of cognitive factors.
Therefore the exact manner of elicitation (for instance, the exact instruction given)
could conceivably have an effect on the performance. In this context,
operationalization of soft neurological signs has been gaining increasing acceptance
among research groups. Substantial progress has been made since the early
compilations of partially overlapping instruments from different groups (which
contained relatively little detailed description of the elicitation and scoring for
individual items). Operationalization of the method used for the elicitation and
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recording of individual signs (29-31) has helped to reduce procedural variations.
Reliability and Validity issues
In general, standardization of an assessment procedure enhances the reliability of the
measurement as it reduces observer and other sources of variance. However in the
assessment of complex phenomena, there may be an inherent limit to what can be
defined explicitly. A trained human observer makes subtle (implicit) adjustments to
the assessment in such a way that the phenomena under observation can be
highlighted. These subtle adjustments often cannot be explicitly operationalized. This
freedom is restricted with the use of standardized instruments. Such problems with
structured assessment are expected to have particular impact in the assessment of
"frontal lobe" phenomena, as it is recognized that some features of the latter are best
manifested in a low-structure, spontaneous setting. An example is that patients with
strong tendencies towards imitation and utilization behaviour in a spontaneous
setting nevertheless may not exhibit the corresponding signs in a structured
assessment procedure (my clinical observation). Thus standardized assessment in this
case would lead to a false negative finding. It is relevant that in a large number of
psychiatric conditions, the putative site for psychopathology involves functions of
the frontal lobes. The cost of standardization in the assessment of neurological signs
in psychiatric condition is an issue that needs to be addressed in future studies.
Nevertheless, for the works addressed in this dissertation, the advantages of using
standardized assessment appear to out-weight their limitations.
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Dimensionality ofmeasurement
Many data analysis procedures require the phenomena under investigation to be
graded along a dimension. A common consequence of quantification is the
compression of complex phenomena consisting of a number of dimensions into a
single linear dimension. For instance, a symptom which comprises a number of
partially independent dimensions (e.g. hallucination has the dimension of frequency,
intensity, vividness etc) is nevertheless coded by a single severity score in many
symptom-rating scales. Algorithms for reducing the complex phenomena into a
single dimensional score need to be clearly specified in order to resolve conflicts
between different dimensions. Modern SNS rating scales only partially address this
issue (see below).
Quantification of SNS
Quantification of SNS would require that it is meaningful to describe a sign as
having an ordered grading in severity. That is, there are instances ofmanifestation
that could be said to be "more serious" than others. To consider an example, in
"finger thumb tapping" the subject makes regular tapping movement using the thumb
against the index finger. When the sign is "mild", movement is on the whole smooth,
apart from the occasional error. When the sign is "severe", there is almost a complete
breakdown ofmovement. It is usually not problematic to make comparison between
these two extremes. The difficulty however becomes more apparent if the
manifestation falls in the intermediate spectrum between these two poles. For
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instance, the subject could follow the movement but only at the expense of an overall
slowing. If asked to speed up the subject might make inaccurate taps where the
thumb and index fingers misses each other. To complicate the matter, there is more
than one way ofbeing inaccurate. One could miss the contact (spatial inaccuracy), or
one could miss the rhythm (temporal inaccuracy). Depending on the strategy used by
the subject, there may be a tradeoff between these two dimensions. It would be
difficult to assert a priori that spatial inaccuracy is more severe than temporal
inaccuracy, or vice versa. Currently not enough is known to render it practicable to
devise a conversion factor between the two performance dimensions. Future studies
that examine each signs individually may address some of these issues. In any case,
one solution is to use a rating scale with a small number ofpossible scores, so that all
intermediate situations are described by one score, thus avoiding the necessity to
make comparisons between them. One alternative approach is to elicit the sign in
such a way that performance along one dimension is fixed, for instance, the rate of
tapping can be paced so that the subject is instructed to keep to the pace regardless of
whether the fingers make contact with one another. Such afford is only partially
successful and examples are to be found in certain standardized instructions given to
subjects.
Subgrouping of SNS
The issue of whether signs belong to natural groups is a difficult question to address.
The usefulness of categorization depends on the level of details considered. At higher
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resolution, each sign can be regarded as a category on its own. At lower resolution all
soft signs could be summarized under one single category. Between these two
extremes there are a number ofways to classify soft signs. It is important to realize
that the bases for these classifications are usually a priori, and come largely from
theoretical considerations. (The common basis on which subgrouping are made are
discussed in Chapter 2)
When signs are grouped together into subgroups it is pertinent to consider how the
item scores should be treated to yield a subgroup score. One important issue is
whether one treats the number of positive signs and the severity of each sign as
convertible (i.e. whether the presence of a single sign scored "two" can be
considered as equivalent to the presence of two separate signs, each scoring "one").
In addressing this problem, there is currently not much empirical guidance. One way
to avoid the above reduction of information is to use the number of positive signs
(regardless of the severity) as a measure in constructing the subscale scores. This is
the approach adopted in this dissertation.
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2 Soft Neurological signs in schizophrenia: a review
In this chapter, key findings involving soft neurological signs in schizophrenia are
reviewed and discussed.
The review starts with a consideration of the evolution of SNS research from the
early studies to the more recent research studies, with notes on how the definition,
categorization and application have changed. Major empirical findings are then
reviewed. The prevalence and specificity of SNS in relation to schizophrenia is first
considered. This is followed by data on SNS in relation to at-risk groups and a
discussion of the demographic and clinical correlates of SNS. Finally the review ends
with a consideration of data on the relationship between SNS and cognitive function.
Concepts and overview
Early studies of SNS in childhood
Systematic studies addressing soft neurological signs in schizophrenia appeared in
the 1960's. SNS has initially been more widely applied to the study of childhood
disorders. In one of the earliest accounts, Bender described the presence of
"characteristic disturbances in patterned motor behaviour" and "primitive reflex
patterned activities that outlived the stage to which they belong" in a study of
"childhood schizophrenia"(32). Though the nosological status of "childhood
schizophrenia" was subsequently challenged, soft signs were considered relevant to
the studies of learning difficulties as well as the then evolving concepts of "minimal
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brain dysfunction" and "hyperactivity".
Adams et al (33) reviewed studies of soft neurological signs in relation to children
with learning disability. They pointed out that up to that time many studies of SNS
have been conducted non-systematically but the studies are poorly controlled and
there is a lack of normative data. At the time, soft neurological signs were broadly
defined by some authors as "those neurological variations that are equivocal or
intermittent". Amongst these studies, Denhoff (34) suggested a positive relationship
between diadochokinetic signs and school performance. Importantly, Grant (35)
pointed out diadochokinetic ability did not fully develop until 9 to 10 years. Rutter
(36) also noted the association between choreiform movements, hyperkinesis, and
learning problems. Association of finger agnosia (a skill which matures in late
childhood) and dyscalculia in the context of developmental disorder has also been
well described.
Adams (33) studied 368 10-year old normal children and children with learning
disability in relation to the following set of neurological signs (eye-hand preference,
balance, stereognosis, graphesthesia, choreoathetosis, finger localization (agnosisa)
and diadochokinesia). They concluded that amongst these signs diadochokinesia and
graphesthesia were most discriminating between normal and learning disabled
children. However, the magnitude of the difference was modest and the groups
cannot be readily discriminated solely on the basis of SNS. Landman (37) studied
SNS in children and noted that SNS are associated with impaired school performance.
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However they also pointed out that SNS are also present in normal functioning
students. Study in preschool children revealed no relationship between the presence
of SNS and cognitive dysfunction, linguistic abilities, memory or thinking. However
since some of the SNS are not fully developed till late childhood, their application to
the preschool age group might have compromised the findings.
Shaffer (38) compared adolescents at the mean age of 17 between those known to
have had exhibited SNS at age 7 and those that did not have SNS at age 7, and found
that the former group had lower IQ and more depressive symptoms, withdrawal, and
anxiety at age 17. There was no relationship with attention deficit or conduct
disorders. Most of the variance was accounted for by SNS independently of IQ. This
study focused on psychopathology other than schizophrenia as the age of the study
group did not extent to the peak onset age for schizophrenia. SNS as an expression of
risk for schizophrenia will be discussed in sections below.
Early application of SNS to schizophrenia
Amongst early accounts of SNS in schizophrenia, Meehl (39) suggested the
consideration of soft signs as indicators of "neurointegrative deficit". Fish (1963,
cited in Erlenmeyer-Kimling (40)) viewed soft signs as a measure that reflects
developmental dysregulation in high-risk individuals who subsequently developed
schizophrenia spectrum disorders. Rochford (41) also suggested that SNS should be
viewed as indictors of non-specific diffuse CNS dysfunction "denoting deviations in
neurological organization reflected in impaired cognitive functions, decreased ability
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to control attention, impulse and motor functions in varying combinations".
In a similar vein, Quitkin (42) employed soft neurological signs as indicators of
"Central Nervous System damage" in a study that attempted to demonstrate that
schizophrenia associated with poor pre-morbid adjustments has an "organic" basis.
Using SNS as a maker, the study revealed that schizophrenic patients with poor pre¬
morbid adjustment had increased SNS, in contrast to patients with other forms of
schizophrenia. It is thus apparent from the early stages of SNS research in
schizophrenia that SNS was conceived as (1) an "integrative" (rather than primary
sensory or motor) deficit, and (2) an indication of organic CNS dysfunction.
Shaffer (43) reviewed the then available literature and distinguished between two
groups of signs: those that are non-localizing but can be elicited reliably, and those
that cannot be reliably detected (e.g. reflex or tone asymmetries). Since this pivotal
distinction was made, the study of SNS has largely been able to focus on the first
group. The emphasis on reliability has enabled SNS to evolve as a robust and
legitimate "target feature" in further studies. It has also paved the way for subsequent
refinement by the use of operational criteria.
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Theoretical issues in SNS
SNS as frontal dysfunction
In the context of investigating neuropsychological impairments associated with
frontal lobe dysfunction, Luria (44) described a set of neurological signs (fist-edge-
palm, Ozeresky sign etc.) which had subsequently been included in many soft
neurological signs batteries. In some batteries these signs are grouped together as a
distinct subscale (e.g. complex motor sequencing in NES). The study of Cox (45)
exemplifies a common approach at the time. While acknowledging the non-
localizing nature of SNS, soft signs were nevertheless grouped according to putative
primary brain systems involved. "Frontal" signs included the grasp reflex,
palmomental reflex, "conceptualization" (L/R hand signaling in response to upper
and lower stimulus), visual perseveration of spoken commands, tendency to mirror
movement after examiner demonstrate movement, left-right disorientation, and
word-list learning. "Parietal" signs included complex motor acts (tying shoelaces),
imaginary acts, oral "apraxia", tactile discrimination, extinction, two-object test, and
stereoagnosia. "Temporal" signs included memory, nystagmus, face drawing,
recognition ofmissing parts, and rhythm tapping. "Occipital" signs comprised visual
field deficits and optic agnosia. The inclusion of frontal signs was different from
those selected by other researchers (e.g. complex motor sequencing in Heinrich and
Buchanan (46)). Some of the tests involved are more often considered as cognitive
function proper (e.g. memory, drawing, conceptualization). The potential blurring of
boundary between SNS and cognitive function was highlighted in this study and this
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theme has persistent up to some of the more recent studies. Some issues concerning
the boundary between SNS and neuropsychological function have already been
discussed in Chapter 1.
SNS as motor dysfunction
Manschreck (47) discussed a wide range of voluntary motor disturbance in
schizophrenia. They broadly categorized motor disturbance into those that are
spontaneous and those that are elicited. Motor soft signs are included in the "elicited"
subgroup. In addition they also included some sensory integration soft signs
(agraphesthesia and astereognosis). Manschreck's approach highlighted a broadening
of perspective in viewing SNS in the context of a wider range ofmovement disorders.
This is an approach that has subsequently been taken up by several investigators but
would deserve more systematic exploration.
SNS as indicator of complex neural system dysfunction
In Woods (48) the meanings of hard and soft signs were contrasted. Hard signs are
proposed to reflect localized damage whereas soft signs are considered as reflecting
functional dysconnection between cortical and subcortical systems (30;49;50). A
further hypothesis relates signs to presumed aetiological factors, neurological signs
are categorized into "focal" or "integrative" signs (51). "Focal" signs are postulated
to be prevalent in sporadic cases whereas "integrative" signs are expected more in
cases with family history and in their first-degree relatives.
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SNS as target features
As mentioned, the general role of SNS in schizophrenia research can be summarized
as in Tsuang's model of "target features" (12). SNS was conceptualized as one of the
features that potentially have relevance in addressing etiological factors. The concept
of target features was elaborated as "clinical or neurobiological characteristics that
are expressions of the underlying predisposition to the illness'. The model considers
illness as resulting from multiple genetic and environmental variables that may be
additive or interactive. These variables act upon three stages: neurodevelopment,
later adolescence (around onset), and after onset of psychosis. This model
accommodates etiological heterogeneity by postulating that if a relatively small
number of variables out of a large possible pool are sufficient for expression of the
illness, then a wider range of different permutations of underlying variables could be
associated with illness manifestation.
Subgrouping of SNS
Different research groups have attempted a number of subgrouping schemes for SNS.
Some of these were based on the nature of the signs, some were based on putative
brain systems involved, and some were based on statistical clustering of signs.
Heinrich and Buchanan (46) in reviewing a larger number of earlier studies have
arrived at a more widely adopted subgrouping of soft signs. They grouped together
signs such as extinction, astereognosis in the area of "integrative sensory function".
These are "integrative" function in the sense that their impairments are demonstrated
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against a background of intact primary sensory functions. Motor coordination
consisted of signs such as finger thumb opposition, dysdiadochokineses and mirror
movements. Once again, they are present despite the intact functioning ofmuscle
strength and reflexes. A further group, sequencing of complex motor acts, have been
proposed. These signs included the fist-edge-palm, the fist-ring test and the Ozeretski
test (adopted from Luria (44)). All of these assessed the subject's ability to perform
regular repetitive alternations in hand positions.
The boundary of items between complex motor acts and motor coordination has not
yet been thoroughly considered. More detailed comparison would suggest that,
similar to the complex sequencing subgroup, a number of signs in the motor
coordination subgroup also involve repetitive alternation in hand positions (finger
thumb opposition, dysdiadochokineses). The difference between these and Luria's
signs appears to be a matter of quantity (the number of elements in a repeat sequence)
rather than quality. On the other hand, signs such as primitive reflexes and mirror
movements did not involve movement sequences and might have different
significance.
In the Cambridge Neurological Inventory (29), this subgrouping was further refined,
motor coordination included all signs that involve repetitive sequencing. Sensory
integration remained unchanged. A new category, "disinhibition signs", included
those signs that involved manifestation of spurious movements in a time and place
where they were not expected.
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Factor analysis of SNS rating scales
One approach to studying the structure of neurological signs is to conduct factor
analysis based on empirical data using structured examination scales. Several authors
have attempted factor analysis of items on SNS rating scales.
Schroder (52) has performed factor analysis on a SNS scale and found that Luria-
type frontal signs (FS) loaded in motor coordination and complex motor acts and are
partly independent of other neurological signs which contributed to 4 other factors.
Malla (53) also attempted factor analysis ofNES data from 100 schizophrenic
patients. The result yielded 5 factors, which the authors identified as sensory
integration, motor integration, motor coordination, sequencing planning, and
extrapyramidal signs. Disappointingly, the correspondence to conceptual item
classification was only modest. Finally, Krebs (54) constructed a new SNS scale in
which factor analysis yielded 5 different factors, namely, motor coordination, motor
integrative function, sensory integrative function, involuntary movement or posture,
as well as quality of lateralization.
There are a number of difficulties associated with attempts to factor analyze items in
SNS scales. Firstly for most individual items, the prevalence ofpositive score is
usually relatively low (below 10 or 20 percent). This results in a significant skewing
of data towards zero and renders the item less suitable for inclusion in factor analysis
(which ideally requires for continuous variables with a normal distribution). The
quantification of severity for an individual item is also problematic as often the rating
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is given for a dichotomous (present, absent) or 3-category (absent, present, severe)
classification. The large number of items usually included in SNS scales also
necessitates a large sample size for proper factor analysis, i.e. a ratio of variables to
subjects of 1:10 (55). This has seldom been achieved (for instance the ideal sample
size for factor analysis of a scale consisting of 50 items would be around 500).
SNS in schizophrenia
Prevalence
Heinrichs and Buchanan (46), in reviewing 25 years of research on SNS, noted that
without exception SNS are increased in schizophrenia. They emphasized that despite
their non-localizing nature, SNS are reliably elicited by standard procedures. They
highlighted that despite different diagnostic criteria being used in these studies,
findings across the time periods yielded largely similar results i.e. that SNS are
increased in schizophrenia.
Specificity
Apart from being increased in schizophrenia, soft neurological signs are present in
the normal population and in other psychiatric conditions. Their presence in other
psychiatric disorders may shed light on common etiological features shared by the
disorders. The main questions are firstly, whether SNS are also increased in other
psychiatric disorders such as affective disorder, anxiety disorder and personality
disorders, and secondly, whether the increase is to a similar extent as in
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schizophrenia. Currently most of the available data address SNS in affective disorder.
SNS in affective disorder and schizophrenia
Studies which could address the specificity of SNS to schizophrenia relative to
affective disorders up to 1986 was reviewed by Heinrich and Buchanan (46). In the
majority of the studies, SNS were found to be significantly increased in
schizophrenia relative to affective disorder (41;45;47;56-61)
In the study ofRochford (41) SNS in patients with schizophrenia (n=26) were
compared with patients with personality disorders and neurosis (n=27), neurotic
depression (n=9) and psychotic depression (n=3), items included those used by
Hertzig and Birch (62;63) (cranial nerves, stereognosis, graphesthesia, reflexes,
coordination, sensation, movement disorders, speech, activity, developmental
abnormalities, extinction, motor impersistence, auditory-visual integration, and
adventitious motor overflow). They found that schizophrenia patients have more
SNS compared with the other groups. However affective disorder patients did not
have more SNS compared with controls. Interestingly the personality
disorder/neurosis group was found to have increased SNS similar to the
schizophrenia group
Cox (45) compared SNS in schizophrenia, alcohol dependence syndrome, unipolar
disorder, bipolar disorder, mixed personality disorder, anxiety disorders and healthy
controls. They grouped SNS according to the putative cortical areas of involvement
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into frontal, parietal, temporal and occipital subsets. Schizophrenic patients were
significantly more impaired compared to all other diagnostic groups in relation to
frontal signs. For parietal signs, unipolar depressive patients were as impaired as
schizophrenia patients, both groups being more impaired than other groups. The
authors concluded that the specific increase in frontal signs and the relatively specific
increase in parietal signs in schizophrenia may be related to attention impairment in
schizophrenia. The authors also highlighted the lack of difference between most
other diagnostic groups and controls although this conclusion is weakened by the
relatively modest sample sizes (n=10-20). This study was also characterized by the
inclusion of a number of cognitive assessments (particularly in the frontal and
temporal subscales). Some of these were not often included in other SNS definitions.
Walker (60) compared "neuromotor" functions (stereognosis, mirror movements, L/R
orientation, oculomotor function, muscle tone, movement regularity) between
patients with schizophrenia, schizoaffective disorder and affective disorder (15 in
each group). She also found that greater abnormality was found in the schizophrenia
group (differences reached significance for stereognosis, Left Right orientation, and
oculomotor functions).
Nasrallah (64) studied 44 schizophrenia patients, 28 mania patients , and 29 controls.
He found that SNS in manic and schizophrenic patients were both increased relative
to controls. SNS level in mania was not significantly different from schizophrenic
patients. Gureje (65) reported that in Nigerian patients, most signs were found in
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similar levels between schizophrenic and affective disorder patients. When compared
with controls, only left-right disorientation distinguishes schizophrenic patients from
controls. The findings in this study are different from most other studies in that high
prevalence of SNS were also present in the control group. This raised the potential
question of ethnic variation in SNS. The author also pondered the possibility that
there might be an association with obstetric complications. Krebs (54) also found that
SNS score was higher in schizophrenia than in affective disorder patients (48;66). In
a further review of the specificity of neurological signs in schizophrenia, Boks (67)
reviewed 17 studies and evaluated the weighted mean prevalence of 30 neurological
signs. The authors concluded that most signs were equally present in mood disorder
and in schizophrenia. However, several signs were more prevalent in affective
disorder (stereoagnosia and rhythm tapping). Other signs are more prevalent in
schizophrenia compared with mood disorder (extinction, dysdiadochokinesis, tandem,
finger thumb opposition, articulation) and thus appear more specific for
schizophrenia, the specificity of "motor sequencing" signs are unclear.
Comparison studies are needed to assess different diagnostic populations with the
same methodology. In addition the stage of illness when the patient is under
investigation may also affect the result. For instance it is possible that in addition to
being a trait marker, SNS may also increase during an episode of psychosis or mood
disturbance. It is important that comparison be carried out in comparable stages,
preferably in remission from episodic disturbance.
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Currently, it is still unclear whether there is an increase in overall SNS in
schizophrenia relative to affective disorder. The meta-analysis results of Bok (67)
suggested an interesting possibility that certain SNS may be specifically increased in
schizophrenia while some others are more specific for affective disorder. Few studies
have directly addressed this issue on an item-to-item basis. This is an important area
requiring further study. In addition to the possible inherent heterogeneity amongst
SNS, some of the variation may be related to the boundaries ofmood disorders, as
there is considerable heterogeneity within mood disorder itself.
SNS in schizophrenia and other psychiatric disorders
In the reviewed by Heinrich and Buchanan (46), SNS was found to be higher in
schizophrenia compared with patients with personality disorder, neurosis and
substance abuse in a number of studies (41;45;56;58;62;63;68;69). In addition,
Almeida (70) found that SNS (finger-thumb opposition, dysdiadochokinesia, fist
edge palm, foot taps, agraphesthesia) was increased in late paraphrenia compared
with controls. Patients with SNS also had more cognitive impairment and negative
symptoms (71).
Predictive specificity
There is little available data directly addressing the predictive specificity of SNS for
schizophrenia. The presence of SNS in high-risk subjects will be discussed in a
following section. In terms of specific predictive value of childhood SNS, Shaffer
(38) compared adolescents known to have SNS at age 7 and those that did not have
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SNS at that age, and found that the former group had lower IQ and more depression,
withdrawal, and anxiety. There was no relationship with attention deficit or conduct
disorders. Importantly most of the variance was accounted for by SNS independently
of IQ. This study has sometimes been interpreted as indicating a relationship between
soft signs and future affective disorder rather than schizophrenia. It is important to
note that the identified conditions of depression, withdrawal and anxiety are more
prevalent than schizophrenia in the age range studied. In addition the follow-up age
of 17 years was largely before the peak onset age for schizophrenia. Since some of
these symptoms are known to be present in prodromal stages of schizophrenia, the




Amongst MZ twins discordant for schizophrenia, SNS was found in both twins, but
were more pronounced in the affected twin compared with the well twin (72-74). The
level of SNS in the well co-twin lies in between the ill co-twin and the normal
population (75). Taken together the evidence suggests that both genetic and
environmental factors are important in determining the level of SNS.
Cantor-Craae (73) further found that the extent of SNS in the well discordant co-twin
was related to a history of neonatal complication, while a history of substance abuse
and postnatal cerebral trauma were not related to SNS level. The authors concluded
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that peri-natal complication might contribute towards SNS manifestation.
Family studies
Several reports have found that first degree relatives of schizophrenic patients have
more neurological abnormality including SNS (46;50;76).
Rossi et al (50) using a 26-item SNS battery based on Quitkins (42), studied 58
DSM-III schizophrenic patients, 31 first degree relatives and 38 normal control
(mean age 34.8 education level 8 years). They found that SNS prevalence amongst
first degree relative was similar to schizophrenic patients, while both groups had
increased SNS compared with normal control. Likewise Chen et al (77), in a sibling
study involving 15 patient and their siblings using the CNI, found that there was a
differential pattern in subgroups of signs. Disinhibition signs were similar between
sibling and patients groups. Motor coordination signs of sibling were at a level
between patients and control. Sensory integration signs were similar between sibling
and control subjects. This finding suggests possible heterogeneity amongst SNS in
the extent of genetic contributions.
High-risk studies
In line with family studies, increased SNS have been found in studies ofhigh-risk
groups (40;78;79). Lawrie (80) in the Edinburgh high-risk study found that SNS was
more frequent in 152 medication-free high-risk subjects whether with or without
psychotic symptoms. There are as yet few studies on general populations with
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measures of "psychosis proneness" or schizotypal personality traits. Obiols et al (81)
studied adolescence with poor CPT performance in (motor coordination, motor
overflow, sensory signs, asymmetry) but found no association between SNS and CPT
performance.
Perinatal complications
SNS was found to be increased in children with perinatal obstetric complications
(82). It is suggested that obstetric complications are related to SNS expression (83).
Schizophrenic patients with a history of perinatal complications appear to have
particularly more neurological aberrations and cognitive deficits (9;84).
Demographic correlates
Age
The relationship between age and SNS is inconsistent across studies. Several studies
did not found a relationship between age and SNS (74;85) while some studies
reported a correlation (68;86). In Merrian (87), 28 chronic schizophrenic patients
were assessed with a scale including apraxia, fine motor function, prefrontal, parietal
and non-localizing signs. No association with age was found. However, Cuesta
(88;89) studied frontal signs (FS) and neuropsychological performance and found
that FS was related to age. Different inclusion age range amongst studies was
considered as a potential contributor to the inconsistency. One important limitation in
a cross-sectional study is that age is confounded by illness duration, which might




More SNS impairments in males were reported in a few earlier studies (41 ;61).
However, in most studies of SNS, no gender difference in the overall level of soft
neurological signs was identified (53;62;63;84;85;89-92). However an interesting
observation emerged from the studies looking at SNS correlates. Malla (53) found
that there was a gender difference in the clinical correlates of SNS factors. Different
SNS factors were related to Psychomotor poverty in male and female patients.
Intelligence and education level
The relationship between lower intelligence level and SNS amongst schizophrenic
patients has been reported in a number of studies (74;88;89;91). Notably, the
relationship was not only observed in chronic patients with more severe disabilities,
but also in younger patients, with good functioning levels and early in the course of
the illness (91).
The correlation between SNS and intelligence level was found not only in
schizophrenia, but also in personality disorder and affective disorder patients (42);
normal children, learning disabled children (93), as well as in high-risk children
(with family history of schizophrenia) (94).
A smaller number of studies did not find this relationship (87;95;96). Two notable
exceptions to the findings were Merrian (87), who in 28 chronic schizophrenic
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patients did not find associations between with SNS and IQ. The conclusions are
limited by the small sample size. However Flashman et al (95) divided 176
schizophrenic patients into those with (n=68) or without (n=108) SNS and compared
neuropsychological performance between the two groups. He found no difference in
WAIS-R Verbal and performance IQ between the two groups.
A further study compared people with co-morbidity of schizophrenia and learning
difficulties (IQ 50-70 range, mean age 48.6) (n=39) (97), with matched (age and
gender) control groups either (1) mild learning disability without schizophrenia
^=28); or (2) schizophrenia without learning disability (n=34). Subjects were
assessed using the NART, the Quick IQ test, the Rivermead Behavioural Memory
Test as well as SNS assessment with the NES. Mean IQ scores between learning
disabled subjects with or without schizophrenia did not differ. The co-morbid group
and the learning disability group both showed increased SNS compared with the
schizophrenic group. There was no correlation between SNS and intelligence score in
any of the groups. The study also found a tendency for co-morbid subjects to belong
to multiple affected families and raised different possible mechanisms in which
schizophrenia might be associated with intelligence impairment.
Ethnicity
Buchanan and Heinrich (31) reported that healthy African Americans have an
increased level of soft signs compared with Caucasians. The increase was
particularly found in the sensory integration subscale. Gureje (65) also found
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increased prevalence of SNS among Nigerian patients as well as control subjects and
speculated that it might relate to the level of obstetric care. There is no systematic
data on SNS for other ethnic groups.
Premorbid functioning
The presence of SNS was found to be related to poor premorbid adjustments in
Gupta (49). Quitkin (42) also reported increased SNS in schizophrenic patients with
poor premorbid functioning. This association was however not found in some other
studies (68;85).
Clinical correlates
A number of studies have addressed SNS in relation to clinical symptom dimensions.
Commonly there are two approaches. In the first approach patients are classified into
subgroups and then SNS are compared between the subgroups. In the second
approach the statistical relationship between SNS and symptoms dimensions are
considered in the same population of patients.
Comparison of SNS between schizophrenia subtypes
A relatively small number of studies followed this approach. Nasrallah (98)
compared paranoid (n=20) and non-paranoid (n=24) schizophrenic patients
(according to the Tsuang-Winokur criteria) with respect to 19 soft neurological signs
and found no difference between the groups. Gureje (65) also found that SNS did not
differ between paranoid and non-paranoid schizophrenia. Galderisi (99) found that
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SNS was increased in simple schizophrenia compared to other subtypes.
Relationship with symptom dimensions
Negative symptoms
A substantial number of studies reported correlation between SNS and negative
symptoms (41 ;47;53;87;91; 100-102). Some of these are further described below. In
the study ofMalla (53), NES scores were correlated with negative symptom scores.
In Liddle's (103) study involving a group of 47 chronic schizophrenic patients, SNS
were correlated with the psychomotor poverty syndrome (r=0.34) and the
disorganization syndrome but not with reality distortion syndrome scores. Within the
psychomotor poverty syndrome, decreased spontaneous movement and poverty of
speech were particularly correlated with SNS scores. A subsequent study also
identified that the signs of dyspraxia and agnosia associated most strongly with
negative symptoms (104). In Merrian (87), "Prefrontal" signs were associated with
negative symptoms, positive symptoms were associated with parietal and non-
localizing signs. King (105) studied 16 chronic schizophrenic patients; SNS were
correlated with both positive and negative symptoms. In Wong (100), 37 patients
with chronic schizophrenia (18-65, DSM III R) were assessed using Convits
Quantified neurologic scale (covering frontal, SNS and cerebellar signs). SNS and
frontal signs were both found to be correlated with negative symptoms. Smith (106)
also found that neurological signs correlated with negative symptoms. In Cuesta (89)
frontal signs were found to be related to SANS scores but not SAPS scores. Likewise,
in Mohr (91), both negative symptoms and positive symptoms correlated with SNS
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scores. In Arango (107), deficit syndrome was related only to sensory integration
signs. Only a small number of studies yielded negative findings (e.g. Kolakowska et
al (85) found that SNS was not related to negative symptoms). Thus, the relationship
between negative symptoms and SNS appears to be a robust observation found in
most studies.
Formal Thought Disorder and disorganization
In an early study of Tucker (68), 109 patients with mixed diagnoses were classified
as being schizophrenic (n=38) and non-schizophrenic (New-Haven Schizophrenia
index and Schneider First Rank Symptoms Scale), thought disorder was scored with
the Goldstein-Scheerer Object Sorting test, targeting overinclusive, idiosyncratic, and
underinclusive thinking. SNS (including finger agnosia, finger tip writing, tactile
form recognition and the Halstead Tactual Performance test) were found to be related
to both a diagnosis of schizophrenia and the presence of thought disorder. In a
subsequent study, SNS, along with other motor dysfunction, was also found to be
related to thought disorder (47). In Liddle 1987's (103) study involving a group of 47
chronic schizophrenic patients, SNS were correlated with disorganization syndrome
scores (r=0.37). Amongst other signs, dyspraxia and agnosia were particularly
associated with the disorganization syndrome (104). Schroder (108) also found that
SNS was increased in patients with disorganization symptoms (n=50, mean age =32,
using the Heidelberg scale). In the study ofArango (107), disorganization was related
to total NES score but not the subscale scores. However, in Mafia's (53) data (NES in
n=100 age= 33, illness duration 3 years), no relationship between SNS and
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disorganization was found. The overall picture remains conflicting, though there is
suggestive evidence for the association between SNS and thought disorder.
Positive symptoms
Generally studies have not identified a robust relationship between SNS and positive
symptoms. Kolakowska (85) found that SNS were not related to positive symptoms.
In Liddle 1987's (103) study described above, SNS while correlated with
disorganization syndrome and psychomotor poverty (negative) syndrome, were not
correlated with reality distortion (positive) syndrome scores. Cuesta (89) also found
that frontal signs related to SANS but not to SAPS scores. In the Arango (107) study
involving 83 patients positive symptoms were not related to SNS. Likewise in Wong
(100), neither SNS nor frontal signs was correlated with positive symptoms scores.
However, Merrian (87) reported that while prefrontal signs were associated with
negative symptoms, positive symptoms were associated with parietal and non-
localizing signs. King (105) studied 16 chronic schizophrenic patients and found that
SNS were correlated with both positive and negative symptoms. Likewise, Mohr (91)
also found that both negative symptoms and positive symptoms correlated with SNS
scores.
One difficulty in clarifying the relationship with positive symptoms is that in cross-
sectional studies, it is often not clear whether positive symptoms are related to
relapse or represent residual symptoms. These two situations may have different
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significance in terms of relationship with underlying features.
Age of onset
The relationship between SNS and age of onset is also contentious, SNS was found
to be related to earlier age of onset in some studies (46;52;58) but this finding has not
been replicated in other studies (69;85;89). It is important to note that while age of
onset, current age, and illness duration might each be linked to SNS through different
mechanisms, they are at the same time confounding one another.
Course and outcome
SNS has been found to be increased in medication-nai've first-episode schizophrenic
patients (52; 109; 110). When Flyckt et al (111) compared hard signs and psychomotor
tests and found no significant difference between first episode and chronic patients,
they concluded that the level of SNS identified at first episode appears to be stable
with time. This conclusion is limited by the power of the study and the difference in
sampling between the acute and the chronic patient samples. Generally speaking, a
subset of first episode patients (particularly those who do well) are less likely to be in
contact with the service over a long period of time, and patients who do less well are
more likely to be recruited into a cross-sectional study. If SNS is related to illness
severity, this would tend to bias the study in favor of finding increased SNS in more
chronic patients. Therefore, the finding of similar level of SNS between first episode
patients compared with chronic patients would even suggest possibly a degree of
improvement in SNS for some patients after the first episode.
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lllness chronicity
Whether SNS progresses with longer illness duration is an important question. If
SNS are stable with time it would suggest that they reflect features largely
determined at the developmental stages. On the other hand if SNS increases with the
course of illness, it would suggest that SNS might express features that are
vulnerable to deterioration. Data addressing the relationship between SNS and illness
duration is conflicting. In Kolakowska's study (112), subjects with SNS were found
to have longer illness duration than those without, however when stratified into
smaller groups according to illness duration, the proportion of those with SNS was
not significantly different. In Flashman et al (95), patients with more SNS had a
longer illness duration (i.e. they had a younger age of onset when compared with a
comparison group with the same current age). Cuesta et al. (88;89) also found that
frontal signs were related to duration of illness. Others have failed to find a
relationship (91; 113). Flyckt et al (111) compared motor tests (including SNS)
between first episode psychotic patients and chronic patients and found no significant
difference.
Outcome
Johnstone et al (114) found that neurological signs were associated with worse
outcome in 253 first-episode schizophrenia patients (in terms of staying for more
thanlOO days in hospital in first 2 years). In Wong et al (100), SNS and frontal signs
were each found to be correlated with GAF, social performance and PANSS negative
symptoms. Kolakowska et al (112) however found that SNS was not related to
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overall clinical outcome. SNS was also not related to re-hospitalizations at 3 years
(92).
Medication
Comparison studies between medicated patients and medication-free patients
generally revealed no difference in SNS (45;47;56;57;59;60). Flyckt (111) compared
hard signs and psychomotor tests performances between medicated and medication
free patients (relatively small sample) and found no difference between the groups.
Most studies also found no relationship with duration on medication and cumulative
dosage ofmedication (74;88;111;112). Notably NES scores remained stable despite a
change from conventional antipsychotics to clozapine medication (115). In terms of
side effects, King (105)studied 16 chronic schizophrenic patients (average illness
duration of 21 years) on 10 SNS and found that SNS were correlated with tardive
dyskinesia. In addition, Motor coordination score in NES was also found to be
correlated with extrapyramidal signs (115).
Relationship to cognitive function
Impaired cognitive performance in schizophrenia has been extensively studied and
documented. A full account is beyond the scope of the current dissertation. Briefly, it
is likely that there is a "generalized" cognitive impairment in schizophrenic patients
(116). It is more contentious whether additional specific impairments can be
identified. The current view is that specific impairments probably do exist but there
is considerable heterogeneity. They include variable profile of impairments in
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attention, memory, language, as well as executive functions.
Existing evidence suggest that like SNS, subtle intellectual impairments may be
present many years before the onset of overt psychosis. Significant
neuropsychological impairment is already present at the first presentation of illness
(117) though there has been some debate over whether cognitive impairment
subsequently runs a deteriorating course. Such a progressive course would suggest a
degenerative process, whereas an absence of progression would suggest a static
process that occurs around (or prior to) the onset of the psychosis, but remains stable
thereafter.
Progression in cognitive impairment in schizophrenia have been systematically
studied over the last few decades (118; 119). Some of the earlier studies were
conducted before standardized diagnostic criteria were widely used. There have been
few recent longitudinal studies and those conducted tend to suffer from small sample
sizes, high drop-out rates and relatively short follow-up periods. Waddington et al
(120) followed 51 relatively older patients for five years (mean age 57 years) and
found no overall decline on a 10-item global cognitive rating. Goldstein and Zubin
(121) compared younger and older schizophrenic patients on their performance in the
Halstead-Reiten Battery and found no significant difference in rate of cognitive
decline compared with those of controls. Among cross-sectional studies, Heaton et al
(122) compared neuropsychological deficits in 85 younger, and 35 older early-onset
patients, as well as 22 late-onset patients and concluded that deficits were no more
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marked in patients with longer duration of illness. However, Bilder et al (117)
compared 33 first-episode schizophrenic patients with 34 chronic patients and
reported evidence for progression in cognitive deficit. In a cross-sectional study
comparing 74 patients in different age ranges, Goldberg et al (123) and Hyde et al
(124) reported no evidence of cognitive decline using an extensive
neuropsychological battery. Prefrontal dysfunction has been postulated to be pivotal
to the cognitive difficulties manifested in schizophrenia. Schizophrenic patients have
been found to perform poorly on prefrontal function tasks (such as the Wisconsin
Card Sorting Test and semantic fluency). Whether the prefrontal dysfunction is
progressive is contentious. Set off against the negative findings ofHyde et al (124)
described above, Sweeney et al (125) compared 27 first episode patients with 33
chronic patients and described poorer semantic fluency and Wisconsin Card Sorting
Test performance in the chronic patients. Unfortunately in this study there was no
attempt to control for the effect of age and it is difficult to ascertain to what extent
the poorer performance was related to agingper se.
Theoretical considerations
In considering the relationship between cognitive function and SNS, it is important to
examine the underlying assumption about explanatory levels. One position is to
consider cognitive function as phenomena at a more "basic" level of explanation and
to attempt to explain certain neurological signs in terms of these more basic cognitive
processes. While this may make some sense for particular cases, in general the
assumption cannot be uncritically justified. Indeed from the consideration of the
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boundary between cognitive paradigms and neurological signs in Chapter 1, as well
as from the design of some of the existing studies, it is clear that it is also possible to
consider both cognitive function and SNS as phenomena occurring at the same
explanatory level. That is to say, they are both driven by more basic processes not
captured in either approach. In this situation it would not make sense to attempt to
explain one domain in terms of another. Instead, it would be more prudent to
examine the relationship between the two domains without prior assumption about
directions of causality. This is the approach that is taken in the current analysis.
Empirical relationship between SNS and cognitive function
Although there have been few systematic studies of the relationship between
neurological signs and cognitive functions, a limited number of studies have reported,
among other findings, global correlation between neurological signs and
neuropsychological impairment in the same sample of schizophrenic patients. Owens
and Johnstone (101) found that there was a modest correlation between cognitive
performance and neurological signs (mostly extrapyramidal signs) in 510
schizophrenic inpatients. However, in a further study involving 120 patients
discharged from hospital, the research group did not find significant correlation
between neurological abnormality and cognitive performance (126). In contrast, in a
small sample of 16 patients, King et al. (105) reported a strong correlation between
neurological signs and cognitive ability (Spearman coefficient -0.818, p<0.01).
Likewise, in another study involving 37 patients, total score in neurological signs
was also found to be correlated with a global score in cognitive function (85). Liddle
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(103) further observed that in 47 patients, total neurological signs score was
correlated with scores in a variety of cognitive tests. With a slightly different design,
Merrian et al (87) divided neurological signs into five areas (prefrontal, parietal,
praxis, fine motor coordination, and non-localizing) and applied a vocabulary test
and a visual reproduction test to the patients. They studied 28 patients and concluded
that they could not detect correlation between neurological signs and cognitive
performance.
Taken together, while these earlier studies suggest a potential relationship between
neurological signs and neuropsychological impairment, the exact relationship
remains unclear. Most of these studies employed a relatively small number of
subjects. Often a single measure was derived from either neurological signs or
cognitive performance, thus potentially masking more specific relationship between
smaller unit of analysis within these two domains. In addition, few of the studies
considered the potential confounding effects of age and education level.
Several more recent studies began to address the relationship in more detail. Mohr
(91) reported that in 93 patients all NES subscale scores were correlated with
standard progressive Raven matrices (as a measure of intelligence) and with WCST
perseveration. The correlation with WCST performance remained significant after
partialing out Progressive Raven matrices scores, thus suggesting a specific
relationship with executive function independent of general intelligence. Cuesta (89)
studied FS and neuropsychological performance and also reported a specific pattern
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of relationship. Importantly they also used partial correlation to account for effects of
age, education level and illness duration. A specific profile of correlation between
frontal signs and various neuropsychological tests emerged. FS was found to be
related to WAIS similarity, digit span, vocabulary, block design, Rey complex figure
and, Trail-making, but neither with visual memory nor verbal fluency. In another
approach, Flashman (95) divided schizophrenic patients (n=176) into those with
(n=68) or without (n=108) SNS and compare neuropsychology performance between
the 2 groups. It was found that those with SNS performed worse in cognitive tests
that required motor speed and coordination (finger tapping, Purdue Pegboard, Trail B,
Rey Osterreith complex figure copy) even after partialing out extrapyramidal signs
and dyskinesia scores. However the groups did not differ in a range of other tasks
(verbal memory, Ray complex figure memory, Benton visual retention WCST
categories or perseverative errors, Stroop, verbal fluency, continuous performance
tests, as well as WAIS-R Verbal and performance scores). The authors suggested that
the relationship between SNS and cognitive functions was circumscribed rather than
general. In the study ofWong described above (100), Convits Quantified neurologic
scale scores were associated with impairment on the visual illusion and span of
apprehension tasks. Backward masking impairments were associated with SNS alone
(not frontal tasks). Arango et al (127) attempted to explore whether NES (as well as
frontal release signs, eye movement, short term memory) scores predict
neuropsychological performance (Trailmaking, fluency, WMS, Stroop, Mooney faces,
WAIS-R block design, CPT, Span of apprehension, MMSE, WAIS-R verbal and
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performance). Their results indicated that "sensory integration" score was the most
frequent predictor of neuropsychological test performance. It predicted the
performance in fluency, trailmaking, Block design, logical memory, visual
reproduction, visual pairs, MMSE, as well as WAIS-R verbal and performance scales.
"Motor coordination" jointly predicted "visual pairs" performance. "Complex
sequencing" predicted Stroop test and figural memory subscale scores. The authors
pointed out that neurological signs did not explain most of the variances of
neuropsychological performance and suggest that SNS and neuropsychological
performance each capture unique variances.
Although some of these studies did not employ a sufficient sample size in view of the
large number of variables investigated, the overall relationship between global
cognitive function and SNS seems to be supported by several studies. However, the
extent to which this relationship is influenced by the known relationship between
SNS and intelligence has not been clarified. This issue necessitates a consideration of
the complex relationship between intelligence and cognitive function performance.
Several studies have also suggested relationship between specific domains of SNS




In this chapter a description of the assessment procedures common to the set of
studies that constitute the dissertation will be provided. These studies were carried
out at two locations (Hong Kong and UK) spanning a period of ten years, and
involved a number of sites and collaborators (details in Appendix I). The themes that
thread the studies together are the investigation of the characteristics of soft
neurological signs in schizophrenic patients, using a similar set of instruments. The
investigations started with cross-sectional studies in order to identify demographic,
clinical and cognitive correlates of SNS. These were followed by two longitudinal
studies to address the changes in level of SNS over time in different stages of
schizophrenia. One of the longitudinal studies addressed stable patients with long
illness duration; the other study addressed first episode psychosis patients.
Consistency and coherence within this set of studies lies in the fact that similar
instruments and definitions have been employed across these studies. Despite the
uniformity in methodology, each study was conceived with independent research
questions at the time and each was exposed to unique sets of practical constraints.
These will be described more fully in subsequent Chapters.
Some minor variations have emerged over time (e.g. in the item inclusion in
subscales). Consequently, in order to extract more comparable information across the
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studies, it has been necessary to review the definition of SNS subgroups and
subgroup scores, so that a standardized set of criteria is used. This has necessitated a
fresh analysis of raw data from the studies. The set of studies will be briefly
described below. This is followed by a description of the evaluation instruments used
in the studies.
Overview of studies
For the sake of clarity numbering is assigned to the studies. All the studies has
approval from the relevant research ethics committees. Unless otherwise specified
the studies were carried out in Hong Kong and involved ethnic Chinese subjects.
Study 1
The study focused on a large clinical sample of schizophrenic patients at various
stages of their illness. In this study the primary objective was to explore relationship
between soft neurological signs and other demographic, clinical and cognitive
features of the disorder (Chapters 5 and 6). A local normative sample was also
evaluated.
Study 2
This cross-sectional study included Caucasian subjects from the UK. There was a
normative sample and a clinical sample of chronic schizophrenic patients. As
reliability was monitored across study 1 and study 2, it was possible to carry out a
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cross-ethnic comparison between healthy control subjects in the two studies. Data
from this study was used only for the purpose of cross-ethnic comparison in this
dissertation (Chapter 5). Extensive clinical information was not available for this
sample.
Study 3
This study aimed at 3-year longitudinal follow-up data in a group of stable chronic
inpatients. The sample had relatively long illness duration and was also approaching
the fifth decades in age (Chapter 7). The key issue addressed was whether there was
a progression in SNS over the 3-year follow-up period independent of any clinical
changes.
Study 4
In this study motor soft neurological signs were studied in first episode patients with
followed-up at regular intervals for a period of two years. This was part of a larger
study involving longitudinal follow-up of patients with first episode psychosis. The
key questions addressed were whether the level of SNS in medication-naive patients
was increased, and whether there was longitudinal change in SNS in the 2 years after
treatment of the first episode (Chapter 8). This study also provided the opportunity to
investigate correlates of SNS in a first episode sample.
-65-
Assessment Tools and procedures
Assessment of SNS
The Cambridge Neurological Inventory (CNI)
In the construction of this assessment instrument for soft neurological signs it was
emphasized that items in the inventory should be operationalized to reduce variations
in elicitation and scoring, and that items contained in SNS subscales should also be
explicitly listed so that comparison across studies could be facilitated.
A literature review was carried out to identify all CNS signs of potential significance
in psychiatric disorders. Items were taken from established descriptions and scales of
SNS (18;31 ;42;60;87; 128; 129) (also see Appendix 4). For neurological signs not
covered by these established instruments, descriptions from primary source were
traced and operationalization constructed (e.g. utilization behavior). In addition an
abbreviated standard neurological examination was incorporated after consultation
with a neurologist (JRH). Where different descriptions existed preference was given
to 1) more detailed and explicit operationalization in elicitation and rating; and 2)
more widespread use in previous research. Some previous batteries have included
cognitive tests. Such direct tests of higher cognitive function (e.g. language, memory,
spatial performance) were not included in the CNI, and so were tests requiring
extensive use of specific equipments (such as reaction time tests).
After initial piloting, signs that were difficult to administer or rate were excluded (e.g.
blink rate and utilization behaviour). A revised version of the inventory was then
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constructed. A full description of the CNI examination procedure, as well as the
elicitation and scoring of each of the signs, is included in appendix 2. To ensure
consistency, apart from textual description, an instructional videotape was made
demonstrating the elicitation of each of the signs. The candidate personally trained
all raters involved in the studies.
The CNI offered instructions for eliciting and rating a comprehensive range of
neurological signs in 7 domains. Three of these CNI subscales addressed SNS (motor
coordination, sensory integration, disinhibition) and they are included in the main
analysis of the present study. Items included in these subscales are shown in Table
3.1. The motor coordination subscale consisted of SNS that involved regularly paced
repetitive positioning involving the upper limb. These signs ranged from the simple
finger tapping to the more complex fist-edge-palm test. The sensory integration SNS
involved higher cognitive processing of perceptual information from different
sensory modalities. The disinhibition subscale included SNS that elicit spurious
responses that are irregular either in time (e.g. go-nogo) or in space (e.g. mirror
movements).
In the original ratings scale, scoring was made according to standardized anchor
points to indicate "normal" response (0), "equivocal" response (0.5), "abnormal"
response (1) or "grossly abnormal" response (2). In data analysis throughout this
dissertation, items scores were further collapsed into either "absent" (covering
"normal" or "equivocal" scale scores) or "present" (covering "abnormal" or "grossly
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abnormal" scale scores). For items that can be scored on both left and right, each is
treated as an independent score. To facilitate comparison between different subscales,
a scaled score is defined as the summed items score divided by the possible score
range for the subscale, and then converted to a 0-to-100 scale (i.e. percent score). In
the studies reported, it was not possible to make the raters of neurological signs blind
to the group of the subjects (i.e. patients or healthy controls).
Table 3.1. SNS subscale items in the CNI
Motor coordination
Finger-thumb opposition (Left and Right)
Finger-thumb tapping (Left and Right)
Dysdiadochokinesia (Left and Right)




Finger agnosia (Left and Right)
Stereoagnosia (Left and Right)










The following raters were involved in the studies
1 CK (Studies 1,3,4)
2 LL (Study 1)
3 DN (Study 1)
4 EC (Studies 1,2,3,4)
5 RC (Study 1)
6 JS (Study 2)
Interrater reliability on the subscale scores was calculated for each of the subscales
based on investigators' ratings on the same set of 15 videotaped CNI examinations.
The interrater reliability scores were calculated based on pooled data from the 6
investigators involved in the UK and the HK studies. Overall intraclass correlation
for the soft neurological signs subscales ranged from 0.88 to 0.94. (Table 3.2)
Table 3.2. Intraclass correlations for CNI total and SNS subscales scores
F-value df p-value ICC
Motor Coordination 13.37 82, 656 <0.0005 0.93
Sensory integration 4.46 70, 490 <0.0005 0.78
Disinhibition 2.71 80, 560 <0.0005 0.68
Total CNI score 6.07 69, 6348 <0.0005 0.84
ICC Intraclass correlation coefficient
Assessment of clinical picture
Schizophrenic symptoms
In studies 1 and 3, symptom assessments were carried out with the 18-item Brief
Psychiatric Rating Scale (BPRS) (130), which has been successfully applied to Hong
Kong Chinese patients (131). Interrater reliability of the BPRS items for the
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investigators ranged from 0.84 to 0.99 (intraclass correlation). In study 4, symptoms
were assessed using the PANSS. The reliability for the PANSS in study 4 was
separately assessed. The overall intraclass correlation coefficient for the PANSS was
0.83 (0.83 for the positive subscale, 0.73 for the negative subscale). These symptoms
rating scales were scored according to standardized instructions based on clinical
interview and medical records.
Negative symptoms
Negative symptoms were in addition assessed using the High Royds Evaluation of
Negativity (HEN) (93). The HEN consisted of subscales in the domains of
appearance, behaviour, speech, thought, affect, functioning as well as a global score.
Validation of the HEN for use in Hong Kong Chinese patients has been previously
reported (132). The interrater reliability for global score in the HEN was 0.92. The
intraclass correlation for the subscales ranged from 0.74 (thought) to 0.85 (speech).
Medication
For studies 1 to 3, all patients were on conventional antipsychotics. Dosages were
converted to chlorpromazine equivalence according to Davis (133). The dosage of
anticholingeric medication (Benzhexol) was also recorded. Atypical antipsychotics
(risperidone and olanzepine) were only involved in study 4 and the number of
patients on atypical anitpsychotics was noted.
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Side-effects rating scales
In studies 1 to 3, extrapyramidal signs and dyskinesia were assessed with build-in
subscales in the CNI. In study 4, extrapyramidal signs were assessed with the
Simpson Angus scale (134), dyskinesia was assessed with the Abnormal Involuntary
Movements Scale (AIMS) (135), akasthisia was assessed with the Barnes scale (136).
Assessment of cognitive performance
Cognitive function tests were selected based on the following criteria
• Addressing cognitive function domains of interest in schizophrenia (attention,
memory, executive functions)
• Acceptability and portability
• Tests widely employed in other studies
• Previous use by the candidate and his research collaborators
Tests were carried out in a fixed order with flexible rest periods provided as needed.
They are described in the following sections.
Semantic fluency
Semantic fluency was assessed by requesting the patient to name as many exemplars
as possible from each of three categories ('food', 'animal', and 'furniture') in one
minute. In study 3 and 4, only one category (animals) was assessed. The responses
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were tape recorded and later transcribed for analysis. A total score was computed by
counting the number of correct items produced in one minute (repeated items and
items clearly outside the category were not counted).
Wisconsin Card Sorting Test
In studies 1 to 3, the Wisconsin Card Sorting Test was performed and scored
according to standard procedures (137). In the WCST, subjects were presented with
cards in which design elements were printed in different colors, numbers and shapes.
Four cards were laid on the table and the subjects were given additional cards one by
one. Subjects were instructed to relate the additional card to one of the four cards on
the table according to a rule that the examiner was aware of but the subject was not.
Subjects were told only whether the sorting was correct or not. A next card was then
presented for the next round of sorting. The sorting rule could be according to color,
shape, or number. After 10 consecutive correct responses, the sorting rule changed.
Sortings according to previously correct but currently incorrect rule are considered
perseverative errors. Perseverative errors were scored as defined in Heaton (137).
The modified Wisconsin Card Sorting test
The modified Wisconsin Card Sorting test was adopted in study 4. The procedures
describe by Nelson (138) was followed. Briefly, in the modified version, only 64
cards were used. The modified version also excluded conditions where two possible
rules were simultaneously compatible with a given feedback. Subjects were also
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alerted to a change of rule when it occurs.
WAIS-R subscales
Digit Span (forward and backward), Comprehension, Similarity and Information
subtests from the Wechsler Adult Intelligence Scale WAIS-R-HK (139) (Revised
Cantonese Version, Hong Kong Psychological Society, 1989) were carried out and
rated according to standard procedures. Digit Span assessed the ability to hold a
limited number of digits for several seconds. Digits were presented at a rate of one
item per second in order to avoid chunking effect. Sequences started from 3 digits
and following successful attempts, successively longer sequences were presented
until the subject was unable to correctly recall the sequence. The length of the
longest sequence successfully recalled was the forward digit span. Backward digit
span was tested in a similar fashion with the additional requirement that the subject
had to recall the digits in a reversed order. Bothforward and backward digit spans
were used to calculate verbal intelligences according to standardized procedures. In
the information subscale, subjects were asked a range of questions on common
knowledge items. In the similarity subscale, subjects were asked to describe the
similarity between pairs of objects. Their responses were recorded and scored
according to standard procedure. In the comprehension subscales, subjects were
presented with everyday scenarios in which they were asked how they would have
responded. Again, responses were recorded and scored in a standardized manner.
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Memory tests
Logical Memory and Visual Reproduction were performed as described in the
Wechsler Memory Scale Revised (139) (adapted for Cantonese speaking patients,
C.W. Wong, personal communication). In the Logical Memory test, subjects were
presented with short narratives. They were instructed to listen to the narrative and to
recall it immediately afterwards (immediate recall) as well as 30 minutes later
(delayed recall). The number of units of information that were successfully recalled
was scored. It was found that immediate recall and delayed recall performance were
highly correlated. Unless otherwise specified, immediate recall performance data was
presented. The Visual Reproduction subscale of the WMS involved memorizing
abstract line figures, subjects were instructed to reproduce the figures after the they
were withdrawn from sight (immediate recall) and 30 minutes later (delayed recall).
Once again, the immediate and delayed recall performances were highly correlated
and only immediate recall data were presented in the data analysis.
The tone counting task
Sustained attention was assessed by the tone counting task (adapted from (140)).
Subjects were asked to silently count the number of tones embedded in each of the
12 trains of brief pure tones (360 Hz frequency, 250 msec duration) presented at a
regular pace of one per second. The tones were delivered by a loudspeaker adjusted
to a comfortable level of loudness for the patient. For each of the 12 trials, the
number of tones varied between 1 and 12 in a randomized order. After each train of
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stimuli, subjects were asked to immediately report the number of tones counted.
Accuracy was scored as the number of correct counts out of the 12 trials (maximum
12, minimum 0). This simple test of attention has been validated
neuropsychologically (140). Application of this test as a measure of sustained
attention in schizophrenia has been reported elsewhere (132).
Premorbid intelligence estimation
For Chinese subjects, verbal IQ estimates was derived from the information subscale
of the WAIS-R-HK (139). The information subscale was selected as data from a
previous pilot study indicated that amongst other subscales it correlated most
strongly with the prorated verbal IQ score obtained from using a larger number of
subscales (Digit span, comprehension, similarities, information). Unfortunately at the
time of the study, the validity of the vocabulary subscale for use in the Hong Kong
population was yet to be established. Attempts to construct a local equivalent
measure to NART have not yet been achieved, largely due to the prevalence of
bilingualism amongst Hong Kong Chinese subjects.
In the UK normative sample, verbal intelligence was estimated from the National
Adult Reading Test (NART, (141)). The NART required subjects to pronounce a set
of irregular nouns (in which the pronunciation could not be inferred directly from the
spelling). It has been validated as a briefmeasure of verbal intelligence. It is
acknowledged that intelligence estimate of the Chinese and Caucasian sample were
based on different measures. Direct comparison between intelligence levels between
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the two samples was avoided.
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4 Samples characteristics and descriptive results
Introduction
In this Chapter a detailed description of the recruitment and inclusion criteria, as well
as the basic characteristics and descriptive statistics for neurological signs scores for
each of the samples shall be provided.
The following core inclusion and exclusion criteria were used in all the studies unless
otherwise specified.
Recruitment criteria
Recruitment criteria were considered based on information from interview with
patients and medical records.
Inclusion Criteria
For schizophrenicpatients
• Age 18 to 65 with DSM-III-R/IV criteria for schizophrenia (study 4
employed DSM-IV criteria, schizoaffective and schizophreniform patients
were also recruited in study 4)
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For control subjects
• Age 18 to 65 with no personal history of schizophrenia
Exclusion Criteria
• Neurological or serious medical illnesses such as epilepsy, head injury, stroke,
diabetes, and endocrine disorder
• History of regular substance abuse
• History ofECT within 6 months




Subjects in the normative sample in Hong Kong were unpaid volunteers recruited
through a series of public education events. The events were announced publicly and
were free of charge. Participants either obtained prior registration or walk in to the
venue. Potential subjects were screened with a structured questionnaire for exclusion
criteria (see above). In addition to the CNI and cognitive function tests, subjects were
assessed using the Information subscale in the WAIS-R HK in order to arrive at an
estimate of intelligence level.
A total of 94 subjects (32 males and 62 females) were recruited. The mean age and
education level was 38.3 years (SD = 12.9) and 8.9 years (SD = 3) respectively.
Schizophrenic Patients
Subjects with a clinical diagnosis of schizophrenia were invited to be considered for
participation from 3 inpatients units in Hong Kong (KCH, QMH, LCKH, see
appendix 1). KCH and QMH contained acute inpatient units. KCH and LCKH
contained chronic rehabilitation units. The sample thus consisted of a mixture of
patients in different stages in the course of the illness. Research diagnosis was made
by consensus involving two experienced clinicians according to DSM-III-R criteria,
making use of clinical interview and information from case records and informants.
-79-
Subjects recruited into the study received a more extensive clinical and cognitive
evaluation in addition to neurological signs assessments.
The sample consisted of 195 patients (120 males and 75 females). One hundred and
eighty four patients were right handed, 4 were left handed, and 7 were mix-handed
(handedness was determined using the Annett scale (142)). The mean age was 39.7
years (SD = 12.1). The number of years of education was 8.1 years (SD = 3.5). The
mean illness duration was 14.7 years (SD = 9.7). The mean anti-psychotics dosage
(chlorpromazine equivalence) was 922.13 mg/day (SD = 917.47). The mean daily
dosage of anti-cholinergic was 3.28 mg of benzhexol (SD = 3.34). Benzhexol was
the only anti-cholinergic medication encountered in the sample. Study 1 CNI
subscale scores for patients and healthy controls are presented in Table 4.1.
Prevalence of individual signs are presented in Appendix 3a
Table 4.1. SNS subscale scores in Chinese patients and healthy control
subjects
CNI subscale Normal control subjects Schizophrenic patients
(n = 94) (n= 195)
SNS subscale Mean SD Mean SD
Motor coordination ** 10.64 14.38 20.61 25.66
Sensory integration ** 9.41 11.31 20.90 30.05
Disinhibition * 10.11 12.33 15.56 14.13





The normative sample was obtained through recruitment of paid healthy volunteers
from employees of a large commercial institution based at Cambridge. Recruitment
was effected by internal advertisement within the institution. Participants were
screened for inclusion and exclusion criteria (see above) using a standard
questionnaire. In addition to the CNI subjects were also evaluated with the National
Adult Reading Test (NART, Nelson, 1982) to arrive at an estimate of the general
intelligence level.
In the 80 subjects recruited there was a male preponderance (65 males, 15 females).
Handedness was assessed clinically (70 right-handed, 8 left-handed, 2 mixed). The
mean age was 42.0 years (s.d. 13.7 years). The IQ estimates (WAIS-R) was 112.5
(SD = 6.5).
Chronic schizophrenic patients (Caucasian)
Patients with chronic schizophrenia were recruited from an inpatient rehabilitation
unit at Fulbourn Hospital, Cambridge. Diagnosis of schizophrenia was made
according to DSM-III-R criteria by an experienced research psychiatrist (PJM).
Subjects were assessed with the CNI after giving informed verbal consent.
The sample consisted of 52 patients (34 male and 18 female). 45 were right-handed,
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7 were left-handed. Mean age was 39.3 (sd 11.0). Mean illness duration was 17.1
years (sd 11.8). The mean dosage ofmedication (daily chlorpromazine equivalent)
was 1728 mg/day (SD = 2699). It was noted that this represents a relatively high
antipsychotics dosage and may reflect the lack of pharmacological options for the
severely unwell patients necessitating long-term hospitalization in a period before
clozapine or atypical antipsychotics became more widely used. CNI Subscale scores
for Caucasian patients and healthy controls are shown in Table 4.2. SNS item
prevalences are shown in appendix 3b.
Table 4.2. SNS subscale scores in Caucasian patients and healthy control
subjects
SNS subscale
Normal control subjects (n = 80)
Mean SD
Schizophrenic patients (n = 52)
Mean SD
Motor coordination** 6.39 10.43 43.97 29.48
Sensory integration** 16.25 17.27 42.33 26.31
Disinhibition** 6.09 9.33 18.75 15.08
*p<0.01; **p<0.0001, unpaired t-tests, Non-parametric Man-Whitney U-tests produced similar
significant levels
Study 3
Study 3 was a longitudinal study of SNS in patients with chronic schizophrenia. 38
patients fulfilling inclusion criteria from LCKH were follow-up three years after the
initial assessment and a repeated assessment of their cognitive function and
neurological signs were carried out. In addition to the core inclusion and exclusion
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criteria, patients had to be clinically stable (i.e. not in relapse) at the time of the study.
The sample consisted of 29 males and 9 females. The mean age was 47.3 years (SD
= 7.2) and the mean education level was 6.7 years (SD = 2.9). The mean illness
duration was 25.9 years (SD = 9.4) at the beginning of the study. Average dosage of
conventional antipsychotic medication was 844 mg chlorpromazine equivalence per
day (SD = 691), and the average dosage of anticholingeric medication (Benzhexol)
was 4 mg (SD = 3). At follow up, the average daily dosage of antipsychotic
medication was 829 mg chlorpromazine equivalence per day (SD = 688), and the
average dosage of anticholingeric medication was 5 mg (SD = 3). Study 3 subscale
scores are shown in Table 4.3. Item prevalences are shown in appendix 3c.
Table 4.3. Longitudinal comparison of SNS among Chronic patients
Baseline 3 year follow-up Paired t-tests
SNS subscales Mean (SD) Mean (SD) p-value
Motor coordination (n = 36) 22.86(28.64) 29.84 (31.4) 0.0321
Sensory integration (n = 25) 14.5 (21.25) 25.5 (22.09) 0.0364
Disinhibition (n = 26) 13.46 (13.66) 28.85 (19.29) 0.0002
Study 4
Study 4 was a longitudinal study ofmotor SNS in first episode schizophrenia,
schizophreniform psychosis and schizoaffective psychosis. Consecutive subjects
were recruited from a defined catchment area (Hong Kong Island and off shore
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Islands). Subjects presented with a psychotic disorder for the first time to outpatient
or inpatient services based at QMH and PYNEH (Appendix I). DSM-IV diagnoses
were made using the SCID. Clinical and cognitive assessment, as well as an abridged
version of the CNI (covering mostly motor coordination signs) was employed in the
study. Subjects were assessed as soon as possible after contact, and then again after
the psychotic symptoms were stabilized. They were then followed up longitudinally
on a four-monthly basis. At the time ofwriting, all subjects have been followed up
for at least 2 years after stabilization from the first episode.
Data from 68 patients (30 male and 38 female) with initial diagnosis of schizophrenia,
schizophreniform psychosis or schizoaffective disorder are analyzed. The mean age
was 32.9 (s.d. 9.5) years. Average duration of untreated psychosis (DUP) was 562
days (s.d. 906, in 7 subjects the DUP could not be reliably ascertained). The DSM-IV
diagnoses and medication are presented in the Tables 4.4 and 4.5.
Table 4.4. Diagnoses in first episode patients
SCID Diagnosis Percentage
Schizophrenia-disorganized type 1 (1.5%)
Schizophrenia-paranoid type 28(41%)
Schizoaffective disorder 2 (3%)
Schizophreniform disorder 28(41%)
Schizophrenia-Undifferentiated type 9 (13.5%)
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Table 4.5. Medication dose prescribed for first episode patients
Schizophrenia (n = 68)
Initial contact Clinical stablization
Mean SD Mean SD
Chlorpromazine equivalence (mg/day) 171.97 490.17 348.49 352.31
Benzhexol (mg/day) 5.92 5.95 5.3 2.94
Clozapine at stabilization n = 1, Risperidone at stabilization n = 5, Benzhexol at stabilization
n = 43
A matched control group was drawn from a larger pool of normative data from study
1 (see above) so that the age and the education level matched those in the patient
group. Table 4.6 shows that the mean age for the 68 normal subjects (22 males, 46
females) was 32 years (SD = 8.4), and the number of years of education was 9.4
years (SD = 2.6). There was no significant difference between patients and controls
in these variables. In addition, 34 patients were assessed in a medication-nai've state
(50%), the rest were assessed within 7 days of starting medication. They do not differ
significantly on the demographic variables (Table 4.7).




Mean SD Mean SD
Age 32.9 9.5 32.0 8.4
Education level (years) 10.2 3 9.4 2.6
Gender (M:F) 30 : 38 22:46
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Table 4.7. Comparison of motor coordination signs between recently-










Education level (years) 9.9 3
Gender (M.-F) 15:19








The CNI subscale scores at the initial assessment are summarized below (Table 4.8).
The basic scores for the patients at first assessment were listed separately for those
who were assessed in medication-nai've state and those assessed after they have been
recently medicated (Table 4.9). Item prevalences are presented in appendix 3d.
Table 4.8. Comparison between patients and healthy control subjects
First episode patients Matched controls
Mean SD Mean SD
Motor subscale* 1.74 2.00 0.85 1.33
*p<0.003, unpaired t-test
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Table 4.9. SNS comparison between medication-naive patients, recently-
medicated patients and healthy control subjects at initial presentation
Medication-nai've Recently- Matched controls
patients medicated patients
(n = 34) (n = 34) (n = 68)
Mean SD Mean SD Mean SD
Motor subscale score* 1.68 2.06 1.79 1.97 0.85 1.33
*p<0.05 for both ANOVA and Kruskal-Wallis Test between medicated cases and normal
control subjects
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5 Demographic and clinical correlates of SNS
Introduction
This chapter describes a study of the relationships between SNS and key
demographic variables: age, gender, ethnicity, education level and intelligence level,
as well as illness duration and clinical correlates. The relationship between age and
SNS is a complex issue in cross sectional studies as it is confounded by illness
duration. Additional analyses to evaluate the relative importance of age and illness
duration are attempted.
Education and intelligence level, and gender effects
The relationship between SNS, education level, intelligence level, as well as gender
is explored within each healthy control subjects and patients groups in studies 1 and
2. Further data of interest from studies 3 and 4 (not primarily addressing these issues)
will be presented in later chapters.
Chinese healthy control subjects
In the Chinese control sample, lower education level is modestly but significantly
correlated with increased motor coordination signs (rho = -0.34, p = 0.001) (Table
5.1). Older age tends to correlate with motor soft neurological signs (rho = 0.21, p =
0.05). Verbal IQ estimates were also significantly correlated with motor soft
neurological signs (rho = -0.26, p = 0.04) and sensory integration signs (rho = -0.33,
p = 0.008). The modest but significant correlation between age and motor SNS in the
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control group is notable as this relationship is not complicated by the confounding
variables of age of onset and illness duration as in the patient sample (see below).
Table 5.1. Correlations between soft neurological signs and demographic







Age Pearson 0.13 0.09 0.13
Spearman 0.21* 0.06 0.16
Education level Pearson -0 35**** -0.23* -0.17
Spearman -034**** -0.18 -0.22
Intelligence level Pearson -0.3* -0.33** -0.22
Spearman -0.26* -0.33** -0.18
*p<0.05, **p<0.01, ***p<0.005, ****p<0.001
Comparison between SNS in male and female healthy subjects initially revealed that
significantly more motor coordination signs were found in female subjects in the
Chinese normal sample (Table 5.2). Male and female subjects appeared to be
matched for age but female subjects had a lower education level. Since SNS scores
may co-vary with education level, an ANCOVA controlling for education level was
conducted with SNS scores as dependent variables. No significant difference was
found in sensory integration [F(l,91) = 2.329, p>0.05], disinhibition [F(l,91) = 0.33,
p>0.05], and total soft signs [F(l,91) = 1.327, p>0.05]. However there was a
persisting trend for female subjects to have higher motor coordination signs than
their male counterparts [F(1,91) = 4.665, p = 0.03] (significance level after multiple
comparison correction = 0.0125).
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Table 5.2. Comparison between male and female Chinese healthy control
subjects
Male Female
CNTCOII (n = 62)
Mean SD Mean SD t-value df p-value
Age 39.8 13.9 37.6 12.3 0.81 92 0.4188
Education level 9.5 3.1 8.6 2.93 1.40 92 0.1657
Motor coordination 5.6 10.6 13.2 15.4 -2.84 91 0.0055
Sensory integration 8.5 12.2 9.9 10.9 -0.56 91 0.5733
Disinhibition 9.4 13.5 10.5 11.8 -0.41 92 0.6819
Total soft signs score 22.0 23.8 33.6 27.2 -2.02 91 0.0455
Chinese schizophrenic patients
Amongst Chinese schizophrenic patients motor coordination and disinhibition signs
were correlated with age, intelligence level, and illness duration (see Table 5.3). All
SNS were correlated with education and intelligence levels. This is supported by
both parametric and non-parametric analyses.
Table 5.3. Correlations between neurological signs and demographic








Age Pearson Q 2 J **** 0.14 0.20**
Spearman 0 30**** 0.08 0.19
Education level Pearson -0 33**** -0 33**** -0 25****
Spearman -0 33**** -0 31 **** -0.22***
Intelligence level Pearson -0 46**** -0 45**** -0 35****
Spearman -0 47**** -0.55**** -0 36****
Duration of illness Pearson Q 0.12 0 22***
Spearman 0 30**** 0.11 Q 23****
*p<0.05, **p<0.01, ***p<0.005, ****p<0.001
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In Chinese schizophrenic patients, male and female subjects do not appear to differ in
the SNS scores after multiple group comparison adjustment. Non-parametric
Wilcoxon test indicated similar results (Table 5.4).
Table 5.4. Comparison between male and female Chinese patients
Male Female
(n=120) (n = 75)
Mean SD Mean SD t-value df p-value
Age 40.4 12.0 39.5 12.6 0.540 191 0.5898
Education level (year) 8.2 3.3 7.9 3.6 0.488 CO OO 0.6264
Duration of illness (year) 15.7 9.9 14.1 9.6 1.160 193 0.2473
Chlorpromazine
equivalence (mg/day) 822 111 1168 1296 -2.091 191 0.0389
Benzhexol (mg/day) 3.07 3.11 3.73 3.72 -1.344 192 0.1804
Motor coordination 18.3 24.8 24.3 26.7 -1.597 191 0.1118
Sensory integration 18.0 21.1 25.6 40.3 -1.632 176 0.1045
Disinhibition 13.8 13.0 18.2 15.4 -2.001 133.32 0.0475
Total soft signs score 48.23 46.83 65.93 7.99 -2.078 171 0.039
Caucasian healthy control
Table 5.5 summarizes the correlations between demographics and soft neurological
signs. In healthy Caucasian subjects, lower intelligence level is associated with
increased motor coordination (rho = -0.27, p = 0.02) and sensory integration soft
signs. Increased motor soft signs are also correlated with older age. The same pattern
is found with non-parametric analysis. There appears to be no significant gender
effect on SNS as shown in Table 5.6. This conclusion is however limited by a
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relatively small sample size for female subjects (n=15).
Table 5.5. Correlations between soft neurological signs and demographic
variables among Caucasian healthy control subjects
Correlation
coefficients Motor coordination Sensory integration Disinhibition
Age Pearson 0.29** 0.11 0.1
Spearman 0.30** 0.13 0.06
Intelligence level Pearson -0.30** -0.32*** -0.22
Spearman -0.27* -0.34*** -0.18
*p<0.05, **p<0.01, ***p<0.005, ****p<0.001
Table 5.6. Comparison of prevalence of neurological signs between male and
female Caucasian healthy control subjects
Male Female
(n = 65) (n = 15)
Mean SD Mean SD t-value df p-value
Motor coordination 5.6 9.0 9.6 15.1 -0.985 78 0.339
Sensory integration 16.9 17.6 13.3 16.0 0.723 78 0.472
Disinhibition 5.6 9.1 8.3 10.2 -1.032 78 0.305
Total SNS 28.1 25.6 26.5 6.8 -0.428 78 0.67
Caucasian schizophrenic patients
Amongst Caucasian patients, no significant correlation was found between SNS and
either age or illness duration (Table 5.7). Medication dosages were inversely
correlated with disinhibition signs (r = -0.31,p<0.05; rho = -0.32, p<0.05). As in the
control subjects, there were no gender differences in the prevalence of neurological
signs in Caucasian schizophrenic patients (Table 5.8).
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Age Pearson 0.17 0.12 0.09 0.07
Spearman 0.12 0.04 0.12 -0.02
Duration of illness Pearson 0.12 0.14 0.2 0.05
Spearman 0.04 0.01 0.22 -0.06
Medication Pearson -0.10 -0.02 -0.31* -0.2
Spearman -0.20 0.18 -0.32* -0.17
*p<0.05, **p<0.01, ***p<0.005, ****p<0 001
Table 5.8. Comparison of prevalence of neurological signs between male and
female Caucasian patients
Male Female
mII (n = 18)
Mean SD Mean SD t-value df p-value
Age 40.0 11.4 37.9 10.7 0.6606 50 0.5119
Duration of illness 18.0 10.7 15.8 8.3 0.7165 40 0.4778
Chlorpromazine
equivalence (mg/day) 2031.4 3041.9 1155.1 1835.7 1.1163 50 0.2696
Motor coordination 44.1 28.1 43.8 32.7 0.0313 45 0.9752
Sensory integration 45.5 27.9 36.8 23.0 1.0714 42 0.2901
Disinhibition 17.9 15.8 20.1 14.3 -0.4966 44 0.6219
Total soft signs score 103.2 55.6 95.8 49.7 0.4298 37 0.6698
Summary of key findings
On the whole there are significant associations between most SNS subgroups and age,
verbal intelligence, as well as education level. Amongst the SNS subscales the
relationship between motor coordination and age appears most robust. There is a
suggestion of gender effect (more SNS in female subjects in the HK control sample)
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but this might be related to sampling bias and will require further studies to confirm.
Ethnicity effects
SNS scores from normative samples from study 1 (Chinese) and study 2 (Caucasian)
were compared, taking into consideration potential confounding effects of other
variables. Scores from patient samples could not be directly compared as the clinical
state of the two patient samples were not directly comparable.
Demographic characteristics in normative samples
Table 5.9. Comparison of demographic variables between Caucasian and





1? II CO o (n = 94)
Mean SD Mean SD
Age 42.09 13.68 38.34 12.87
Intelligence level 112.5 6.5 95.3 8.6
Education level N/a N/a 8.87 2.99
Gender (M:F) 65:15 32: 62
Table 5.9 shows that no significant difference was found between the Caucasian and
Chinese normative samples in age (t(l72) = 1.859, p>0.05). However, the Chinese
sample comprised significantly more female subjects than their Caucasian
counterparts (chi-square (1) = 39.041, p <0.0005).
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Soft neurological signs in normative samples
Analyses of subscales scores show that Chinese healthy subjects tended to score
higher in the motor coordination and the disinhibition subscales, whereas Caucasian
healthy subjects tended to score higher in the sensory integration subscale (Table
5.10).
Table 5.10. Prevalence of SNS between Caucasian and Chinese healthy
control subjects
Caucasian normal Chinese normal
(n = 80) (n = 94)
Mean SD Mean SD t-value df p-value
Motor coordination 6.39 10.43 10.64 14.38 -2.252 167.9289 0.0256
Sensory integration 16.25 17.27 9.41 11.31 3.028 132.5478 0.0030
Disinhibition 6.09 9.33 10.11 12.33 -2.439 169.7467 0.0157
Analyses of covariance (ANCOVAs) were carried out between Chinese and
Caucasian healthy control subjects, controlling for age and intelligence. In this
analysis there was no significant ethnicity effect on the total SNS scores. Analyses of
subscales scores however suggest that after correction for multiple comparisons,
there was a trend [F( 1,161) = 5.80, p=0.017] for Caucasian healthy subjects to have
higher sensory integration signs than their Chinese normal counterparts.
Summary of findings
There is no significant difference in total SNS scores between normal Chinese and
Caucasian subjects. However there was a trend for Chinese subjects to have lower
score in the sensory integration subscale.
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Clinical correlates
The relationship between SNS and clinical picture was explored by correlation
analysis between each subgroup of SNS and individual items in clinical symptom
rating scales. Table 5.11 summarizes the relationships between neurological soft
signs and symptoms. When the entire sample was considered, modest correlations
were found between motor coordination and HEN speech domain (rho = 0.16,
p<0.05) and HEN thought domain (rho = 0.2, p<0.01). These correlations however
become trends upon corrections for multiple comparisons.
In addition, motor coordination was also inversely correlated with anxiety factor of
the BPRS (rho = -0.25, p<0.001). Sensory integration and disinhibition were
inversely correlated with positive symptoms of BPRS (r = -0.18, p<0.05).
Disinhibition was also inversely correlated with positive symptoms of BPRS (r = -
0.155, p<0.05). Once again, all these relationships would become trends after
corrections for multiple comparisons.
When correlation analysis is carried out separately for male and female subjects an
interesting pattern emerged. In female patients, the "thought" domain of the negative
symptom scale HEN was significantly correlated with motor coordination (r = 0.37,
p = 0.001), with sensory integration (r = 0.36, p = 0.003), as well as total SNS (rho =
0.42, p = 0.0005). In contrast, there was no significant correlation between SNS and
HEN symptom domains in male patients.
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Summary of findings
Correlation between SNS and symptoms are modest. However, when males and
females subjects were considered separately, there is a significant correlation
between SNS and "thought" subscale of the negative symptom rating scale HEN.
Table 5.11. Symptom correlates of neurological soft signs in patients
HEN HEN HEN HEN HEN HEN BPRS BPRS BPRS BPRS BPRS
Appear- Behavior Speech Thought Affect Function-negative positive affective anxiety thought
ance ing symptom symptom symptom
MC
All patients 0.06 0.04 0.18* 0.17* 0.11 0.08 0.08 -0.17* -0.04 -0.20* -0.06
Male 0.08 -0.03 0.19* 0.09 0.08 0.16 0.14 -0.17 -0.11 -0.22* -0.16
Female 0.08 0.18 0.24* 0,37*** 0.20 0 0.07 -0.24* 0.07 -0.17 0.02
SI
All patients 0.03 0.01 0.09 0.13 -0.02 0.04 0.02 -0.18 -0.06 -0.13 -0.08
Male 0.02 -0.12 0 0.03 -0.08 -0.06 -0.02 -0.26** -0.10 -0.10 -0.12
Female 0.08 0.17 0,25* 0,36*** 0.09 0.16 0.16 -0.20 -0.04 -0.18 -0.08
DI
All patients 0.08 -0.04 0.10 0.08 -0.04 0 0.03 -0.12 0.06 -0.13 0.04
Male 0.23* -0.03 0.18 0.13 0.02 0.12 0.06 -0.09 0.04 -0.11 -0.07
Female -0.05 -0.03 0.05 0.08 -0.06 -0.13 0 -0.32** 0.06 -0.04 0.12
Total SNS
All patients 0.10 0.02 0.13 0.18* 0.04 0.07 0.04 -0.19* -0.02 -0.17 -0.05
Male 0.11 -0.10 0.10 0.13 0 0.07 0.06 -0.22* -0.08 -0.17 -0.16
Female 0.15 0.22 0.29* 0.42*** 0.15 0.11 0.15 -0.25* 0.04 -0,17 0.01
MC, motor coordination; SI, sensory integration; DI. Disinhibition. *p<0.05, **p<0.01,
***p<0.005, ****p<0.001, Pearson correlation coefficient
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Age and illness duration effects
In this Section a more detailed exploration of the relationship between SNS and the
variables "age" and "illness duration" is attempted. The use of a cross sectional
sample has inherent limitations in addressing these issues, however it has the
advantage of being able to cover a wide range of different ages and illness durations.
Since longitudinal studies addressing a long follow-up period (spanning decades) is
difficult to carry out, as much information as possible should be extracted from
analyses of cross sectional samples. Longitudinal studies addressing specific stages
of the illness, with shorter follow-up periods (2 to 3 years) will be presented in later
Chapters.
Simple correlations between age and SNS have been presented in the previous
sections. Correlation coefficients however would be compromised if there were non-
linearity in the relationship between SNS and age or illness duration. For instance,
the relationship between the variables could be more pronounced at a particular age
range, rather than over the entire age range. Attempt was made to address this by
grouping subjects according to age or illness duration, and then making comparisons
between the groups.
In the first stage of the analysis, effect of age was assessed by stratifying the sample
into groups of different ages and then comparing the level of SNS between them.
Following this, patients are re-categorized into groups of different illness duration
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and their levels of SNS are compared. A further comparison was carried out by
contrasting SNS in groups of younger and older patients with long and short illness
durations.
Age effects
Patients and healthy controls were assigned to four groups according to age (16-25,
26-35, 36-45, >45). ANOVA with linear trend analysis was first carried out to
ascertain if there were linear and non-linear relationships between SNS scores and
age. F value and p value for the weighted linear term were reported. This was
followed up with ANCOVA for patient and for control groups separately using
education level as a covariate, and SNS scores as dependent variables.
Characteristics of patients in each group are summarized in Table 5.12 below. The
four groups did not differ significantly in terms of gender proportion (chi-sq (3) =
1.01, p>0.05) and medication [F(3,190) = 1.13, p>0.05]. However, significant
differences were found in education level among the four groups [F(3,186) = 6.19,
p<0.0005]. Post-hoc analyses showed that Group IV (age >45) was significantly less
educated than Group I (age 16-25) (p<0.03) and Group II (age 26-35) (p<0.003).
In addition, as expected, differences were found in illness duration between the
groups [F(3,191) = 55, p<0.0005]. Post-hoc analyses indicated that Group I (age 16-
25) had a significant shorter illness duration than Group III (age 36-45) (p<0.0005)
and Group IV (age >45) (p<0.0005). At the same time, Group II (age 26-35) also had
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significant short illness duration than Group III (age 36-45) (p<0.0005) and Group
IV (age >45) (p<0.0005), whereas Group III (age 36-45) had significant shorter
illness duration than Group IV (age >45) (p<0.0005).
Table 5.12. Comparisons of demographic variables among different age
groups in patients
Group I Group II Group III Group IV
(age 16-25) (age 26-35) (age 36-45) (age 46 +)
(n = 26) (n = 45) (n = 51) (n = 64) F-value
Mean SD Mean SD Mean SD Mean SD Chi-sq p-value
Age 22.1 2.9 30.1 2.7 39.7 2.5 53.4 5.7 515.21 <0.0005
Gender (M:F) 16:10- 25:20- 31:20- 40:24- 1.01 0.799
Duration of illness
(year) 4.1 3.4 8.8 5.6 15.8 6.9 22.3 9.1 55 <0.0005
Education level
(year) 9.3 1.8 9.4 2.9 7.7 3.6 6.9 3.7 6.19 <0.0005
Chlorpromazine
equivalence
(mg/day) 884.6 953.8 818.3 768.8 1204.5 1103.3 788.6 808.5 1.13 0.338
Benzhexol
(mg/day) 2.46 2.85 3.5 3.9 3.7 3.3 3.2 3.1 0.72 0.543
Group I: age 16-25; Group II age 26-35; Group III age 36-45; Group IV age >45
Analysis of variance with linear trend analysis revealed that there was a significant
linear trend increase in total SNS across age groups [weighted linear term, F(1,169)
=5.2, p=0.023], Subscale scores analysis showed that the increase was found in the
motor coordination [weighted linear term, F(1,189) =12.5, p=0.003] and disinhibition
subscales [weighted linear term, F(l,180) = 5.46, p = 0.02] but not in the sensory
integration subscale [weighted linear term, F(l,174) = 2.16, p=0.42] (Figure 5.1).
Since significant differences were found among the age groups in terms of education
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level [F(3,186) = 6.193, p<0.0005]. ANCOVA was carried out to control for
education level. After this adjustment, no significant difference was found among age
groups as a whole [F(3,183) = 2.377, p <0.1], post-hoc analysis indicated however
that the 16-25 age group had significantly lower motor coordination signs than others
groups (t = 2.088, p = 0.038) and group above 45 years had significantly higher
motor signs than the rest (t=2.222, p = 0.027). The other soft sign subscales and total
soft signs scores did not differ significantly across age groups.
These results indicate increase in motor coordination signs and disinhibiton signs
with older age. However this is complicated by the tendency towards lower
education level in these groups. The relationship with age was no longer significant
in further analysis of covariance taking into consideration of education level. Thus on
the whole the data did not suggest an unequivocal deterioration of soft signs
associated with age across a wide age span. A noteworthy remark is that post hoc
analysis identified that at the extremes of ages; there may be a difference in motor
coordination signs (the youngest patients have less, and the oldest patients have more,
but patients in between are not significantly different from one another). This
possibility cannot be ruled out since any such specific effects at either ends of the age
range would have been "diluted" by relative stability of SNS levels in the middle age
ranges.
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Figure 5.1: The prevalence of soft neurological signs among different age
groups
To summarize, this initial analysis suggests that there is a trend for SNS (total SNS,
motor coordination and disinhibition) increase associated with age. However, the
relationship with age became non-significant after controlling for education level.
Illness duration effects
Similar to the analysis of age, patients were categorized into six groups according to
illness duration (Group I: less than 5 years; Group II: 6-10 years; Group III: 11-15
years; Group IV: 16-20 years; Group V: 21-25 years; Group VI: more than 25 years).
The six groups did not differ significantly in terms of gender proportion (chi-square
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(5) = 2.37, p>0.05) and medication dosage [F(5,188) = 1.85, p>0.05] (Table 5.13).
ANOVA on duration of illness with linear trend analysis was conducted. F value and
p-value for the weighted linear term were reported. Characteristics of patients in
illness duration groups are summarized in the table. Significant differences were
found among the groups in terms of age [F(5,187) = 29.27, p<0.0005] and education
level [F(5,184) = 4.41, p= 0.001].
Post-hoc analyses indicated that Group I was significantly younger than Group III (p
= 0.001), Group IV (p<0.0005), Group V (p<0.0005), and Group VI (p<0.0005).
Group II was also significantly younger than Group IV (p<0.0005), Group V
(p<0.0005), and Group VI (p<0.0005). Group III was significantly younger than
Group V (p<0.001), and Group VI (p<0.0005). At the same time, Group VI had
significantly lower education level than Groups I and II.
Table 5.13. Comparison of demographic variables among different illness
duration groups
Group I Group II Group III Group IV Group V Group VI
(n=39) (n=33) (n=37) (n=26) (n=23) (n=28) F-value p-value
Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD chi-sq
Age 29.4 10.3 33.1 8.7 37.3 9.1 45.5 9.5 48.3 7.5 52.0 7.5 29.27 <0.0005
Education level 9.4 2.9 9.1 3.1 7.2 2.9 oqOO 8.1 3.3 6.1 3.9 4.41 0.001
Gender (M:F) 21:18 21: 12 22:15 19:7 15:8 19:9 2.37 0.80
Group I: illness duration 0-5; Group II illness duration 6-10; Group III illness duration 11-15;
Group IV illness duration 16-20; Group V illness duration 21-25; Group VI illness duration
>25
ANOVAwith linear trend analysis revealed that there was a significant linear
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increase in total SNS associated with longer illness duration [weighted linear term
F(l, 167) = 13.3, p=0.0004]. Amongst the subscales, motor coordination signs
increased as the duration of illness increased [weighted linear term F(l, 187) = 18.86,
p<0.00005]. There was a trend increase for sensory integration signs [weighted linear
term F(l,172) =4.0, p = 0.04] and disinhibition signs [weighted linear term F(l,178)
=7.8, p = 0.015], However, they became non-significant after correction for multiple
comparisons.
ANCOVAs were also carried out using SNS scores as dependent variables, illness
duration as the independent class variable, controlling for education level. Significant
difference was still found in motor coordination signs among groups [F(5,181) =
3.677, p= 0.003], Post hoc analysis revealed that patients with 16-25 years of illness
had significantly lower motor coordination signs than others and those with over 25
years illness duration had significantly higher motor signs than the rest. The other
soft sign subscales and total soft signs scores did not differ significantly across
illness-duration groups.
This analysis shows that motor coordination signs increase with illness duration,
even after controlling for education level and accounting for multiple comparisons.
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Subgroups with different illness duration and age
In a further examination of the relative effects of age and illness duration, patients
are assigned into one of the following four subgroups, Group I (n=16) consists of
those with older age (>38) but a shorter illness duration (<12); Group II (n=17)
consists of those with younger age (<38) but a long illness duration (>12); Group III
(n = 74) consists of those with older age (>38) and a longer duration of illness (>12);
Group IV (n = 61) consists of those with younger age (<38) and shorter illness
duration (n = 12). One-way ANOVA was conducted among these groups (Table 5.14).
Post hoc comparisons between individual groups were also carried out. In addition, a
further analysis controlling for education level was conducted.
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Table 5.14. Comparisons of demographic characteristics and SNS among
patient groups with different age and illness duration
Group I Group II Group III Group IV
Older Younger Older Younger
Shorter ID Longer ID Longer ID Shorter ID
(n = 16) (n = 17) II (n = 61) F-value p-value
Mean SD Mean SD Mean SD Mean SD














coordination 7.64 13.89 18.30 22.20 26.43 28.30 13.30 20.57 4.71 0.0035
Sensory
integration 12.19 11.79 24.26 13.60 25.00 40.54 17.21 21.43 0.458 0.712
Disinhibition 8.59 10.92 22.06 12.91 16.89 15.40 11.89 12.38 4.16 0.007
Total soft signs
score 28.42 23.02 64.62 32.87 68.32 67.98 42.40 43.97 4.08 0.008
ID: illness duration, Group I: Age>=38 & Du<=12; Group II: Age<38 & D>12; Group III: Age>=38 & Du>12; Group IV:
Age<38 & Du<=12
Significant differences were found among the groups in terms of education level (F =
7.48, pO.OOOl) and information subscale (F = 3.21, p = 0.025). Post-hoc analyses
indicated Group IV had significantly higher education level than Group II (p = 0.004)
and Group III (p = 0.0002). Group IV also received more education than Group III (p
= 0.05).
In the neurological soft signs, significant differences were found among the groups in
motor coordination (F = 4.7, p = 0.0035), disinhibition (F = 4.16, p = 0.007), and
total soft signs scores (F = 4.08, p = 0.008).
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Post-hoc analyses indicated that Group III (older and longer illness duration)
exhibited significantly more motor coordination signs and total soft signs score than
Group I (older but shorter illness duration) (p = 0.03; p = 0.05, respectively), and
Group IV (younger and shorter illness duration) (p = 0.01; p = 0.04, respectively);
but was not significantly different from Group II (Younger but longer illness
duration). This would suggest that for total SNS and motor coordination signs, illness
duration has a more important effect than age per se.
Likewise for disinhibition signs, Group II (younger age with longer illness duration)
demonstrated significantly more disinhbition signs than Group I (older but with
shorter illness duration) (p = 0.03) and Group IV (younger and shorter illness
duration) (p = 0.04). This also suggests that illness duration has a more profound
effect on disinhibition signs.
Table 5.15. Post-hoc analysis of demographic characteristics and SNS







Gp II vs Gp II vs
Gp III Gp IV
Gp III vs Gp
IV
Education level ns ns ns ns 0.004 0.0002
Intelligence ns ns ns ns ns 0.05
Motor coordination ns 0.03 ns ns ns 0.03
Sensory integration ns ns ns ns ns Ns
Disinhibition 0.03 ns ns ns 0.04 Ns
Total soft signs score ns 0.05 ns ns ns 0.04
Group I: Age>=38 & Du<=12; Group II: Age<38 & D>12; Group III: Age>=38 & Du>12; Group IV: Age<38 & Du<=12
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ANCOVA controlling for education level
In view of the significant differences in education level found among the groups, an
ANCOVA controlling for education level was conducted. After controlling for
education level there was no main effect on age and illness duration found in motor
coordination [F(3,186) = 2.545, p>0.05], sensory integration [F(3,170) = 0.458,
p>0.05], disinhibition [F(3,174) = 2.215, p>0.05], and total soft signs score [F(3,165)
= 1.94, p>0.05].
Post-hoc analyses indicated that Group III (older and longer illness duration)
exhibited significantly more motor coordination signs than Group IV (younger and
short illness duration) (p = 0.03), but was not significantly different from Group II
(Younger but longer illness duration). This would also support the position that for
motor coordination signs illness duration has a more important effect than age per se.
Likewise, Group II (younger age with long illness duration) demonstrated
significantly more disinhbition signs than Group I (older but with shorter illness
duration) (p = 0.04) and Group IV (younger and shorter illness duration) (p = 0.04).
Once again, this suggests that illness duration has a more profound effect.
Section Summary
This section presents further analysis of the effects of age and illness duration. Firstly
patients and control groups were divided into subgroups of different ages and SNS
scores were compared. After consideration of co-variation with education level, there
was no significant different between subgroups of different ages. It was noted in post
hoc analysis however that, in the patient groups, the extremes of lower age and
higher age had less and more SNS respectively. Patients were then grouped
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according to illness duration and then compared. There was a significant increase in
motor coordination signs associated with illness duration. Finally patients were
grouped according to both age and illness duration in to four groups. Although after
controlling for education level, there was no overall difference in SNS, post hoc
analysis indicated that patient with long illness duration (whether younger or older)
had more SNS.
Summary of findings for Chapter 5
There are correlations between SNS, education level and intelligence level. Overall
gender effect of SNS is not apparent although there may be a trend difference in
motor coordination. There is a gender difference in the pattern of correlation with
symptoms. Though there is no unequivocal ethnicity effect for total SNS, there is a
suggestion that sensory integration signs might be lower in Chinese subjects.
Relationship with symptoms is very modest apart from a relationship with the
"thought" domain in negative symptoms amongst female patients. There is an effect
of illness duration on the level of SNS which appears to be more important that the
effect of age per se.
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6 SNS and cognitive functions
Introduction
In this chapter the relationship between cognitive function domains and neurological
signs is considered. The exploration starts with correlation relationships between
SNS and cognitive functions. When relationships between a larger numbers of
domains are considered, correlation analysis on its own may be insufficient. This is
particularly important when internal correlations exist between these variables. The
questions then arise as to the extent to which the correlation between one variable
and another is mediated by their mutual correlation with a third variable. Regression
analyses were carried out to take into account internal correlation amongst variables.
Cognitive correlates related to age, education, and illness
duration
Preliminary correlation analysis was carried out to assess the extent to which
cognitive performance were related to variables such as age, illness duration and
education level. The sample consisted of 195 patients from Study 1.
After correction for multiple comparisons (Bonferroni method), there were
significant correlations between age and sustained attention, verbal performance,
verbal fluency, visual reproduction, and Wisconsin Card Sorting Test criterion score
(Table 6.1). Significant correlations were also found between education level
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sustained attention, verbal performance, verbal fluency, logical memory, and visual
reproduction, and perseverative error and category score in Wisconsin Card Sorting
Test. These results indicate that similar to SNS, a number of cognitive functions are
correlated with age, education level and illness duration. Therefore, in further
exploration of the relationship between SNS and cognitive functions, age, education
level, and illness duration were controlled for in the partial correlation analysis.
Table 6.1. SNS correlates of age, education level, and neurocognitive
functions
Age Education level
Attention -0 29**** Q 44****
Logical memory _Q 24**** Q 29****
Digit span forward -0 35**** 0 5i****
Verbal intelligence -0 39**** 0.66****
Verbal fluency -0 29**** Q 41****
Visual memory -0 43**** 0 52****
WCST perseverative errors 0 21*** -0 29****
WCST category -0 31 **** 0 36****
*p<0.05, **p<0.01, ***p<0.005, ****p<0.001
Relationship between SNS and cognitive functions: partial
correlation analysis
Correlation analysis of the relationship between neurological signs and cognitive
performance was carried out using partial correlation coefficients controlling for age
and education level (Table 6.2). Because of the large number of correlation analyses,
Multiple comparisons were allowed for by adjusting the significance level to 0.0015
(for 33 comparisons). The results indicate that motor coordination soft signs are
related to sustained attention, verbal fluency, verbal and visual memory functions,
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verbal intelligence whereas sensory integration signs are primarily related to verbal
intelligence. There is however some overlap in these relationships (both motor
coordination and sensory integration are related to digit span, verbal intelligence and
visual memory). The relationship between disinhibition signs and cognitive functions
appeared less prominent.
Table 6.2. Partial correlation coefficients between soft neurological signs and
neurocognitive functions (controlling for age and education level)
Attention Logical Digit Inform Compre Similarity Verbal IQ Verbal Visual WCST p WCST c
forward fluency memory
memory span
Motor -0.3* -0.17 -0.27* -0.2 -0.17 -0.18 -0.3* -0.29* -0.35* -0.04 -0.01
Sensory -0.21 -0.21 -0.35* -0.41* -0.33* -0.3* -0.44* -0.26 -0.27* 0.14 -0.22
Disinhbition-0.15 -0.07 -0.25 -0.15 -0.07 -0.16 -0.22 -0.17 -0.21 -0.03 -0.05
lnform:lnformation,Compre:Comprehenion,WCST p: WCST perseverative errors, WCST c:
WCST categories score. *Statistically significant after adjustment for multiple group
comparison (p<0.0015)
Factor analysis of cognitive function and neurological signs:
From another perspective, an exploration of the relationship between cognition and
neurological signs was carried out using factor analysis (principal component
analysis with varimax rotation). The analysis starts with no prior assumption about
the grouping of neurological signs and cognitive function domains. All key domains
in both cognitive function as well as SNS are included. Two factors with eigenvalues
greater than one were extracted, accounting for 57 percent of the variance (Table 6.3).
It is noteworthy that the analysis treated each variable (whether cognitive function or
neurological signs) on an equal basis. The result was that cognitive functions loaded
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on one factor whilst neurological signs loaded on another factor. This result supports
the construct of SNS as reflection of a functional domain that can largely be
considered separately from cognitive function domains.
Table 6.3. Factor analysis of soft neurological signs and neurocognitive
domains
Factor 1 Factor 2 Eigenvalues % of Variance Cumulative %
VIQ 0.82 -0.36
Logical memory sum 0.74 -0.11
WCST perseverative error -0.72 -0.13
Visual memory 0.67 -0.41
Verbal fluency 0.59 -0.37
Attention 0.45 -0.37 2.86 31.73 31.73
Disinhibition 0.00 0.82
Motor coordination -0.18 0.78
Sensory integration -0.31 0.66 2.30 25.59 57.32
Principal Component Analysis with Varimax Rotation
Regression analyses
Since domains of cognitive functions, as well as SNS are mutually correlated,
regression analysis is carried out to identify the most important features related to a
particular domain (the dependent variables). Since there was no prior assumption
about the relative status of SNS and cognitive functions (as dependent or
independent variables) analysis was carried out in both directions. In the first
instance, each SNS domain was treated as dependent variables with cognitive
domains as independent variables. In the second analysis, each cognitive domain was
treated as dependent variable and the SNS domains were treated as independent
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variables.
Soft signs as dependent variables
Significant cognitive contributors to motor coordination signs included sustained
attention and visual memory (Table 6.4). Significant contributor to sensory
integration signs included only verbal intelligence. Visual memory also contributed
to disinhibition signs
Table 6.4. Multiple stepwise regression analyses using each soft neurological
signs subscale as dependent variables






Step 1 visual memory -1.07 0.16 -0.46 -6.525 <0.000005 0.21 0.21
Step 2 visual memory -0.80 0.19 -0.34 -4.299 0.00003 0.24 0.04
attention -1.66 0.58 -0.23 -2.844 0.00503
Sensory
integration
Step 1 Verbal IQ -0.75 0.11 -0.48 -6.827 <0.000005 0.23 0.23
Disinhibition
Step 1 visual memory -0.45 0.11 -0.32 -4.240 0.00004 0.10 0.10
Soft signs as independent variables
Verbal IQ, sustained attention, logical memory, and visual memory were predicted by
both motor and sensory SNS. WCST category was predicted by sensory integration
(Table 6.5). However, none of the soft signs predicted WCST perseverative errors.
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Table 6.5. Multiple stepwise regression analysis using soft neurological signs as
independent variables
Unstandardized Standardized t-value p-value R Square R Square
Coefficients Coefficients
B Std. Error Beta Change
Verbal IQ
Step 1 Sensory SNS -0.21 0.03 -0.45 -6.644 <0.000005 0.21 0.21
Step 2 Sensory SNS -0.15 0.03 -0.32 -4.291 0.00003 0.28 0.07
Motor SNS -0.17 0.04 -0.30 -4.070 0.00007
Attention
Step 1 Motor SNS -0.05 0.01 -0.42 -6.010 <0.000005 0.18 0.18
Step 2 Motor SNS -0.04 0.01 -0.33 -4.252 0.00004 0.21 0.03
Logical memory
Step 1 Motor SNS -0.16 0.04 -0.27 -3.644 0.00036 0.07 0.07
Step 2 Motor SNS -0.12 0.05 -0.20 -2.369 0.01898 0.09 0.02
Sensory SNS -0.08 0.04 -0.16 -1.990 0.04826
Verbal fluency
Step 1 Motor SNS -0.66 0.12 -0.39 -5.424 <0.000005 0.15 0.15
Step 2 Motor SNS -0.48 0.14 -0.28 -3.546 0.00051 0.19 0.04
Visual memory
Step 1 Motor SNS -0.19 0.03 -0.46 -6.503 <0.000005 0.21 0.21
Step 2 Motor SNS -0.15 0.03 -0.37 -4.914 <0.000005 0.25 0.04
WCST category
Step 1 Sensory SNS -0.02 0.01 -0.26 -3.525 0.00055 0.07 0.07
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Summary of findings for Chapter 6
The analysis of relationship between cognitive function and SNS is complicated by
the fact that internal correlation exists between domains within these areas. Analyses
from several different perspectives have been carried out to obtain a richer picture.
Regression analyses also support a prominent contribution of verbal intelligence to
sensory integration signs. For motor coordination signs, in addition to verbal
intelligence, sustained attention and visual memory are significantly related.
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7 Longitudinal study in chronic schizophrenic patients
Introduction
This chapter presents a longitudinal study in which a sample of stable chronic
schizophrenic patients was studied with respect to SNS and followed up for 3 years
and reassessed. The sample consisted of 38 inpatients with chronic schizophrenia; the
characteristic of the sample was described in Chapter 4. Data analysis first compared
and identified any change in clinical parameters in the sample over the follow-up
period. It is important to recall that the mean age for this sample was 47.3 years and
the mean illness duration was 25.9 years.
Did clinical parameters remained unchanged at follow-up?
Symptom changes between baseline and year 3 were compared with paired t-tests
(Table 7.1). There was a significant reduction of negative symptoms at year 3.
Therefore in assessing change in SNS during the follow-up period it is important to
determine if it was related to negative symptoms changes.
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Mean SD Mean SD t-value p-value
Chlorpromazine equivalence
(mg/day) 844.61 690.75 828.78 687.55 -0.119 0.9058
Benzhexol (mg/day) 4.22 3.22 5.08 3.11 1.654 0.1069
HENS total
2.51
(1.02) 1.02 1.86 0.77 3.393 0.002
BPRS total 27.68 6.83 28.63 6.21 0.725 0.4733
MADRS total 2.89 3.74 1.74 2.39 1.906 0.0645
Extrapyramidal signs 13.16 13 17.43 14.1 2.012 0.057
HENS: High Royds Negativism Scale; BPRS: Brief Psychiatric Rating Scale; MADRS:
Montgomery Asberg Depression Rating Scale
Is there any deterioration in SNS during the follow-up period
Longitudinal comparison between soft neurological signs at year 1 and year 3 was
carried out using paired sample analysis (Table 7.2). There was a significant increase
in motor coordination, sensory integration, and disinhibiton signs.
Table 7.2. Longitudinal changes in neurological soft signs in chronic patients
Baseline 3-year
Follow up
Mean SD Mean SD p-value
Motor coordination (n = 36) 22.86 28.64 29.84 31.4 0.0321
Sensory integration (n = 25) 14.5 21.25 25.5 22.09 0.0364
Disinhibition (n = 26) 13.46 13.66 28.85 19.29 0.0002
- 118 -
Does the difference remain after controlling for negative
symptoms?
Since there was a change in negative symptoms across the follow-up period, within-
subject analysis of covariance was carried out to control for this variable. The
dependent variables are each of the SNS subscale scores. Difference in HEN score
was used as a covariate. Significant increase was present in motor coordination
(F=7.03, df=l,32; p=0.012) and disinhibiton signs (F=13.52, df=l,23; p=0.001),
trend increase was observed in sensory integration signs (F=3.53, df=l,22; 0=0.074).
Summary of findings for Chapter 7
Significant increase in motor coordination, sensory integration and disinhibition
signs were observed in a chronic patient sample in a longitudinal study of 3-year
follow-up period. The changes in motor coordination and disinhibition signs are still
significant after taking into account changes in negative symptoms.
This is a sample of patients without clinical relapse or substantial changes in
medication, and there was a decrease in negative symptom score in the follow-up
period. The data indicate that an increase in SNS was detected in spite of an
improvement in negative symptoms. Either aging or degenerative processes may
operate and they appeared to act independently ofmechanisms that mediate negative
symptoms.
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8 Longitudinal study in first episode psychosis
Introduction
In this Chapter data addressing motor soft neurological signs in the early stages of
schizophrenia and related psychosis are examined in more detail. In particular the
assessment ofmedication-naive patients and the longitudinal follow-up design (4-
monthly for 2 years) enable the data to address a number of research questions:
1. Are motor SNS increased in first episode patients?
2. Are motor SNS in first episode patients comparable to chronic patients?
3. Is there progression in the level of soft neurological signs in the first two
years of the illness?
4. Does motor SNS improve after resolution of the psychotic episode?
5. Do soft neurological signs deteriorate after a relapse?
6. Is there a phase-specific relationship between motor SNS and cognitive
function?
7. Is there a phase-specific relationship between motor SNS, clinical features,
and cognitive function?
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The data presented in this chapter is obtained in the context of a larger study
investigating the longitudinal changes in cognitive function following first episode
psychosis. The sample is a set of consecutively diagnosed patients from a defined
catchment area within Hong Kong (Hong Kong island and offshore islands). The
patients are assessed at the point of first contact (initial assessment), and then after
the resolution of the first psychotic episode (clinical stabilization). The mean
duration between the two time points is 42.5 days (SD = 37). Subsequently
assessments were carried out at regular intervals (4 monthly) for a period of 2 years.
Basic characteristics of the sample have been presented in Chapter 4.
Because of limitations in the length of the assessment session, it was not feasible to
incorporate the full CNI into the study. An abridged soft signs assessment consisting
of the motor coordination subscale was adopted. This choice was based on the earlier
observation that among the soft signs, sensory integration signs were more strongly
associated with verbal cognitive performance (see Chapter 6 for details), which are
already addressed by other cognitive function tests (WAIS information, WMS logical
memory, and semantic fluency). Extra-pyramidal signs and dyskinesia were assessed
by independent rating scales. The data that will be considered consists of signs in the
motor coordination subscale.
Sample characteristics
The clinical and neurocognitive profile of the sample at initial presentation are
presented in Table 8.1.
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Table 8.1. Clinical and cognitive profile of first episode patients
Mean SD
Clinical Profiles
PANSS positive 20.49 6.12
PANSS negative 16.88 7.52
PANSS general pathology 34.41 12.30







Logical memory (immediate) 36.51 17.79
Logical memory (delay) 29.07 17.59
Visual reproduction (immediate) 18.38 4.57
Visual reproduction (delay) 16.47 5.79
Information subscale 13.54 4.95
Forward digit span 11.07 2.25
Verbal fluency 16.15 5.04
WCST perseverative errror 8.22 9.26
WCST category score 3.75 2.00
PANSS: Positive and Negative Symptoms Scale; HEN: High Royds Evaluation of Negativity
MADRS: Montgomery and Asberg Depression Rating Scale; CAL: Calgary Depression Scale
YBSEV: Yale-Brown Obsessive Compulsive Scale; AIMS: Abnormal Involuntary Movement
Scale; SIMS: Simpson-Angus Movement Scale; BARNES: Barnes Akathisia Scale
Are motor soft signs increased in a first episode psychosis?
To address this question motor soft signs scores from patients were compared with a
control group matched for age and education level (Table 8.2).
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Table 8.2. Demographic data in first episode patients and healthy control
subjects
First episode patients Healthy controls
(n = 68) (n = 68)
Mean SD Mean SD
Age 32.9 9.5 32.0 8.4
Education level (years) 10.2 3 9.4 2.6
Gender (M:F) 30 : 38 22:46
The results are shown in the Table 8.3. Significant differences were found between
the two groups with a moderate effects size. Non-parametric analysis (Mann-
Whitney U-test) also confirmed a significant increase in motor soft sign in patients.
The result thus supports the notion that motor soft signs are increased in first-episode
schizophrenia.
Table 8.3. Comparison of motor SNS between first episode patients and
healthy control subjects
First episode Healthy t-value/ df p-value effect size
patients controls . .
z-statistics
(n = 68) (n = 68)
Parametric analysis Mean 19.28 (22.19) 9.48 (14.78) 3.031 134 0.0029 0.53
(SD)
Non parametric analysis 77.71 59.29 0.292 — 0.003
mean rank
Are motor soft signs increased in medication-naive patients
Since only around 50% of the 68 initial assessments were conducted in a medication-
naive state (the rest were carried out shortly after initiation of antipsychotics therapy),
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the subset ofmedication-naive patients (n=34) was further examined. Table 8.4
summarizes the characteristics ofmedication-na'ive patients as compared to those
who had been started on medication for days. No significant differences was found
among the groups in terms of age, education level and gender proportion.
Table 8.4. Comparison of demographic variables among recently-medicated
patients, medication-nai've patients and healthy control subjects
Medication-nai've Recently- Healthy controls
patients medicated patients
(n = 34) (n = 34) (n = 68)
Mean SD Mean SD Mean SD
Age 32.7 9.2 33.1 9.9 32 8.4
Education level (years) 9.9 3 10.4 2.9 9.4 2.6
Gender (M:F) 15:19 15:19 22:46
As seen in Table 8.5, both parametric and non-parametric analyses indicated a
significant increase ofmotor soft signs in medication-nai've first episode patients.
Table 8.5. Comparison of motor SNS between medication-naive patients and
healthy control subjects
Medication- Healthy t-value/ df p-value effect
nai've patients Controls . . size
z-statistics
(n = 34) (n = 68)
Parametric analysis 18.63 (22.84) 9.48 (14.78) 2.441 100 0.0164 0.18
Mean (SD)
Non-parametric 60.09 47.21 2.257 — 0.024
analysis
mean rank
When comparison was made between medication-naive and medicated patients, no
significant differences were found between the two groups in motor soft signs (Table
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8.6). This would support that there was no immediate change in motor soft signs
following initiation of treatment.
Table 8.6. Comparison of motor SNS between recently-medicated and
medication-naive patients
Medication- Recently- t-value/ df
nai've patients medicated-














Comparison between first-episode and chronic patients
To address the question ofwhether the extent of soft signs found in first episode
patients is comparable to that found in chronic patients; a comparison was made
between the first episode sample and an age/education-matched sample of chronic
schizophrenic patients drawn from Study 1.









Mean SD Mean SD /Chi-sq df p-value size
Current age 32.91 9.51 32.23 7.01 0.535 166 0.5934 0.08
Education level (years) 10.16 2.96 9.37 2.72 1.787 166 0.0757 0.28
Gender (M:F) 30:38 — 62:38 — 5.224 1 0.027 -
Demographic information of the comparison sample is presented in Table 8.7. The
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mean illness duration of the chronic patients was 10.4 years (s.d. 7.5). No significant
difference was found in motor signs between first episode patients and patients with
chronic schizophrenia. In fact the mean SNS scores were lower in chronic patients
compared with patients with first episode psychosis (Table 8.8).
Table 8.8. Comparison of motor SNS between first episode patients and
chronic patients
First episode Chronic patients t-value/z df p-value effect
patients statistics size
(n = 68) (n = 100)
Parametric analysis 19.28 22.19 13.56 18.66 1.9 164 0.06 0.28
Mean (SD)
Non-parametric analysis 140.25 — 128.05 — 1.92 — 0.06
Mean rank
Since the level of soft neurological sign in first-episode patients might have been
enhanced by the psychotic state, a further comparison between the chronic patients
and first episode patients after clinical stabilization was also carried out (Table 8.9).
Table 8.9. Comparison of motor SNS between first episode patients after
clinical stabilization and chronic patients
Stabilized first Chronic patients t-value/ df p-value Effect
episode patients . . size
z-statistics
(n = 68) (n= 100)
Parametric analysis 15.52 21.9 13.56 18.66 0.625 164 0.625 0.1
Mean SD
Non-parametric analysis 86.28 — 83.29 -- 0.42 — 0.675
Mean rank
- 126 -
It can be seen that when assessed soon after clinical stabilization, the level ofmotor
soft signs in first episode patient is comparable to that seen in chronic patients. This
observation suggested that there is probably no substantial deterioration in soft
neurological signs from first episode to chronic schizophrenia (average illness
duration 10 years).
Comparison between first presentation and clinical stabilization
To address the question ofwhether the psychotic state itself substantially increases
the presence ofmotor soft signs, a within-subject comparison was carried out
between scores at initial presentation and scores after clinical stabilization. No
significant difference was found (Table 8.10). Non-parametric Wilcoxon signed rank
test showed similar insignificant findings. The result suggests that the increase in
motor soft sign is not merely secondary to acute psychotic symptoms.
Table 8.10. Comparison of motor SNS between first presentation and clinical
stabilization




Parametric analysis 19.28 22.19 15.52 21.90 1.29 67 0.202 0.17
Mean/ SD
Is there a longitudinal decline in SNS in the two years
following a first episode psychosis?
The mean level ofmotor soft neurological signs was considered across the different
time points in the first 2 years (Figure 8.1). A linear regression analysis showed that
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the slope of the regression line ofmotor soft signs scores in relation to time was not
significantly different from zero thus suggesting that there was no overall increase in
the level of signs across time.
Table 8.11. Changes of motor SNS across a 2-year time period
First Clinical
presentation stabilization 4-month 8-month 12-month 16-month 20-month 24-month
Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
Motor
SNS 19.3 22.2 15.5 21.9 14.2 16.3 14.2 16.3 16.8 19.7 17.0 22.3 15.3 20.8 18.5 21.7






The data suggest that in the early course ofpsychosis, motor soft signs remain at an
increased level and did not reveal evidence of decline over the first two years.
Do SNS deteriorate during a relapse?
For the 16 patients who experienced a relapse (defined as a deterioration in positive
symptoms leading to re-hospitalization), motor soft signs were examined during
acute relapse and after treatment of the relapse. Table 8.11 shows that no significant
differences were found between admission and discharge during a relapse (defined
by re-hospitalization). This was also confirmed with non-parametric Mann-Whitney
U-test. This comparison has to be interpreted as preliminary in view of the relatively
small sample size for those patients in whom a relapse occurred. It is noted that the
mean motor soft signs score in the group of patient who relapse appeared to be lower
that the scores for the entire group of patients at the end of the first episode.
Table 8.12. Comparison of motor SNS between acute relapse and after
treatment of the relapse
Acute relapse After treatment of t-value/ df p-value Effect size
relapse , . .1 ^-CTanctmcz-statistics
Cn= 16) (n = 16)
Parametric analysis 11.81
Mean / SD






Clinical and demographic correlates ofmotor soft signs
At initial presentation
Onset age and education level were significantly correlated with motor soft signs. A
higher onset age is modestly associated with increased level ofmotor soft signs
(r=0.29, p=0.02). A higher level of education is associated with a decreased level of
soft neurological signs (r=0.47, p=0.0001). DUP was not found to be associated with
the level of soft neurological signs. Notably, the association with age at the beginning
of psychosis suggests that onset age contributes to the level of SNS independent of
illness duration.
There was no significant correlation between the levels of soft neurological signs and
the level of positive and negative symptoms, affective and obsessive compulsive
symptoms, as well as measures of extrapyramidal signs.
Clinical stabilization
After clinical stabilization, the level of soft signs was found to be modestly positively
correlated with negative symptoms scores (r=0.26, p=0.03). In addition there was
also a correlation with the level of extrapyramidal signs (r=0.3, p=0.01). The
relationship with negative symptoms thus became more apparent at clinical
stabilization. The relationship with extrapyramidal signs raises the possibility that
side effects to antipsychotic medication might interact with the expression of soft
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neurological signs.
The significant relationship between motor SNS and negative symptoms disappears
after controlling for extrapyramidal effects. This indicates that the relationship with
negative symptoms could be mediated by extrapyramidal effects. It is important to
note that extrapyramidal signs though often attributed to antipsychotic medication,
may also reflect illness-related features that are present before the onset of
medication treatment, and in fact may constitute target features in their own right.
The contribution of medication side effects towards manifestation of SNS is a
difficult issue to resolve. The presence of increased level of SNS in medication-nai've
patients suggests that medication effects could not entirely account for the expression
of SNS. However, it is difficult to rule out the possibility that after treatment with
antipsychotic medications, part of the SNS expression might be mediated by
medication. While most of the time extrapyramidal side effects are controlled by
dosage adjustments and anticholinergic medications, extrapyramidal signs were
found to be modestly correlated with SNS after antipsychotic treatment was initiated.
It is intriguing, however that the overall level of SNS did not increase (actually there
was a trend decrease). These observations suggest that other state variables, such as
the presence of psychosis, might also interact with manifestations of SNS in a
dynamic and stage-specific manner.
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SNS correlation with cognitive function performances in first
episode psychosis
The relationship between motor soft signs and cognitive functions was explored in a
series of correlation analysis using data from different time points in the course of
early psychosis (Table 8.13).
On admission, significant inverse correlation was found between motor soft signs
and visual reproduction (delayed score) as well as verbal fluency.
After the stabilization of the psychotic symptoms, motor soft signs were significantly
correlated with immediate logical memory recall, immediate and delayed visual
reproduction, digit span, verbal fluency, and category score ofWCST. Similar trends
and pattern were observed between motor SNS and the neurocognitive performances
at 1 year and 2 years.

















-0.17 -0.16 -0.23 -0.29 -0.23 -0.19 -0.25 0.05 -0.18
Clinical
stabilization
-0.30 -0.23 -0.59* -0.47* -0.21 -0.33 -0.32 0.12 -0.25
Year 1 -0.32 -0.23 -0.45* -0.33 -0.24 -0.46* -0.25 0.24 -0.42*
Year 2 -0.27 -0.19 -0.41* -0.35 -0.27 -0.37 -0.44* 0.36 -0.28
LM: logical memory; Vis mem: visual reproduction; VF: Verbal fluency; WCST per: WCST
perseverative error; WCST cat: WCST category
*significant after adjusting multiple group comparison, i.e. p<0.0005
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A similar picture was observed after partialling out the effects of education level, as
well as the information subscale of the WAIS (a measure of verbal intelligence)
(Table 8.13). Thus the correlational relationships between motor soft sign changed
with time in the course of early psychosis. Initially a more restricted range of
correlation appeared. After clinical stabilization a wider range of cognitive functions
were related to motor soft signs. This pattern persisted in subsequent comparison at
year 1 and year 2. Motor soft signs were related to both prefrontal functions such as
WCST score and verbal fluency scores. There was also a relationship with memory
functions (visual reproduction and digit spans). These relationships survived the
partialling out of education level and general intelligence effects.
Table 8.14. Partial correlation coefficients between motor SNS scores and
cognitive variables (controlling for education level and intelligence
estimate)
LM LM Vis mem Vis mem Digit Verbal WCST WCST cat
(immed) (delay) (immed) (delay) forward fluency per
First -0.15 -0.15 -0.1 -0.25 -0.19 -0.24 0.03 -0.07
presentation
Clinical -0.24 -0.15 -0.55* -0.41 -0.23 -0.27 0.05 -0.16
stablization
Year 1 -0.30 -0.17 -0.45* -0.34 -0.42* -0.16 0.17 -0.38
Year 2 -0.23 -0.15 -0.37 -0.3 -0.29 -0.35 0.32 -0.23
LM: logical memory; Vis mem: visual reproduction; VF: Verbal fluency; WCST per: WCST
perseverative error; WCST cat: WCST category
*significant after adjusting multiple group comparison, i.e. p<0.0005
Regression analysis
Since there may be internal correlation between different cognitive functions,
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regression analyses was carried out at each time point to evaluate the relative
contribution of different cognitive variables in their association with motor soft signs.
Table 8.14 shows that at initial presentation in the medication-na'fve state, education
level was the only contributor ofmotor coordination signs. After clinical stabilization,
visual reproduction performance became the most important correlates ofmotor soft
signs, followed by age of onset. At the end of year one, visual reproduction, forward
digit span, and WCST category score were the most important correlates. At year 2,
age at onset, visual reproduction score and verbal fluency score were the most
important predictors ofmotor soft signs levels.
To summarize, education level and onset age seemed to be the crucial correlates of
motor soft signs at first presentation and clinical stabilization of psychosis. From
clinical stabilization onwards up to two years follow-up, visual reproduction score is
the most important predictor ofmotor soft signs. Forward digit span and WCST
category score were also significant predictors at the end of year 1.
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education -3.63 0.82 -0.49
t Sig. R Square R Square
Change
















-5.775 <0.000005 0.34 0.34
-4.905 0.00001 0.42 0.08
2.928 0.00473
Year I
Step 1 Digit forward -4.62 1.10 -0.46 -4.207 <0.000005 0.21 0.21
Step 2 Digit forward -3.27
Visual
reproduction
1.17 -0.33 -2.803 0.00666 0.29 0.08
(immediate) -1.64 0.62 -0.31 -2.648 0.01014
Step 3 Digit forward -2.66
Visual
reproduction
1.17 -0.26 -2.270 0.02657 0.34 0.05
(immediate) -1.34 0.62 -0.25 -2.166 0.03403
WCST
category -2.67 1.24 -0.24 -2.149 0.03546
Year 2
Step 1 Onset age 1.10 0.25












0.48 4.40 0.048 0.23
0.41 4.03 0.0001 0.36 0.13
-0.36 -3.5 0.0008




Summary of findings for Chapter 8
Motor SNS are increased in medication-nai've first episode psychosis patients. The
level ofmotor signs seen in first episode patients is not significantly different from
those seen in chronic patients. There is a suggestion that the mean level ofmotor
signs is slightly reduced following clinical stabilization of the first episode illness. At
initial presentation the level of SNS is related to education level and onset age. DUP
was not related to the level ofmotor soft signs, suggesting that soft signs did not
reflect any processes that may progress during the DUP. SNS was not related to
symptoms and extrapyramidal signs at presentation. However, the pattern of SNS
correlates changed after antipsychotic therapy had brought about clinical stabilization.
SNS were modestly correlated with both negative symptoms and with
extrapyramidal signs at this stage. The correlation with negative symptoms appeared
to be mediated by extrapyramidal signs. This suggests that although the overall total
score change was insignificant; there may be more subtle changes in SNS expression.
Further analysis of SNS in the 16 patients who experienced a relapse during the
study period did not suggest a change in motor SNS before or during a relapse,
although this conclusion is limited by the relatively small number of patients who
had a relapse during the study period. The pattern of correlation between SNS and
cognitive function also changes with treatment, at initial presentation SNS was only
modestly related to a small number of cognitive functions (visual reproduction and
verbal fluency). Following treatment and stabilization SNS become associated with a
broad range of cognitive function (digit span, WCST, logical memory, visual
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reproduction and verbal fluency). This pattern of correlation then persisted in the
subsequent assessment during the 2-year follow-up period. Verbal fluency and visual
reproduction remained as the strongest predictors for SNS during the period.
Interestingly visual reproduction was also found to be an important correlate of SNS
in the cross-sectional study (Study 1). Longitudinally there was no overall change in
SNS level in the 2-year follow-up period.
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9 Discussion
Overall summary of findings
This dissertation describes a series of studies addressing manifestations of soft
neurological signs in schizophrenia. In study 1 a larger cross-sectional sample of
schizophrenic patients were studied with a corresponding healthy control group. The
study firstly addressed relationship between SNS, education level and intelligence
level. The data confirms a robust relationship between SNS and education level as
well as intelligence. This relationship was identified not only in the patient sample
but also amongst healthy control subjects. The relationship between SNS, age and
illness duration was further addressed by subgroup comparison with analyses of
variance. The analyses suggest that longer illness duration is related to the presence
of increased motor SNS, there is also a suggestion of a relationship with age but that
was confounded by education level differences in the samples.
Further analysis allowed a more detailed exploration of the relationship between SNS,
clinical picture, cognitive function and other neurological signs. This revealed that
there is little relationship between SNS and positive symptoms, however a gender-
specific association between SNS and negative symptom ("thought" domain)
emerged in female patients. Apart from revealing extensive relationship between
cognitive function domains and SNS, the data suggest a differential relationship
between motor SNS and certain cognitive functions (such as sustained attention and
visual memory), as well as a relationship between sensory integration signs and a
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broader range of cognitive functions.
A comparison between healthy control group in Chinese subjects and Caucasian
subjects also provided data addressing the ethnic variation of SNS. The data suggest
that there is no significant variation in overall SNS between Chinese and Caucasian
patients, however there is a suggestion that the subgroup of sensory integration signs
might be less prevalent in Chinese subjects.
Cross-sectional data was complemented by two sets of longitudinal data. A 3-year
longitudinal study of SNS in stable chronic schizophrenic patients provided evidence
supportive of the possibility of deterioration in soft neurological signs for at least a
subset of patients in late middle age with chronic illness. The 2-years study ofmotor
SNS in first-episode patients revealed that SNS was already increased in the first
episode psychosis before treatment. The level of SNS appeared to remain stable for
the first 2 years of illness. However the pattern of correlates changed with time,
suggesting that while the overall SNS level was stable, the nature and constituent
processes might be evolving. These findings, their limitations as well as their
relationship with existing findings are further discussed in the following sections.
Intelligence and education level
The current data suggests that SNS is correlated with intelligence and education level
not only in patients but also in healthy control subjects. This relationship was seen in
both the Chinese and the Caucasian control samples. The current results also confirm
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that amongst schizophrenic patients both intelligence and education level are
associated with SNS. Subscale analysis revealed that correlation was found in all the
three subscales (motor coordination, sensory integration and disinhibition) of the
CNI.
In the light of increasing recognition that schizophrenia has a neurodevelopmental
component, intelligence and education level probably should not be viewed as mere
"demographic" variables that constitute simple antecedent risks for the disorder.
Instead, similar to SNS, intelligence and education level could be construed as
downstream consequences of earlier developmental events. Thus in pondering their
relationship, it may be more appropriate to consider both SNS and intelligence level
as reflections of developmental features that indicate a neurointegrative dysfunction.
In this perspective, an important question is the extent to which SNS and intelligence
are independent in the expression of the underlying developmental dysfunction. It
has been noted previously that for affective symptoms in adolescence, SNS appear to
relate to psychopathology independent of intelligence^43). It is not clear whether
the same applies to schizophrenia. It is recognized that the prevalence of
schizophrenia is about three times higher in subjects with learning disability (144).
The exact explanation for this is unclear, but one of the hypotheses is that
overlapping underlying features are involved in both schizophrenia and learning
disability. The relationship between intellectual impairment and schizophrenia has
also been explored in a study by Doody et al (97), in which subjects with either mild
learning disability, or schizophrenia, and those with both of the conditions were
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compared. The study found that SNS are higher in the co-morbid group and in mild
learning disability group than in the schizophrenia alone group. The authors
discussed various ways in which the manifestation of SNS in the two conditions
could be related. This includes sharing of common aetiological factors,
epiphenomenon (mental limitations predisposes to psychotic symptoms); as well as
interaction between the two factors to produce schizophrenia with poor prognosis.
Gender effects
In most previous studies, significant gender difference in soft neurological signs was
not found. No significant gender difference was found in overall level of SNS even
after taking into consideration age and intelligence. The lack of gender difference in
SNS expression in schizophrenia is interesting in the context of reports of gender
differences in several other aspects of schizophrenia, including age of onset
(145; 146), cognitive profile (147; 148), symptoms, treatment response and outcome
(149-152). Lack of gender effect in SNS would suggest that these aspects of the
disorder are less likely to be involved in SNS expression. There is of course a
possibility ofmeasurement and sampling variations. There is a need for more
detailed examination of this issue in the same sample of patients where gender-
sensitive and gender-insensitive variables are examined and compared. However
though the overall level of SNS was not different, the correlation between SNS and
symptoms appear to be gender-specific (see below).
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Correlations with Symptoms
In contrast to previous studies, strong correlations between symptom domains and
SNS were not found in the entire sample. However it was found that in particular
amongst female patients, negative symptom sub-domain "thought' was specifically
associated with SNS. No such association was found amongst male patients. This
finding suggests there might be gender variations in the pattern of symptom
correlates amongst neurological signs. The finding of gender difference in symptom
correlates of SNS is in line with Malla et al (53) who found that negative symptoms
correlated with different SNS factors in male and female patients. This potential
gender-related pattern of correlation might underlie inconsistencies in some previous
findings as these studies consisted of samples with different gender ratios.
The pattern of symptom correlation in first episode patients is also noteworthy. It is
important to note at the initial assessment, in the medication-na'ive state, SNS were
not strongly correlated with symptoms. However after clinical stabilization motor
SNS were found to be correlated with negative symptoms as well as extrapyramidal
signs. Partial correlation analysis suggests that the relationship with negative
symptoms may be mediated through extrapyramidal signs. This raises the important
possibility that (though definitely not the sole explanation for SNS) antipsychotic
medication may play a role in SNS in mediating its relationship with negative
symptoms. The relationship is further complicated by the recognition that
extrapyramidal signs are themselves of heterogeneous origin. In addition to
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extrapyramidal signs attributable to medication, spontaneous extrapyramidal signs
have been observed in medication-naive patients (153-155). The extent to which
these spontaneous extrapyramidal signs are related to SNS is an interesting empirical
question. Further studies should be carried out to investigate SNS expression in
patients with and without spontaneous extrapyramidal signs, in order to delineate the
extent to which each of these is an independent feature of the illness.
Ethnicity effects
Buchanan and Heinrich reported that healthy African Americans have an increased
level of soft signs compared with Caucasians. The increase was particularly found in
the sensory integration subscale (31). In the current study it was found that there was
no significant difference in the total SNS score between Chinese and Caucasian
healthy subjects. However, there was a trend for Chinese subjects to have lower
scores in the sensory integration subscale. Taken together, this tentatively suggests
that among the subscales in SNS, sensory integration might be more vulnerable to
ethnic variations. The nature of such variations is unknown. It appears that the
assessment and the rating processes are less likely to be sources of variation, as both
the linguistic and the conceptual demands involved in SNS evaluation are relatively
light, and it is possible to achieve good interrater reliability irrespective of the ethnic
origin of the subjects and the raters. A more likely source for ethnic variations in
SNS could be of a biological rather than cultural nature. Studies of SNS amongst
healthy subjects in different ethnic groups are important for addressing this issue. In
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this context it is interesting to note that Gureje (65) speculated that increased SNS in
the Nigerian control subjects might relate to the level of obstetric care. These issues
require further examination.
An important methodological issue needs to be addressed in future cross-ethnic
comparison of SNS, since SNS expression is confounded by intelligence level, study
design would have to include measurement of intelligence level. The cross-ethnic
comparability of intelligence level estimation (156) will be a difficult issue that
studies will have to address.
Effects ofAge
In the context ofprevious inconsistent findings on the relationship between age and
SNS, the current study found a linear trend for SNS to increase with age. However
the effect became non-significant after covariance analysis controlling for education
level. This highlights the possibility that different approaches to address potential
confounding variables could have contributed to the inconsistencies in previous
findings. A further confound is illness duration, which inevitably confounds age in a
cross-sectional study. Importantly, data from the first episode study can contribute
towards addressing this issue. By comparing between patients at a similar stage of
their illness (first illness episode) effect of age per se should be more discernable. It
was also found that at first presentation, SNS is positively correlated with age. At this
stage SNS is also correlated with age of onset of psychosis but not with duration of
untreated psychosis. This observation did not support the suggestion that during
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untreated psychosis, ongoing neurological damage (as reflected in SNS) is incurred.
Whether there is evidence for neural damage during untreated psychosis is still a
contentious issue (157; 158). The relationship between SNS and age suggested that
normal aging process throughout the lifespan is related to the manifestation of SNS.
This is further supported by the finding of a correlation between SNS and age in the
healthy control sample.
Illness duration
Data addressing the relationship between SNS and illness duration is conflicting. In
Kolakowska's study (85), subjects with SNS were found to have longer illness
duration than those without, however when stratified into smaller groups according
to illness duration, the proportion of those with SNS was not significantly different.
In Flashman et al (95), patients with SNS had a longer illness duration (younger age
of onset and same current age). Cuesta et al. (88;89) also found that frontal signs
were related to duration of illness. On the other hand, Flyckt et al (111) compared
motor tests (including SNS) between first episode psychotic patients and chronic
patients and found no significant difference. In the current sample it was found that
there was a linear trend for SNS to increase with illness duration. The effect appears
to be particularly prominent for the motor coordination subgroup of signs.
The relationship between SNS, age and illness duration is an important issue.
Although SNS is known to be present in high-risk subjects and first episode patients,
it is important to ascertain whether SNS also progresses with age and illness duration.
- 145 -
This issue is important in clarifying whether SNS, as a target feature, represent those
factors only affected by the neurodevelopmental aspect of the disorder, or whether it
is also vulnerable to putative progressive processes in the disorder. In addition, it is
important to distinguish between changes in SNS associated with illness progression
from effects of normal aging. Current analyses suggest that there is an increase in
SNS with both age and illness duration.
It is difficult however, to distinguish whether the effect of age or the effect of illness
duration is the more important. In this regard, one particular limitation is that in a
cross-sectional study, age is usually correlated with illness duration. Further
subgroup analysis between patients with higher and lower age, and illness duration,
respectively suggests that the effect of illness duration probably plays a more
important role in SNS.
Longitudinal studies are required to definitively resolve some of these issues. So far
few longitudinal studies have been carried out. Smith et al (159) demonstrated that
SNS for a sample ofmiddle age chronic patients SNS are largely stable.
In the longitudinal data addressing a sample of stable and older chronic patients there
are some suggestions ofprogression in SNS. This confirms the trends observed in the
larger cross sectional studies. The evidence suggests that at least for a subset of
patients with longer illness duration and older mean age, SNS appear to run a
progressive course.
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Longitudinal studies with a larger sample of chronic patients in their forties or fifties,
and a longer follow-up period will be required to definitively resolve the question of
whether there is longitudinal progression of SNS at specific stages of the illness,
particularly when the patients are approaching old age. It is recognized that cognitive
deterioration could occur in schizophrenic patients as they approach late life (160-
162). The nature of such decline is still unclear as they are not accompanied by
recognizable histopathological changes commonly associated with cognitive deficits
(such as those associated with Alzheimer disease) . It has been suggested that the
decline represents an interaction between mild degenerative changes and diminished
cognitive reserve in schizophrenia (163). The deterioration of SNS in this sample
could be related to an early manifestation of such processes.
From the first episode study, it was observed that SNS are already increased in the
first psychotic episode. In addition, the level of SNS appeared to be stable for the
next two years. The level of SNS did not correlate with the length of the DUP. These
findings, together with previous demonstrations of increased SNS in high-risk
individuals, would argue that at least for the early phase of the illness, SNS appears
to represent a stable target feature. This conclusion is however somewhat
complicated by the finding that although the level of SNS remained stable, the
clinical correlates appear to change in the early course of the illness.
Relationship with cognitive function
There are only a small number of studies investigating the relationship between
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cognitive function and SNS. The exploration of this relationship is important as it
addresses the question of the extent of overlap between SNS and various cognitive
impairments, and thus their independent values as target features in schizophrenia.
Although the overall relationship between SNS and cognitive function appears robust,
the detailed pattern of correlation between individual domains within SNS and
cognition is so far largely inconsistent. The few studies conducted so far have
adopted different designs and included different sets of cognitive assessments. One
of the key debates was whether SNS relates broadly to most cognitive functions, or
whether SNS relates to specific domains in cognitive functions (such as executive
functions). Preliminary findings tend to support overall involvement with a broad
range of cognitive functions. However within this context some degree of specificity
still remains as a possibility. This question is further complicated by internal
correlations between different measures of cognitive functions. One noteworthy
observation in the current studies is that visual memory appears to have a particularly
robust relationship with motor SNS. This relationship was found independently in
both the cross-sectional study, and in the longitudinal study of first episode patients.
Since visual reproduction performance involve a number of component processes, it
would be important in future studies to attempt to identify which of the process are




As in other studies involving SNS, soft signs assessment in the current studies was
not conducted blind with respect to the subject group (patients and controls, and
patients in different assessment time points). In addition, assessment of SNS was
carried out by the same rater involved in cognitive testing. Separate raters were
involved in clinical ratings (including side effects ratings in study 4). The lack of
blindness in some comparisons opened the possibility for observer bias e.g. where
patient vs control comparison was concerned. Certain analyses in studies 1, 2 and 4
were potentially vulnerable to this effect. However, the highly structured assessment
procedure with operationalized rating guide offers some protection against subjective
bias. In other comparisons, for instance, the assessment of soft signs and symptom
were carried out by different raters independently and could be consider blind with
respect to one another. The relationships between soft signs and cognitive function
were assessed by the same rater and were therefore not blind. The possibility of bias
with regards to cognitive function was limited as there is no obvious prior
expectation of specific relationship between the areas. In addition, the assessment of
cognitive function was highly structured and independent on rater judgement, and for
many cognitive assessments the final scores were not apparent until after subsequent
en block data processing. Therefore results were not immediately available to
influence the examination in the same session. In longitudinal studies 3 and 4, though
the raters were aware of the assessment time points, they were blind to the previous
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score of the same subjects. With regards to the comparison between normal controls
and patients, the issue of lack blindness is inherent to the nature of the study. It
would have been extremely difficult to arrange for control subjects and patients to be
assessed in a setting and in such a way as to effectively prevent the examiner from
getting an idea about their group identity. Notwithstanding the structured assessment
and rating, in the comparison between normal control and patients, the possibility of
bias did exist and appropriate caution in the interpretation of the findings should be
made.
The potential contribution of antipsychotic medication in SNS
expression
The presence of increased SNS in individuals at high risk for psychosis suggests that
SNS expression is not entirely secondary to antipsychotic medication. However the
potential role of antipsychotic medication after the onset of treatment is a complex
area. In the past, investigators explored this question using mainly two approaches, in
the first approach, linear correlations were sought between SNS and medication
dosage as well as side effects. In the second approach, SNS levels were monitored as
patients switched from conventional anti-psychotics to atypical anti-psychotics (with
the assumption that atypical anti-psychotics were less liable to produce motor side
effects). In both of these approaches the detection of a relationship between SNS and
medication depended on there being a linear relationship (i.e. the level of SNS is
expected to be related to the type or quantity ofmedication and motor side effects).
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Most previous investigators concluded that the level of SNS was not directly related
to antipsychotic medication. Evidence came from the lack of association between
SNS and medication dosage or between SNS and extrapyramidal signs(46).
Moreover, it was also found that the level of SNS did not change when conventional
antipsychotics were replaced by atypical antipsychotics(115). In contrast to previous
findings, in study 4 in the current data set, an emergent correlation was identified
between soft signs and extrapyramidal signs following treatment of the first
psychotic episode. In study 3, extrapyramidal side effects also increased alongside
with SNS in the longitudinal follow-up period. However, in the cross-sectional study
(study 1), no correlation was detected between SNS and extrapyramidal side effects.
These findings echoed the small number of studies which observed a relationship
between SNS and extrapyramidal signs(106). In summary, the current data set
provided some suggestion that a relationship between SNS and extrapyramidal signs
may exist. This relationship may be difficult to detect based on linearly correlations,
which might become apparent only at certain stages in the illness. However the lack
of a detectable linear relationship does not exclude more subtle relationships between
antipsychotic medication and SNS. For instance, a threshold-based relationship may
exist between antipsychotic medication and SNS expression whereby only the
presence of antipsychotic medication above a certain threshold level has an impact
on SNS expression. Such a possibility is reinforced when the complexity inherent in
the dimensions of SNS is considered. For instance, in a previous study of the
component dimension of SNS, it was identified that at least two dissociable
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dimensions exist, ofwhich one corresponded to the extrapyramidal system (the other
to presumed cerebellar function)(164;165). The existence of such sub-dimensions
could obscure relationship between antipsychotic medication and SNS. In conclusion,
it is not possible to exclude the possibility that antipsychotic medication contribute to
SNS expression. In any study that involves medicated patients, this possibility needs
to be considered in the interpretation of the findings. Simply removing the possibility
of a linear relationship (such as by covariance procedures) does not adequately
address the problem.
Cognitive function as contributor to SNS
The key question is whether SNS expression could be considered as secondary to
cognitive processes such as attentional impairment. The extent and nature of overlap
between cognition and SNS has been explored in detailed in Chapter 6. The data
suggest that while there are overlaps between SNS and cognitive function such as
visual memory, much of the variance in SNS could not be explained by cognitive
functions (including intelligence level). It is also noteworthy that the examination of
SNS involves relatively simple instructions and executions in comparison to most
cognitive function tests. It is therefore difficult to consider SNS simply as an
epiphenomenon secondary to cognitive function impairment. It is more helpful to
consider SNS as parallel phenomena to cognition (which specifically taps certain
motor functions).
In this connection, there may be a difference between motor coordination signs and
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sensory integration signs. As shown in the data reported here, a wider spectrum of
cognitive function is involved in sensory integration, as compared with a more
circumscribed set of associated cognitive function in relation to motor coordination
signs. Given the suggestion that the nosological specificity of SNS is likely to be
more related to motor coordination signs(67), it is important to examine what
cognitive processes are likely to be involved in the motor SNS and to study the
extent to which motor SNS taps similar variance in this cognitive domains. Studies in
the relationship between cognition and SNS are still in its formative stage, and few
consistent results have emerged. Of the candidate functions in this data set, visual
working memory (immediate memory) is a candidate that remains consistently
related to motor SNS in two independent cohorts in the current data set. It is
important to examine in more detail the component processes in the visual memory
task in order to further delineate the relationship. It is noteworthy that in the current
data set, the relationship between cognition and SNS only become apparent after
treatment of the first episode and not at the presentation of the first episode. This
observation also raised the possibility that medication may mediate the relationship
between cognitive function and SNS.
Measurement limitations and suggestions for future SNS
evaluation
This dissertation described data that together with the existing literature clearly
indicate a role for SNS as a potential target feature in schizophrenia research. The
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relationships between SNS and a number of demographic, clinical and cognitive
areas are becoming increasing clarified. However as research questions are becoming
more focused, detailed and demanding, expectations on measurement sensitivities in
future studies will also increase. In this context it appears appropriate to end the
dissertation with a critical review of the current strategy in the evaluation of SNS
with an aim of suggesting further refinements.
Although the commonly applied SNS inventories are operationized and standardized,
and in general achieve good interrater reliabilities, there are several limitations. Some
of the issues have been presented in Chapter 1. They will be further developed here.
Individual signs are rated on a categorical basis, usually on no more than three points
(i.e. absent, present, severe), and very often can only be rated for either present or
absent. Given that fact that SNS are present in a substantial proportion of patients
and controls, the distribution of the underlying abnormality should be conceived as a
continuous variable. Reduction to a categorical rating could result in a lost of
quantitative information which render the severity grading of a SNS scale less
sensitive in relation to the putative underlying disturbance.
The nature of abnormality embedded in an individual sign is likely to be multi¬
dimensional, in fact this can be inferred from certain description of SNS ratings, for
example, in finger tapping or opposition, there may be loss of rhythm, or abnormal
movement trajectory. Either abnormality could cause a sign to be rated positive. Thus
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in current SNS methodology multi-dimensional information are being compressed
into one dimension.
There may be duplication of information in different SNS items. Several SNS are
very similar to one another e.g. finger thumb opposition and finger tapping.
Abnormalities underlying one of the signs might be very similar to those underlying
another. Though it could be argued that they may represent different difficulties level,
yet the rationale has not been explicitly examined. Adding up information from
similar signs may inflate the importance of one type of abnormality.
The use of summative scores for subscale is very common in data analysis. This is
related to the fact that individual signs are usually categorically rated, and the
number of signs is usually relatively large in relation to sample size. Thus the use of
summative scores for subscales reduces the number of variables as well as provides a
score that better approximates a continuous variable. Yet the practice of adding up
scores of individual signs has certain limitations. In the process of summation, the
separate importance of number and severity of signs are lost.
In view of these limitations, attempts should be made to construct a more refined
approach to the assessment of neurological signs in terms of exploration of the
underlying dimensions. Some of these dimensions could be more sensitively
measured. Redundant signs addressing the same dimensions could also be reduced.
This would result in the measurement of a fewer number of signs, each producing
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data on several dimensions.
Some studies have addressed motor dysfunction in schizophrenia with more detailed
assessment ofmotor system abnormalities, for example using reaction time, or
kinematic measures. This approach may enrich the study of SNS. However, currently,
most motor function studies use separate motor paradigms unrelated to SNS. Studies
using quantitative instrumental measure to evaluate motor paradigms that are closely
related to SNS could bridge the current gap and enable an examination of the
underlying dimensions of SNS.
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Appendix
Appendix 1 Clinical Centres involved in the Research
Programme
Abbreviation Clinical centre Location Service nature Studies
involved




QMH Queen Mary Hospital Hong Kong Island, Acute inpatient Study 1 and
Hong Kong unit and outpatient
unit
4







LCKH Lai Chi Kwok Kowloon, Hong Rehabilitation unit Study 1 and
Hospital Kong for chronic
inpatients
3
PYNEH Pamela Youde Hong Kong Island, Acute inpatient Study 4
Nethersole Eastern Hong Kong unit and outpatient
Hospital unit
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Appendix 2: CNISNS subscales
Subscale score calculation
Seven subscales are defined in the CNI (see item description below). 3 of the
subscales concern SNS. 10 items can be scored on both left and right (LR), each is
treated as an independent score. Scaled subscale score is the summed score for the
subscale items divided by the maximum possible score, and then converted to a 0 to
100 scale (i.e. percent maximum score). For the purpose of subscale score calculation,
scores of 0.5 are treated as 0; and scores of 2 are treated as 1.
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THE CAMBRIDGE NEUROLOGICAL INVENTORY (CNI)




* Assessment ofeye movements
* Assessment ofcranial nerves
* Extremity examinations (tone, strength, reflex)
PART 2
* Soft sign examinations (primitive reflexes; repetitive movement; sensory integration)
PART 3
* Assessment ofposture and movements (including catatonia and tardive dyskinesia)
Equipment required: tendon hammer, tongue depressor, pen, torch, a set of 5-10 small
commonly encountered objects (coin, paper clip, match, eraser, rubber band, screw,
battery, shell, and button).
Instruction: Enter rating in [ ] space provided.
Enter additional remarks in the following space [ ]





8 Unable to perform/attempt any part of task despite adequate comprehension
and cooperation
9 Missing. Or unable to test, lack ofcooperation or comprehension
(Additional description can be entered next to rating in the space provided. Additional
information is advisable if ratings 0.5, 8 or 9 are selected. Do not use rating "2" ifa test




Patient is engaged in casual conversation for up to 3 minutes. Introduction to the
examination and instruction to relax are given.
ARTIC POOR ARTICULATION
Poor articulation
Rate during 3 minutes of casual conversation.
0 Normally understandable
1 Patient must repeat to be understood on several occasions
2 Almost incomprehensible
0 0.5 1 2 8 9 [ ] [ ]
APROS APROSODIC SPEECH
Simply unvarying, harsh or stereotyped inflections should not be rated unless marked. Eg.
unnaturally loud, strident, high-pitched, or alternatively feeble, whispering or completely
monotonous intonations. Occasionally also automaton-like, sing-song, rasping, strangled,
or warbling inflections.
0 0.5 1 2 8 9 [ ] [ ]
UNINT UNINTELLIGIBLE SPEECH
Mumbling, non-social speech, not merely due to poor articulation. Do not rate mere
incoherent speech due to thought disorder.
0 0.5 1 2 8 9 [ ] [ ]
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"I am going to test your eyes next."
ASSESSMENT OFEYE MOVEMENTS
There are two main components, smooth pursuit eye movements and saccadic eye
movements. Each of the two components should be conducted en block and ratings
completed afterwards.
SMOOTH PURSUIT EYEMOVEMENTS
Patient asked to focus on a slowly moving target (a pencil or pen) at a distance that the
patient can focus on. Glasses are removed ifpresent.
The target is moved slowly in a horizontal and then a vertical direction.
"Couldyou follow the (eg. pen) with your eyes, keeping the head still."
EXT SPM EXTENT OF SMOOTH PURSUIT EYE MOVEMENTS
Rate as positive if range ofmovement restricted
0 0.5 1 2 8 9 [ ] [ ]
SMO SPM SMOOTHNESS OF SMOOTH PURSUIT EYE MOVEMENTS
Rate as positive if noticeably catchy or jerky
0 0.5 1 2 8 9 [ ] [ ]
IPR GZ GAZE IMPERSISTENCE
Patients asked to fix his/her gaze on an object(eg. a pen) at a 45' angle in the horizontal
plane of the right and then left visual fields for 15 sec each.
"Could you keep looking at this (pen) with your head still, until I tell you to stop."
0 No deviation from fixation
1 Deviation from fixation but able to resume gaze
2 Deviation from fixation repeatedly, unable to resume gaze
0 0.5 1 2 8 9 [ ] [ ]
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SACCADIC EYEMOVEMENTS
Hold one target at the right extreme of lateral vision, and the other target at the left
extreme of lateral vision. Patient is asked to look at one of the targets and then qidckly at
the other-AS FAST AS POSSIBLE, to and fro for several times. Observe for smoothness
ofmovement, presence ofblinking and head movement.
"Couldyou look at the (pen)... and then at this (torch)... and back to the (pen). Do this a
few times as quickly as you can."
SCSMO SMOOTHNESS OF SACCADE MOVEMENTS
0 One smooth movement
1 Slight jerky movements
2 Extremely jerky movement
0 0.5 1 2 8 9 [ ] [ ]
SC BLK BLINK SUPRESSION DURING SACCADES
Blinking is observed during two L-R saccades.
"I notice you tend to blink while you do this, see if you could do it without blinking."
0 No blinks
1 Unable to stop blinks on some (more than two but not all) occasions
2 Unable to stop blinks on all saccades
0 0.5 1 2 8 9 [ ] [ ]
SC HEAD LATERAL HEAD MOVEMENTS DURING SACCADES
"You tend to move your head when you do this, see if you could do it without moving the
head."
0 None
1 Head moves with eyes, unable to suppress on some (more than two but not all)
occasions
2 Head moves with eyes on all occasions
0 0.5 1 2 8 9 [ ] [ ]
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ASSESSMENTINVOL VING THE HEAD REGION
This part could be completed and scored either item by item or en block, depending on
the examiner's familiarity with the assessment.
WINK WINK WITH OTHER EYE OPEN
"Could you wink with the other eye open, like this"
(Demonstrate)
If lateralized, indicate the side in which unilateral blinking is difficult
L 0 0.5 1 2 8 9 [ ] [ ]
R 0 0.5 1 2 8 9 [ ] [ ]
GLAB GLABELLAR TAP
Patient instructed to fix his/her gaze on a point across the room. After explanation, the
patient is approached from above the forehead outside of the visual field, and the
examiner taps the glabellar region 10 times with the index finger.
"I am going to tap your forehead gently. Just try to relax and look ahead at the (fixation
point or object)."
0 One to three blinks (include partial blinks)
1 More than three blinks
2 No habituation at all
0 0.5 1 2 8 9 [ ] [ ]
RAP TN RAPID TONGUE MOVEMENTS
Demonstrate. Touch corners ofmouth with tongue alternately.
"Could you stick the tongue out and move it as quickly as you can between the two
corners of the mouth."
0 Normal, (>4 touches / second)
1 Slow, (<4 touches / second)
2 Very slow or dysrhymic
0 0.5 1 2 8 9 [ ] [ ]
IPRTN IMPERSISTENCE-TONGUE PROTRUSION
Hold tongue out (without using the teeth) for 15 sec.
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"Could you keep the tongue out until I tell you to stop?"
0 Maintains act for 20 seconds
1 Pulls tongue in before 20 seconds, but able to resume test
2 Pulls tongue in before 20 seconds and unable to complete test
0 0.5 1 2 8 9 [ ] [ ]
"I am going to examine your arms next."
EXTREMITYEXAMINA TIONS
These examinations of tone, strength and reflexes in the upper and lower limbs are
performed en block with the patient seated.
Scores are entered on page after the blocks ofexamination.
UPPER LIMB EXAMINATION
TON UL+/- UPPER LIMB TONE
Flexion-extension, pronation-supination of the elbow joint; and flexion-extension of the
wrist joints are examined. The degree of resistance from normal to extreme rigidity is
scored.
"Could you relax and let your arms go as soft as possible while I hold it."
(e.g. for increased tone)
0 Normal
1 Slight to moderate stiffness and resistance
2 Marked rigidity with difficulty in passive movement
STR UL UPPER LIMB STRENGTH
"Could you grasp my fingers as hard as you can?"
"Could you pull me towards you?"
0 Normal
1 Decreased
DTR UL+ UPPER LIMB HYPERREFLEXIA






DTR UL- UPPER LIMB HYPOREFLEXIA
"I am going to examine your legs now. Could you take off your shoes and socks?" (This
is a good point to observe ambitendence but the rating can be enter later: Part 3)
LOWER LIMB ASSESSMENT
0 Normal (skip, end ofPart 1)
1 Abnormality present (ratefollowing items)
TON R/L LL+/- LOWER LIMB TONE
0 Normal
1 Definitely increased or decreased
2 Grossly increased or decreased
STR LB LOWER LIMB STRENGTH
"Could you straighten your leg?"
"Could you point the toes towards you?"
0 Normal
1 Decreased
DTR LL+ LOWER LIMB HYPERREFLEXIA


















L 0 0.5 1 2 8 9 [ J [
R 0 0.5 1 2 8 9 [ J [
END OF PART 1
This is a good point to allow the patient to have a short break before proceeding to Part 2.
"Would you like to take a break for a little while?"
PART 2
SOFTSIGNS ASSESSMENT
There are mainly three groups, the first group of soft sign tests are some "primitive
reflexes". The second group concerned with repetitive sequential motor execution. The
third group are tests related to integration ofsensory information.
Patient is seated facing the examiner (seated opposite). Each test is performed and rated
before going on to the next test.
SNOUT SNOUT REFLEX
After explanation, patient is instructed to relax, and the examiner rests a tongue depressor
against the patient's philtrum and taps gently with the index finger.
"Could you close your eyes and relax. I am going to tap gently on your mouth."
0 No contraction of the orbicularis orris
1 Any contraction of the orbicularis orris
0 0.5 1 2 8 9 [ ] [ ]
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GRA GRASP REFLEX
Patient is instructed to relax and the palm is stroked lightly with the examiner's index
finger. The sign should be demonstrable at least twice on repetition
0 No movement of patient's hand
1 Some flexion of fingers
2 Examiner's finger grasped
0 0.5 1 2 8 9 [ ] [ ]
P-M PALMOMENTAL REFLEX
The patient is instructed to relax. Muscle activity around the lips is observed. Then the
thenar eminance is stroked vigorously with a blunt pointed object. Induced movement of
the mentalis muscle is observed.
"I am going to stroke the palm. Could you close your eyes and relax."
0 No movement observed
1 Movement of the mentalis muscle
0 0.5 1 2 8 9 [ ] [ ]
FG NOS FINGER-NOSE TEST
Patient is instructed to close eyes and touch the tip of his/her nose with the tip of his/her
index finger.
"Could you close your eyes and touch your nose with this finger." (patient's index finger
touched)
0 No intention tremor or passpointing
1 Mild intention tremor or passpointing
2 Marked intention tremor or passpointing
L 0 0.5 1 2 8 9 [ ] [





Patient asked to touch tip of thumb with tip of index finger as quickly as possible
"Could you do this (demonstrate), now start."
0 Normal
1 Minor mistakes, slow or clumsy, but no major disruption ofmovements
2 Major disruption or repeated breakdown of sequence
L 0 0.5 1 2 8 9 [ ] [ ]
R 0 0.5 1 2 8 9 [ ] [ ]
FG TH FINGER-THUMB OPPOSITION
Patient asked to place both hands palm up with fingers fully extended on his/her legs. The
patient is to start with his/her dominant hand and is to touch the tip of his/her fingers with
the tip of his/her thumb, from index finger to little finger, returning to index finger, for a
total to 10 repetitions.
"Now could you do this (demonstrate) and carry on 10 times. Start now." (Observe for
mirror movement)
0 Normal
1 Minor mistakes, slow or clumsy, but no major disruption ofmovements
2 Major disruption or repeated breakdown of sequence
L 0 0.5 1 2 8 9 [ ] [ ]
R 0 0.5 1 2 8 9 [ ] [ ]
MIRROR1 MIRROR MOVEMENTS
The patient's hand, which is not performing the Finger-Thumb Opposition Test, is
observed for mirror movements (tendency for the resting hand to move in a way
symmetrical to the performing hand)
0 No observable movement
1 Minor movements of the fingers
2 Consistent, distinctive movements of the fingers
L 0 0.5 1 2 8 9 [ ] [





The patient is asked to make a fist with one hand and pat the back of the fist with the
other hand alternately using the palm and the dorsum.
Demonstrate 5 times, rate as FG TH
0 Normal
1 Minor mistakes, slow or clumsy, but no major disruption ofmovements
2 Major disruption
L 0 0.5 1 2 8 9 [ ] [ ]
R 0 0.5 1 2 8 9 [ ] [ ]
MIRROR2 MIRROR MOVEMENTS
The patient's resting hand, holding a fist, is observed for mirror movements
0 No observable movement
1 Minor pronation or supination movements
2 Consistent, distinctive pronation and supination movements of the forearm
L 0 0.5 1 2 8 9 [ ] [ ]
R 0 0.5 1 2 8 9 [ ] [ ]
FEP FIST-EDGE-PALM TEST
The patient is shown the task and then asked to perform the following: using a smooth
and steady rhythmic pattern, to touch the table with the side of his/her fist, the edge of
his/her hand, and the palm of his/her hand. The patient is to break contact with the surface
of the table between each change in hand position, but not to bring the arm back in full
flexion. The patient is to repeat this sequence of position changes 10 times.
"Watch me do this."
Demonstrate 5 times, without verbal instruction
"Now see if you could do it." (Repeat demonstration once if patient fails to perform)
0 Normal
1 Minor mistakes, slow or clumsy, but no major disruption ofmovements
2 Major disruption or repeated breakdown of sequence
L 0 0.5 1 2 8 9 [ ] [





Patient is to place both hands on the table, one hand palm down and the other hand in the
shape of a fist. The patient is then asked to simultaneously alternate the position of his/her
hands in a smooth and steady motion. The patient is asked to repeat this motion 15 times.
"Watch me do this."
Demonstrate 5 times.
"Now see if you could do it" (repeat demonstration once only if patient fails to perform)
0 Normal
1 Minor mistakes, slow or clumsy, but no major disruption ofmovements
2 Major disruption or repeated breakdown of sequence
0 0.5 1 2 8 9 [ ] [ ]
RHY TAP RHYTHM TAPPING TEST
Ask the patient to reproduce exactly the series of taps heard while the patient has eyes
closed.(5 trials using stimulus sequence suggested:)
"I am going to tap some sound on the table like this (demonstrate), Could you tap the
same rhythm back to me? Now close your eyes and listen."
STIMULUS SEQUENCE RESPONSE
1 A* kk **
2 k k k
3 k k k




2 Two or more errors
0 1 2 8 9 [ ] [ ]
GO-NOGO GO-NO GO TEST
Patient asked to tap the table once if the examiner taps the table once, but not to tap if the
examiner taps the table twice. Give adequate demonstration and practice to ensure
comprehension of task.
"If I tap once on the table like this (demonstrate), could you tap once. If I tap twice on the
table like this (demonstrate), please do not tap."
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2 Two or more errors
0 1 2 8 9 [ ] [ ]
EXTINCT EXTINCTION
The patient is seated, with hands resting palm down, on his/her knees and with eyes
closed. The patient is told that he/she will be touched on either the cheek, hand, or both,
and is to say where he/she has been touched. If the patient names just one touch, he/she is
asked (the first time this occurs only) if a touch is felt anywhere else. Simultaneous
touching is performed in the following order: right cheek-left hand, left cheek-right
hand, right cheek-right hand, left cheek-left hand, both hands, and both cheeks.
Intact sensation to touch is confirmed in each test area beforehand.
"I am going to touch your face and your hand like this (demonstrate). Could you tell me





























2 Two or more errors
0 1 2 8 9 [ ] [ ]
FG AGN FINGER AGNOSIA
With the patient facing the examiner, hands palm down on the table, fingers spread, eyes
closed, two fingers are simultaneously touched. The patient is asked to state the number
of fingers between the two touched. The answer may be 0, 1, 2 or 3. A total of 5 trials for
each hand is tested.
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"Could you put your hand on the table like this (demonstrate). I am going to touch two of
the fingers like this (demonstrate). I'd like you to tell me how many fingers there are in
between the ones that I am touching. For example, this will be...(demonstrate). Now close
your eyes."
Test sequence: 1 for thumb, 5 for last finger etc.
LEFT
HAND








2 Two or more errors
L 0 1 2 8 9 [ ] [
R 0 1 2 8 9 [ ] [
STEREO STEREOGNOSIS
Patient, with eyes closed, is asked to identify an object placed in his/her hand. Patient is
instructed to feel the object with one hand and to take as much time as needed. If the
patient cannot name the object, he/she is asked to describe for what purpose the object is
used. The patient starts with the dominant hand. 5 trials are conducted for each hand.
Suggested objects (paperclip, coin, rubber band, eraser, screw, small seashell, match, etc)
"Could you close your eyes and tell me what this object is, just by feeling it."
0 No error
1 One error
2 Two or more errors
]
]
L 0 1 2 8 9 [ ] [





The patient, with eyes closed, is asked to identify the number written on his/her palm
with a blunt point, the number being orientated the right way up facing the patient. Five
trials for each hand. Stimulus can be repeated once only upon request by the patient.
"I am going to trace a number on your palm, like this would be a (number).
(Demonstrate). Could you tell me what the number is, with your eyes closed?"
LEFT
HAND








2 Two or more errors
L 0 1 2 8 9 [ ] [ ]
R 0 1 2 8 9 [ ] [ ]
L/R ORN LEFT-RIGHT ORIENTATION
(Examiner should remove wrist watch before the test)
Patient is asked to point to his/her right foot, left hand; place his/her right hand to left
shoulder, left hand to right ear; point to examiner's left knee, then right elbow; with
examiner's arms crossed, point to examiner's left hand with his/her right hand, and
with examiner recrossing arms, point to examiner's right hand with his/her left
hand.








































1 L/R disorientation confined to perception of another person
2 L/R disorientation in selfbody space
0 0.5 1 2 8 9 [ ] [
END OF PART 2
Another break can be taken at this point.




These assessments are completed firstly with the patient seated, then standing up, and
finally walking. The examinations are most conveniently completed en block before
scores are entered. If the examiner is unfamiliar with the assessment, the examination
could be divided into three smaller subunits (see below), each to be carried out as a
block. It is important, however, that ratings for "global" items such as dyskinetic
movements are entered after the examiner has observed the patient perform in all three
blocks. The following sequence ofexamination is recommended:
Block A
1 Patient has been observed during the preceding parts of the assessment for global
items such as perseveration, echopraxia, mutisum etc.
2 Patient seated in chair with hands on knees and legs slightly apart, andfeet flat on the
floor, (observe involuntary movement in the entire body)
3 Patient asked to sit with hands hanging unsupported, if male between legs, iffemale
hanging over knees (observe involuntary movements in hands and body)
4 Patient asked to open mouth (observe involuntary tongue movement)
5 Patient asked to protrude tongue (involuntary movement observed)
6 Patient asked to tap thumb with each finger as rapidly as possible for about 15
seconds, first with the left and then the right hand, (observe facial and leg involuntary
movements)
Block B
7 Patient asked to stand up (posture observed)
8 Patient asked to hold extended arms horizontally in front of them and then have the
eyes closed, (observe pronator drift and Romberg's sign). Then the extended arms are
moved to the side and instruction is given, with demonstration to drop the arms to the
sides of the body (observe increased tone and imposedposture).
9 The examiner instructs the patient to let the arms go loose and then moves the patients
arms into various positions, at times releasing support and note whether the arms drop
freely (imposedposture and gegenhalten).
10 The examiner raises each of the patients outstretched arms in turn with one finger
after instructing the patient to resist this, (testfor mitgehen)
11 The examiner scratches his own head then pats his chest and legs afterfirst instructing
the patient to stand with his arms by his sides, (testfor echopraxia)
Block C
12 Patient asked to balance himselffor 15 seconds on each leg in turn.
13 Patient instructed to walk a few steps, stop and return (observe gait etc.)
14 Tandem walking (see item description)
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GAIT INGAIT (EXAGGERATED ASSOCIATED MOVEMENT)
0 Absent
1 Definitely present
2 Markedly or pervasively present
0 0.5 1 2 8 9 [ ] [ ]
GAIT DEGAIT (REDUCED ASSOCIATED MOVEMENT)
0 0.5 1 2 8 9 [ ] [ ]
GAIT SL SLOW/SHUFFLING GAIT
0 0.5 1 2 8 9 [ ] [ ]
GAIT MN MANNERISTIC/BIZARRE GAIT
Mere clumsy or lumbering gaits should not be rated, and gait should be idiosyncratic
rather than haunched, lordotic, shuffling etc. eg. constrained, mincing, over- precise; or
alternatively extravagant, over-elaborate, featuring interpolated movements such as
sidesteps and bowing. Also bizarre crablike, crouching or anthropoid gaits, and those
with multiple, not easily described abnormalities.
0 0.5 1 2 8 9 [ ] [ ]
FACE DYS DYSKINETIC FACE AND HEAD MOVEMENT
Simple brief/dyskinesia-like
Do not rate tongue movements unless they also involve the mouth or the jaw.
0 0.5 1 2 8 9 [ ] [ ]
FACE SUS SUSTAINED FACE AND HEAD MOVEMENT
Simple sustained/ grimace-like
Do not rate tongue movements unless they also involve the mouth or the jaw
e.g. spasmodic facial contortions; should not be completely fixed
0 0.5 1 2 8 9 [ ] [ ]
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FACE CX COMPLEX FACE AND HEAD MANNERISM/STEREOTYPY
Complex mannerism/stereotypy-like (usually of head; e.g. turning away, side-to-side
looks, searching movements)
0 0.5 1 2 8 9 [ ] [ ]
GEGENH GEGENHALTEN
Resistance to passive movement which increases with the force exerted. Typically has a
"springy" quality and appears automatic rather than willful. May be restricted to just one
muscle group. Resistance increases with increasing force.
0 0.5 1 2 8 9 [ ] [ ]
MITG MITGEHEN
"Anglepoise lamp" raising of arm in response to light pressure, in the presence of an
apparent grasp of the need to resist; should be demonstrable repeatedly. Severity of rating
depends on the rapidity and apparent wish to anticipate the movement. Do not rate if
understanding of instruction is poor.
0 0.5 1 2 8 9 [ ] [ ]




2 Very stooped with downward gaze or rigid and extended
0 0.5 1 2 8 9 [ ] [ ]
CX POSTR COMPLEX ABNORMAL POSTURE
Mere ungainliness or slouching should not be rated.
0 Normal
1 e.g. assuming obviously abnormal hunched, constrained "closed" or alternatively
exaggeratedly slack, over- relaxed positions when sitting; hugging sides, twisting
legs round each other, sitting with torso forward but legs to one side in extremely
uncomfortable way.
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2 Marked or pervasive posturing. E.g. while sitting repeatedly hunching forward and
rocking; while standing or walking striking a succession of poses.
0 0.5 1 2 8 9 [ ] [ ]
IM POSTR PERSISTENCE OF IMPOSED POSTURES
This is tested while testing tone of upper limb. If abnormality suspected, further testing of
positioning the patient's limbs and releasing them is carried out.
0 Normal
1 Not sustained: tendency to retain limb positions passively imposed during testing for
at least several seconds; this should be observed more than once.
2 Sustained "waxy flexibility"
0 0.5 1 2 8 9 [ ] [ ]
TK LB DYS DYSKINETIC TRUNK/LIMB MOVEMENT
Simple brief/dyskinesia-like (eg. stamping movements of legs, rocking trunk movements)
Specify: random/ irregularly repetitive/ rhythmical/ tic- like; including rocking
0 0.5 1 2 8 9 [ ] [ ]
TK LB SUS DYSTONIC TRUNK/LIMB MOVEMENT
E.g. dystonic posturing of extremities, hyperpronation on arm raising, torsion movements
0 0.5 1 2 8 9 [ ] [ ]
TK LB CX TRUNK/LIMB MANNERISM/STEREOTYPY
More stereotypy-like: eg. rubbing the thumb over the forefinger, other kinds of finger
play, touching, rubbing, stroking and patting various parts of the body especially the face.
Also repeatedly turning the head away from the examiner, looking round distractedly
throughout the interview, twisting one arm up behind the back whilst walking, repeatedly
rising from chair and approaching examiner. More mannerism like: eg. holding arms in
an unnatural crooked way, holding an arm out in a meaningless gesture, keeping one arm
tucked under armpit.
0 0.5 1 2 8 9 [ ] [ ]
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PRO PRONATOR DRIFT
Patient asked to hold two arms straight in front of him/her horizontally and close the eye.
Downward drift of one or both of the arms is observed.
"Could you hold your arms out in front of you, like this (demonstrate). Now close your
eyes and keep the arms in the same place."
0 0.5 1 2 8 9 [ ] [ ]
ARM ARM DROPPING
The patient and the examiner both raise their arms to shoulder height and let them fall to
their sides. In a normal subject a stout slap is heard and there is a slight, natural rebound
as the arms hit the sides. If the sign is positive the arms falls very slowly:
"Now relax and let the arms drop to the sides like this (demonstrate)."
0 Normal, free fall with loud slap and rebound
1 Fall slowed with less audible contact and little rebound
2 Arms fall as though against resistance; as though through glue
0 0.5 1 2 8 9 [ ] [ ]
TREMOR TREMOR
0 0.5 1 2 8 9 [ ] [
ROMBERG ROMBERG'S SIGN
Standing with eyes closed and feet together
0 Normally still or slight weaving
1 Widened base to stay in place
2 Unable to stand still with eyes closed
0 0.5 1 2 8 9 [ ] [
BALANCE BALANCE ON ONE LEG
Stand on one leg with eyes open for 10 seconds
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0 No difficulty
1 With great difficulty
2 Unable to perform
Rate irrespective of side
0 0.5 1 2 8 9 [ ] [ ]
WALK WALKING
Walking down the hall at least 5 paces
0 0.5 1 2 8 9 [ ] [ ]
STOP STOPPING ON COMMAND
0 0.5 1 2 8 9 [ ] [ ]
TURN PIVOT WHILE TURNING
0 0.5 1 2 8 9 [ ] [ ]
TANDEM TANDEM WALKING
Heel to toe for 10 paces
0 0.5 1 2 8 9 [ ] [ ]
ABURPT SM ABRUPT/RAPID SPONTANOEUS MOVEMENT
e.g. sudden gestures, acts carried out smartly, springs to attention when asked to stand
0 0.5 1 2 8 9 [ ] [ ]
SLOW SM SLOW/FEEBLE SPONTANEOUS MOVEMENT
Weak, languid, laboured movements
0 0.5 1 2 8 9 [ ] [ ]
EXAGG SM EXAGGERATED MOVEMENTS
Accompanied by flourishes/flurries of adventitious movements
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0 0.5 1 2 8 9 [ ] [ ]
ITER SM ITERATIONS OF SPONTANEOUS MOVEMENTS
Gestures or mannerisms repeated over short space of time: eg. touching face then
repeating this several times; manneristically smoothing hair, then repeating this with
increasing force until striking head; touching ring finger on one hand (while alluding to
ring being stolen), then doing the same on the other hand, then repeated the whole
sequence.
0 0.5 1 2 8 9 [ ] [ ]
OTHER SM OTHER ABNORMAL MOVEMENTS
Specify: echopraxia/ blocking/ ambitendence; do not rate any other abnormalities than
these
Blocking/ambitendence: In practice not easy to distinguish from one another. Eg. freezing
in the act of sitting forward and remaining motionless grasping the arms of the chair for
nearly a minute; extending arm when examiner's is proffered, the halting in mid-action
and moving arm to one side; while walking, stopping, half-turning back, then continuing.
0 0.5 1 2 8 9 [ ] [ ]
MUTISM MUTISM
(l=less than 10 isolated words in whole interview, 2=no speech)
0 0.5 1 2 8 9 [ ] [ ]
NECKRIG NECK RIGIDITY
0 0.5 1 2 8 9 [ ] [ ]
OVERACT OVERACTIVITY
(Do not rate simple restlessness/ akasthisia; do not rate unless substantial)
Typically bizarre rather than resembling simple restlessness; akathisia should be excluded
where suspected.
0 Absent
1 Continual motor unrest: eg crossing and uncrossing legs, looking round, half rising
from the chair; executing unending series of manneristic actions, touching body, then
clasping hands, then gripping the chair arm, etc.
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2 Approaching catatonic excitement: in more or less constant motion, incessantly
performing pointless actions which are reiterated, elaborated and transformed into
one another: eg. touching cardigan, then moving hands up and down the edges,
then unbuttoning it and buttoning it up again, followed by breaking off interview to
clamber over the tables and chairs on the ward. Also full blown excitement: eg. patient
who moved round and round the ward striking an endless series of quasi-symbolic poses.
0 0.5 1 2 8 9 [ ] [ ]
UNDERACT UNDERACTIVITY
(Do not rate it patient is clearly sedated/parkinsonian; do not rate unless substantial)
Some degree of abnormality is commonly observed and should not be rated unless very
noticeable.
0 Absent
1 Sits abnormally still throughout the interview with hardly any postural shifts; slumped
in chair; very passive.
2 Marked hypokinesia, generally with striking absence of postural adjustments: eg
sitting perched on chair in same position throughout interview not turning head
when addressed from different direction; always sitting in same place on ward with
arms in praying position. Also full blown stupor if encountered.
0 0.5 1 2 8 9 [ ] [ ]
AUTO QBE AUTOMATIC OBEDIENCE
May take the form of exaggerated co-operation with instructed movements: eg when
asked to lift a finger, whole arm raised; when arm reached for, whole body leant forward
and turned towards examiner; holding out both hands when examiner's offered for
shaking. Alternatively, spontaneous continuation of actions: eg flapping arms when asked
to drop them to sides, actively continuing passive arm movements during examination for
tone. Occassionally, complying with all requests to an extraordinary degree: eg patient
who screwed up eyes when asked to close them; peered intently in caricatured way when
asked to look out of window; when asked to keep head up while walking, proceeded
across the room with neck hyperextended.
0 0.5 1 2 8 9 [ ] [ ]
NONCOMPL POOR/FEEBLE COMPLIANCE
Inability to perform requested actions not explicable in terms of poor understanding,
general un-cooperativeness, blocking/ambitendence, or parkinsonism; often has a bizarre
quality. Eg when raising arm, movement gradually dies away; carries out most
instructions promptly but fails to comply with some; cannot seem to maintain arms
outstretched; when asked to hold out arms only seems able to do so in half- hearted,
crooked way; when asked to raise a finger, after some delay lifts thumb.
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0 0.5 1 2 8 9 [ ] [ ]
AB BEH OTHER ABNORMAL BEHAVIOUR
Specify: negativism/ hypermetamorphosis
Do not rate any other abnormality than these
Negativism: Should always reflect concrete instances rather than indefinite attitude. Eg.
pulling arm violently away whenever the examiner reaches for it, holding breath when
asked to breathe deeply, shutting eyes tightly when approached with an ophthalmoscope,
jumping up when asked to lie down. Also, taking off socks when told to put shoes on;
getting up from customary reclining position and walking away whenever approached by
examiner. Occasionally, domination of entire behaviour by bizarre contrariness: eg
normally quiet patient who met attempts to examine him with immediate struggling and
vilification; leant backwards when pulled forwards; refused to stand up, then refused to
sit down again.
Hypermetamorphosis: Typically only seen in setting ofmarked overactivity. Eg. attention
repeatedly drawn by specks, bits of fluff, etc. on the floor which are reached for and
scrutinized; randomly approaching various objects including wastebasket, rummaging in
it, extracting apple core and eating it.
0 Absent
1 Definitely present
2 Markedly or pervasively present
0 0.5 1 2 8 9 [ ] [ ]
ECHO ECHOPHENOMENA
Tendency to repeat the examiner's speech or mimic the examiner's action
Echopraxia: incomplete copying movements should not be rated, and exercise judgement
as to whether patient is just trying to be helpful. As well as being merely copied,
movements may be modified or amplified: eg. smoothing of hair substituted for
examiner's scratching of head, echopraxic chest patting progressively exaggerated until
patient pulling at his shirt.
Global rating for echo-phenomena
0 0.5 1 2 8 9 [ ] [ ]
PERSERV PERSEVERATION
Tendency to persist in a particular response after it ceased to be appropriate
Global rating for perseveration
0 0.5 1 2 8 9 [ ] [ ]
END OFEXAMINATION
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Appendix 3 Individual SNS item scores
Appendix 3a: Study 1 SNS prevalence
Normal Patients Chi- Signifance
Signs n=94 % n=!95 % Square level
Motor coordination
Finger-thumb tapping L l 1.06 18 9.23 10.87 0.001
Finger-thumb tapping R 1 1.06 21 10.77 13.21 <0.0001
Finger-thumb Opposition L 10 10.64 41 21.03 4.71 0.033
Finger-thumb Opposition R 9 9.57 40 20.51 5.39 0.02
Dysdiadocokinesia L 6 6.38 26 13.33 3.21 ns
Dysdiadocokinesia R 3 3.19 21 10.77 9.07 0.002
Fist-edge-palm L 29 30.85 70 35.90 0.72 ns
Fist-edge-palm R 15 15.96 71 36.41 12.69 <0.0001
Ozereski sign 1_6 17.02 53 27.18 3.69 ns
Sensory Integration
Extinction 0 0.00 7 3.59 6.05 0.048
Finger agnosia L 27 28.72 64 32.82 0.98 ns
Finger agnosia R 24 25.53 69 35.38 3.65 0.015
Stereognosis L 0 0.00 18 9.23 9.40 0.009
Stereognosis R 0 0.00 21 10.77 10.47 0.005
Graphaethesia L 0 0.00 53 27.18 10.86 0.004
Graphaethesia R 4 4.26 41 21.03 13.86 0.001
L-R disorientation 5 5.32 46 23.59 14.57 <0.0001
Disinhibition
Saccade blink 12 12.77 65 33.33 13.90 <0.0001
Saccadehead 14 14.89 51 26.15 4.71 0.035
Wink 30 31.91 50 25.64 1.25 ns
Mirror movement 1 L 9 9.57 13 6.67 0.76 ns
Mirror movement 1 R 5 5.32 6 3.08 0.87 ns
Mirror movement 2 L 1 1.06 7 3.59 2.85 ns
Mirror movement 2 R 3 3.19 12 6.15 3.01 ns
no-nogo test 3 3.19 37 18.97 16.44 <0,0001
Chi-square statistics computed with all rating categories, ns: p > 0.05.
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Appendix 3b: Study 2 SNS prevalence
Normal Patients Chi- Signifance
Signs oOOIIa % n=52 % Square Level
Motor coordination
Finger-thumb tapping L 0 0.00 7 13.46 11.37 0.001
Finger-thumb tapping R 0 0.00 9 17.31 14.86 <0.0001
Finger-thumb Opposition L 5 6.25 31 59.62 45.25 <0.0001
Finger-thumb Opposition R 7 8.75 30 57.69 37.42 <0.0001
Dysdiadocokinesia L 5 6.25 19 36.54 19.44 <0.0001
Dysdiadocokinesia R 2 2.50 17 32.69 23.32 0.0001
Fist-edge-palm L 12 15.00 31 59.62 30.71 <0.0001
Fist-edge-palm R 7 8.75 31 59.62 42.18 <0.0001
Ozereski sign 8 10.00 33 63.46 47.56 <0.0001
Sensory Integration
Extinction 1 1.25 14 26.92 21.57 <0.0001
Finger agnosia L 26 32.5 29 55.77 11.08 0.001
Finger agnosia R 23 28.75 28 53.85 12.51 0.001
Stereognosis L 6 7.5 18 34.62 17.56 <0.0001
Stereognosis R 8 10 14 26.92 8.31 0.016
Graphaethesia L 15 18.75 28 53.85 19.29 <0.0001
Graphaethesia R 11 13.75 25 48.08 20.19 <0.0001
L-R disorientation 14 17.5 20 38.46 7.24 0.009
Disinhibition
Saccade blink 5 6.25 22 42.31 27.34 <0.0001
Saccade head 2 2.50 11 21.15 14.17 0.001
Wink 5 6.25 22 42.31 25.90 <0.0001
Mirror movement 1 L 7 8.75 2 3.85 1.19 Ns
Mirror movement 1 R 8 10.00 1 1.92 3.24 Ns
Mirror movement 2 L 2 2.50 4 7.69 1.96 Ns
Mirror movement 2 R 9 11.25 7 13.46 0.15 Ns
no-nogo test 1 1.25 3 5.77 2.64 Ns
Chi-square statistics computed with all rating categories, ns: p > 0.05.
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Appendix 3c: Study 3 SNS prevalence
Baseline 3 Year Chi- p-value
Signs n=38 % n=38 % Square
Motor coordination
Finger-thumb tapping L 7 18.42 10 26.32 0.68 ns
Finger-thumb tapping R 7 18.42 13 34.21 2.44 ns
Finger-thumb Opposition L 9 23.68 10 26.32 0.07 ns
Finger-thumb Opposition R 10 26.32 10 26.32 0.00 ns
Dysdiadocokinesia L 7 18.42 8 21.05 0.08 ns
Dysdiadocokinesia R 5 13.16 5 13.16 0.00 ns
Fist-edge-palm L 18 47.37 19 50.00 0.22 ns
Fist-edge-palm R 16 42.11 19 50.00 0.85 ns
Ozereski sign 14 36.84 19 50.00 1.34 ns
Sensory Integration
Extinction 5 13.16 2 5.26 1.76 ns
Finger agnosia L 0 0.00 12 31.58 18.33 0.001
Finger agnosia R 9 23.68 11 28.95 1.21 ns
Stereognosis L 9 23.68 7 18.42 0.59 ns
Stereognosis R 6 15.79 5 13.16 0.11 ns
Graphaethesia L 6 15.79 14 36.84 5.15 0.034
Graphaethesia R 9 23.68 19 50.00 5.15 0.015
L-R disorientation 4 10.53 6 15.79 0.35 ns
Disinhibition
Saccade blink 10 26.32 18 47.37 4.07 ns
Saccade head 11 28.95 23 60.53 8.56 0.005
Wink 13 34.21 21 55.26 3.41 ns
Mirror movement 1 L 1 2.63 4 10.53 1.93 ns
Mirror movement 1 R 0 0.00 3 7.89 3.12 ns
Mirror movement 2 L 1 2.63 3 7.89 1.06 ns
Mirror movement 2 R 2 5.26 5 13.16 1.42 ns
no-nogo test 5 13.16 9 23.68 0.51 ns
Chi-square statistics computed with all rating categories, ns: p > 0.05.
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Appendix 3d: Study 4 SNS prevalence
Initial presentation
Number %
Snout reflex 0.00 0.00
Grasp reflex 1.00 1.47
Palmomental reflex 0.00 0.00
Finger-nose L 10.00 14.71
Finger-nose R 12.00 17.65
Finger-thumb tapping L 5.00 7.35
Finger-thumb tapping R 7.00 10.29
Finger-thumb Opposition L 14.00 20.59
Finger-thumb Opposition R 13.00 19.12
Mirror movement 1 L 3.00 4.41
Mirror movement 1 R 8.00 11.76
Dysdiadocokinesia L 5.00 7.35
Dysdiadocokinesia R 2.00 2.94
Mirror movement 2 L 2.00 2.94
Mirror movement 2 R 5.00 7.35
Fist-edge-palm L 25.00 36.76
Fist-edge-palm R 24.00 35.29
Ozereski sign 23.00 33.82
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3d.2 Comparison of SNS prevalence between first episode psychosis
patients and matched controls
First episode psychsis Matched controls
N=68 N=68
Number % Number % Chi-sq p-value
Snout reflex 0.00 0.00 0.00 0.00
Grasp reflex 1.00 1.47 0.00 0.00 1.01 ns
Palmomental relfex 0.00 0.00 0.00 0.00
Finger-nose L 10.00 14.71 0.00 0.00 10.79 0.001
Finger-nose R 12.00 17.65 0.00 0.00 13.16 <0.0001
Finger-thumb tapping L 5.00 7.35 1.00 1.47 2.79 ns
Finger-thumb tapping R 7.00 10.29 1.00 1.47 4.78 0.029
Finger-thumb Opposition L 14.00 20.59 6.00 8.82 3.75 ns
Finger-thumb Opposition R 13.00 19.12 7.00 10.29 2.11 ns
Mirror movement 1 L 3.00 4.41 8.00 11.76 2.47 ns
Mirror movement 1 R 8.00 11.76 4.00 5.88 1.46 ns
Dysdiadocokinesia L 5.00 7.35 4.00 5.88 0.12 ns
Dysdiadocokinesia R 2.00 2.94 3.00 4.41 0.21 ns
Mirror movement 2 L 2.00 2.94 1.00 1.47 0.34 ns
Mirror movement 2 R 5.00 7.35 1.00 1.47 2.79 ns
Fist-edge-palm L 25.00 36.76 16.00 23.53 2.83 ns
Fist-edge-palm R 24.00 35.29 9.00 13.24 9.00 0.003
Ozereski sign 23.00 33.82 11.00 16.18 5.65 0.017
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n % n % n % Chi-sq p-value
Snout reflex 0.00 0.00 0.00 0.00 0.00 0.00
Grasp reflex 1.00 2.94 0.00 0.00 0.00 0.00 3.02 ns
Palmomental relfex 0.00 0.00 0.00 0.00 0.00 0.00
Finger-nose L 4.00 11.76 6.00 17.65 0.00 0.00 11.66 0.003
Finger-nose R 7.00 20.59 5.00 14.71 0.00 0.00 13.89 0.001
Finger-thumb tapping L 3.00 8.82 2.00 5.88 1.00 1.47 3.10 ns
Finger-thumb tapping R 3.00 8.82 4.00 11.76 1.00 1.47 5.05 ns
Finger-thumb Opposition L 6.00 17.65 8.00 23.53 6.00 8.82 4.22 ns
Finger-thumb Opposition R 7.00 20.59 6.00 17.65 7.00 10.29 2.23 ns
Mirror movement 1 L 1.00 2.94 2.00 5.88 8.00 11.76 2.67 ns
Mirror movement 1 R 3.00 8.82 5.00 14.71 4.00 5.88 2.19 ns
Dysdiadocokinesia L 4.00 11.76 1.00 2.94 4.00 5.88 2.26 ns
Dysdiadocokinesia R 1.00 2.94 1.00 2.94 3.00 4.41 0.21 ns
Mirror movement 2 L 0.00 0.00 2.00 5.88 1.00 1.47 3.07 ns
Mirror movement 2 R 3.00 8.82 2.00 5.88 1.00 1.47 3.14 ns
Fist-edge-palm L 11.00 32.35 14.00 41.18 16.00 23.53 3.46 ns
Fist-edge-palm R 11.00 32.35 13.00 38.24 9.00 13.24 9.32 0.009
Ozereski sign 11.00 32.35 12.00 35.29 11.00 16.18 5.73 ns
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Appendix 4 item inclusion in key SNS studies
Core SNS items
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finger-thumb tap L +
finger-thumb tap R +
finger-thumb opp L +
finger-thumb opp R i
Mirror 1 L +
Mirror 1 R +
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Legend to Appendix 4
B: Joseph M. Rochford, Thomas Detre et al. Neuropsychological Impairments in Functional Psychiatric Diseases. Arch
Gen Psychiatry vol.22 1970 pi 14-pl 19
C: Frederic Quitkin, Arthur Rifkin et al. Neurologic Soft Signs in Schizophrenia and Character Disorders. Arch Gen
Psychiatry vol.33 1976 p845-p853
CI: tongue twister check pronouncation, C2 face hand, C3 adventuous overflow, C4 left right confusion
E: Stephen M. Cox, Arnold M. Ludwig. Neurological Soft Signs and Psychopatholgy I. Can J Psychiatry Vol 24 1979 668-
673
F: Joseph Marcus, Sydney L. Hans et al . Neurological Findings in High-Risk Children: Childhood Assessment and 5-Year
Followup Schizophrenia Bulletin vol.11 1985 p83-pl00
F1 eye movement in different direction, F2 fixation on an object in different direction,F3 pursing an object in different
directions, F4 simultaneous stimualtion of face and hands,
G: J Schroder, Ch. Reitz. M. Binkert, H.Sauer. Translated by D. Barber. Neurological Soft signs-Heidelberg manual
G1 face hand test, G2 arm holding test,
H: Robert W. Buchanan and Douglas W. Heinrichs. The Neurological Evaluation Scale (NES): A Structured Instrument for
the Assessment ofNeurological Signs in Schizophrenia. Psychiatry Research 1989 vol. 27 p335-p350
HI synkinesis, H2 convergence
I: L A Flashman, M Flaum, et al. Soft signs and neuropsychological performance in schizophrenia. Am J Psychiatry, 153
(4), April 1996
J: M J Cuesta, et al. Neurological frontal signs and neuropsychological deficits in schizophrenic patients. Schizophrenia
Research, 20, 15-20
J1 pinao test
K: Celso Arango, et al . Prediction ofNeuropsychological performance by neurological signs in Schizophrenia. Am J
Psychiatry 1999 vol.l56(9) pl349-1357
K1: Sequencing of Complex Motor Acts K2: motor coordination K3: sensory integration K4: others
L: Marie-Odile Krebs, Anne Gut-Fayand, Marie-Chantal Bourdel et al. Validation and factorial structure of a standardized
neurological examination assessing neurological soft signs in schiaophrenia. Schizophrenia Research vol 45 2000 p245-
p260
LI gait arm swinging, L2 lateral preference,
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